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Abstract 
Miss Jemma Victoria Walker 
MOLECULAR CONTROL OF TOOTH MESENCHYMAL STEM CELL 
ACTIVATION 
 
Background 
The continuously growing mouse incisor provides a robust model for studying 
molecular mechanisms of stem cell (SC) fate determination. While the epithelial 
SCs are well studied within this model, the identification and characterisation of 
a mesenchymal SC (MSC) population has yet to be defined.  
 
Aims 
This study aims to identify the molecular signatures of a novel MSC pool within 
the lower murine incisor. This work aims to investigate the molecular mechanisms 
governing the maintenance and transition of MSC cells and their progeny, 
particularly the role of Notch signalling in this process. 
 
Methods 
Isolation of proposed putative MSC containing and known mesenchymal transit 
amplifying cell (MTAC) containing regions were undertaken. Laser capture 
microdissection and subsequent comparative analysis of MSC marker 
expression between populations was performed. Investigation of the molecular 
x 
 
mechanisms governing MSC activation and maintenance was undertaken. 
Specifically, the role of Notch signalling was investigated, through analysis of 
Notch pathway transgenic mouse models including tissue specific RBP-Jκ knock 
out, Dlk1 null, and tissue specific Dlk1 overexpressing strains. In vitro models 
were developed to validate findings. 
 
Results 
MTAC and MSC containing regions exhibited distinct expression signatures of 
quiescent MSC marker genes. Notch pathway ligands, receptors and 
downstream effectors were differentially expressed between these populations. 
Modulation of Notch signalling in vivo impacted the behaviour of incisor MSCs. 
Manipulation of Dlk1 in vitro identified it as a potent regulator of MTAC 
maintenance. 
 
Conclusions 
The novel endogenous MSC population exists within the mouse incisor 
mesenchyme. The MSCs give rise to cells of the MTAC region, which in turn 
express Notch ligand Dlk1. Dlk1 is pivotal in balancing the lineage differentiation 
and maintenance of the incisor MSCs. Thus, Notch signalling plays a key role in 
the molecular regulation of the activation of tooth mesenchymal stem cells. 
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1 Background 
1.1 Stem cells 
Stem cells (SCs) are undifferentiated cells which can both self-renew and give 
rise to progeny of specific fates (Bolontrade and García, 2016). When discussing 
SCs it is important to note that SCs can be categorised by the tissue from which 
they originate and also by their potential to differentiate.   
 
Within the embryo until the completion of the first few cellular divisions, cells are 
described as totipotent as they can give rise to all the extraembryonic material 
(Baker and Pera, 2018).  As the embryo develops these cells begin to commit to 
develop along specific lineages. Through this process of commitment, cells lose 
their potential to differentiate along other lineages (Figure 1). In mammals, at 
conception the newly formed zygote has potential to differentiate into any cell 
type which will make up the embryo and the extraembryonic tissue (Condic, 2014). 
Once the early embryo has formed the multicellular morula, the potential of the 
cells is moderately restricted. By blastocyst stage, the Inner Cell Mass (ICM) cells 
are multipotent as they can give rise to the multiple lineages within the embryo 
 
Figure 1. Differentiation potential decreases as cells differentiate 
Schematic of mammalian cell potency restriction through development. 
. 
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proper, however they can no longer give rise in vivo to the extra embryonic 
material. Within the foetal and adult tissues, cells are generally committed to give 
rise to only the cells of a specific tissue type. Generally, cells which can give rise 
to a specific subset of differentiated cell types are described as pluripotent. 
Further differentiation gives rise to lineage specific cells, which are only able to 
differentiate further into one mature cell type. Once the cells have reached their 
fate, many differentiate to a point whereby they can no longer enter the cell cycle 
and are described as terminally differentiated cells (TDCs) (Serrano, 2010, Hsu 
et al., 2014).   
The regulation of SCs is a vital process in both homeostasis and development 
(Simons and Clevers, 2011, Lane et al., 2014). Careful coordination of the cell 
cycle is necessary to balance the often opposing needs for growth and 
differentiation (Ruijtenberg and van den Heuvel, 2016). If this regulation is lost or 
disturbed, tissue loss and aberrant growth can result (Simons and Clevers, 2011). 
While aberrant growth can cause excessive tissue growth, it has also been 
observed that over proliferation of SCs can result in the depletion of SC pools, 
which can lead to tissue loss and ultimately failure (Singh and Hansen, 2017). 
Similar loss of tissue has also been observed when premature differentiation of 
SCs occurs due to dysregulation of SC maintenance, such as in aging (Choi and 
Artandi, 2009). 
The molecular mechanisms which underpin the maintenance and regulation of 
SCs have been widely investigated. The findings of this large body of work have 
shown a great deal of tissue and temporal specificity (Jung and Brack, 2014). 
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1.1.1 Embryonic stem cells 
It was long suspected that pluripotent SCs existed within the developing embryo, 
however it was not until 1981 that these cells were first successfully isolated and 
cultured in vitro (Evans and Kaufman, 1981). These pluripotent cells were defined 
as embryonic stem cells (ESCs) and characterised for their ability to proliferate 
continuously in culture, as well as their ability to differentiate when cued to do so. 
Traditionally ESCs are defined as cells from the ICM of a blastocyst stage embryo, 
which have the capacity to divide without differentiating spontaneously in culture 
(NIH, 2009). The technique used to isolate these ESCs involved the destruction 
of the blastocyst stage embryo. This technique was adapted and later used to 
isolate the first SCs from the ICM of a human embryo, as outlined in Figure 2 
(Thomson et al., 1998).  
 
 
Figure 2. The isolation and propagation of human embryonic stem cells traditionally requires 
the co-culture of cells with growth factor producing fibroblasts 
A Initially mesenchymal cells are cultured adherently as “feeder” cells. These cells are often Mouse 
Embryonic Fibroblasts (MEFs).  B A biopsy of the Inner Cell Mass of a blastocyst is then performed, 
extracting one or more of these cells. C The biopsied cells are then plated on top of the MEFs, which 
function to provide necessary molecular signals to encourage the embryonic cells to grow and 
maintain pluripotency. D The culture is then allowed to expand, thus increasing the number of 
embryonic cells. This schematic is adapted from (Gepstein, 2002). 
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Concerns over the ethical implications of destroying human embryos for the 
derivation of these cells, drove the development of embryo preserving techniques 
of cell isolation (Ilic and Ogilvie, 2017). Ultimately single blastomeres were able 
to be biopsied from cleavage stage embryos (which themselves were shown to 
be pluripotent cells) while the remaining embryo was still able to continue to 
develop (Chung et al., 2008, Klimanskaya et al., 2006). While this 
circumnavigated some of the ethical debate that had arisen, as these cells are 
not derived from the blastocyst stage embryo, there were new concerns that 
these cells may not fall under the guidelines and regulations that govern human 
embryonic stem cell (hESC) work. 
The potential uses of hESCs clinically and in research are wide ranging. Perhaps 
the most widely publicised potential application for hESCs is in SC transplantation, 
as a therapeutic intervention to encourage regeneration and repair (Keller and 
Snodgrass, 1999). In order to develop clinical grade hESCs, which could be used 
in this manner, there is a drive towards animal product free hESC propagation 
(Stephenson et al., 2012, Lukovic et al., 2014).  
SC therapy employs the ability of hESCs to differentiate to produce new tissues 
within a damaged or deficient host. Currently, studies are underway to investigate 
the therapeutic potential of SC therapy in the treatment of macular degeneration 
(Ouyang et al., 2016), diabetes (Lysy et al., 2016) and spinal cord injuries (Manley 
et al., 2017). In addition to exploiting the differentiation potential of hESCs to 
produce new tissues, researchers have been able to produce potentially viable 
natural killer cells which could go on to help fight cancer in vivo (Woll et al., 2005). 
Recent studies have gone on to suggest that even non-somatic cell types, such 
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as gametes could be made from hESCs as a therapeutic alternative for infertile 
couples (Bhartiya et al., 2017).  
Due to the proliferative properties and differentiation potential of hESCs, such 
cells are also valuable tools for academic researchers. Whether using them in the 
naïve SC state or through first differentiating them, hESCs provide insight into the 
mechanisms that govern embryogenesis, cell cycle regulation  and cell fate 
determination (De Jaime-Soguero et al., 2017, Dvash et al., 2006, Chen et al., 
2017b).  
One interesting application for hESC is the production of cell lines which contain 
disease-specific mutations. Human ESCs can be derived from embryos carrying 
these specific mutations, which is confirmed by preimplantation genetic diagnosis 
(Ilic and Ogilvie, 2017). By using such cell lines researchers are able to 
investigate the specific effects of these natural mutations on the cells’ behaviour, 
thus creating a better understanding of the disease and the molecular 
mechanisms which underpin it. 
The limitations of the applications of hESCs in research and in clinic, are both 
ethical and scientific (Lo and Parham, 2009). One of the major concerns about in 
vitro cell culture is that spontaneous mutations have been observed within the 
genome of the cells being cultured (Rebuzzini et al., 2016). While these mutations 
can be beneficial for the proliferation and survival of these cells (Amir et al., 2017), 
they pose a hazard to the reproducibility of research conducted using these cell 
lines.  
When considering the use of hESCs in SC therapies, their proliferative potential 
is both their strength and their weakness. The characteristics of hESCs are 
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similar in nature to those of cancer cells, their persistence in an undifferentiated 
state and long proliferative life span along with reduced levels of apoptosis, in 
particular (Werbowetski-Ogilvie et al., 2009). These features, among others, 
indicate a potential for hESCs to form teratomas if they are administered into a 
human as part of a therapeutic intervention (Herberts et al., 2011, Hentze et al., 
2009). Furthermore SCs have been shown to affect the growth of existing tumour 
cells (Prockop and Olson, 2007), suggesting that the administration of hESCs to 
patients with underlying tumours could cause further tumour cell proliferation. The 
innate properties of hESCs, coupled with the spontaneous acquisition of genetic 
alterations in culture make the use of hESCs in SC therapies a potential tumour 
formation risk. 
As with all cellular transplantation, SC therapy carries with it a risk of the graft 
rejection by the host. Current data suggests that while SCs can elicit an immune 
response (Nussbaum et al., 2007, Swijnenburg et al., 2007) hESCs more often 
have a low immunogenic potential (Li et al., 2004) and even immune regulatory 
activity (Mohib et al., 2010). However, while the administered cells begin as 
pluripotent hESCs they are able to differentiate within the host and may acquire 
greater immunogenic properties (Herberts et al., 2011).  
Once hESCs are used as a therapeutic treatment their specificity and efficacy are 
yet to be proven (Shroff and Barthakur, 2015). SCs have been shown to be able 
to migrate away from the location of administration (Imitola et al., 2004), raising 
concerns that both the therapeutic effects and negative side effects of SC 
therapies could act on unpredictable sites. 
Arguments against the use of hESCs for ethical reasons have been long debated 
and brought more publicly than the scientific limitations. Particularly with the 
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effectiveness of hESCs, as research and therapeutic tools, yet to be proven and 
the possibility of pluripotent cells being obtained by other means (Takahashi and 
Yamanaka, 2006). The primary concern of many scientists and lay persons alike, 
remains the destruction of the human embryo for the derivation of hESCs 
(Sherley, 2004). Techniques have improved that allow the biopsy of cells from an 
embryo without causing it to arrest, both for use in the production of hESCs and 
also for preimplantation genetic diagnosis (Chen et al., 2017a, Pickering et al., 
2003). However the manipulation of human embryos is a tightly regulated process, 
in the UK this falls under the 1990 Human Fertilisation and Embryology (HFE) 
Act (Lovell-Badge, 2008). As part of this act, it is stated that embryos cannot be 
kept in culture for more than 14 days, as after this time the developing nervous 
system begins to form and the embryo loses its ability to form into twins (Cavaliere, 
2017, Hyun et al., 2016). As hESCs are taken from the early blastocyst, this does 
not involve using embryos past this cut off and so the process is governed under 
many of the same regulations as other embryonic interventions and research. In 
order to be granted permission and funding to derive hESCs in the UK a licence 
must be granted by the HFE Authority (HFEA). Often the embryos used are 
created by in vitro fertilisation (IVF) and are surplus to the requirements of the 
patients receiving treatment, however embryos can be produced solely for the 
purpose of deriving hESCs (Lovell-Badge, 2008). In addition to HFEA licences 
permission from the National Research Ethics Service (NRES) is also necessary. 
Once derived, hESCs are no longer considered under the HFEA’s jurisdiction. 
The process of using IVF to make embryos specifically for hESC derivation is in 
itself another moral grey area due to the physical burden that oocyte recovery 
places on the donor. 
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Although hESCs have great potential in clinical and research fields, the many 
ethical and scientific limitations of these cells have made the rate of advancement 
in these areas slow. Consequently, alternative sources of pluripotent SC have 
been greatly investigated. 
 
1.1.2 Postnatal stem cells 
Within the developing embryo, SCs must proliferate and differentiate in order to 
pattern and grow into the appropriate tissues. Postnatally , while less patterning 
and development is observed, tissue homeostasis and response to injury require 
a great deal of cellular plasticity (Jessen et al., 2015) (Ge and Fuchs, 2018). In 
postnatal tissues, TDCs make up the majority of cells. TDCs are often damaged 
or lost due to injury, ageing and disease. The inability of most TDCs to re-enter 
the cell cycle (Myster and Duronio, 2000) limits the regenerative capability of 
postnatal tissues however multipotent cells persist within many regenerative 
postnatal tissues in order to maintain tissue homeostasis.  
Multipotent postnatal SCs were first identified within the bone marrow (Till and 
Mc, 1961) and have since been identified in other tissues including neural, 
epithelial & mesenchymal derived organs (reviewed in (Gonzalez-Perez, 2012, 
Bianco et al., 2008, Blanpain et al., 2007)). The field of postnatal SC research 
has grown rapidly over the last two decades, leading to the discovery of postnatal 
SCs in many different organs (Figure 3). It is believed that most identified 
postnatal SCs play important roles in regeneration and repair of the tissue and 
so are intriguing research targets which may potentially be important in the 
development of regenerative therapies (Barry and Murphy, 2004).  
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As with hESCs, postnatal SCs have been used in research and clinically. 
Postnatal SCs are often committed to a specific germ layer or tissue lineage, as 
such they can be very useful research tools for the investigation of tissue specific 
mechanisms and behaviours. In addition to their uses in molecular research, 
postnatal SCs have been used therapeutically. Since the first successful 
allogenic transplantation of SCs in the treatment of cancer (Thomas et al., 1971) 
interest in the therapeutic applications has increased, however the successful 
utilisation of such therapies have been limited (Watt and Driskell, 2010). 
Questions about the limited efficacy of existing therapies have led to vast debate 
about the ethical implications of providing these therapies (Poulos, 2018). In 
addition to the direct utilisation of SCs in therapeutic procedures, recent studies 
have begun investigating the possibility of using the exosomes and secreted 
factors. For example the exosomes of postnatal SCs have been collected and 
 
Figure 3. Adult stem cells have been identified and isolated from many human tissues 
Since their initial discovery within the bone marrow, adult SCs have since been identified within all 
of the tissues depicted here (non-exhaustive list) (Diaz-Flores et al., 2006, Gonzalez-Perez, 2012, 
Stange, 2013, Naveau et al., 2014, Hugnot and Franzen, 2011, Yu et al., 2015). 
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applied successfully to promote regeneration of the myocardium after ischemic 
heart attack (Safari et al., 2016).  
Despite these successes in the field, the isolation and propagation of postnatal 
SCs has proven to be a substantial research challenge. The relative low 
abundance of SCs within postnatal tissues makes isolation of SCs particularly 
difficult. Once isolated, postnatal SCs can often be difficult to culture two-
dimensionally (2D) due to the loss of the tissue architecture and supporting cells 
from the niche. In order to circumnavigate the issues of 2D culture, postnatal SCs 
are often grown more successfully in a three-dimensional (3D) organoid culture 
(Drost and Clevers, 2017). As with 2D cultures, postnatal SCs grown into 
organoids have been used in the study of disease progression, drug action and 
for therapeutic transplantation.  Organoid culture can be performed without the 
need for SC isolation from the original tissue (Sato et al., 2009) by using small 
pieces of material. Organoid expansion of postnatal SCs has been successfully 
employed in the modelling of drug actions in specific genetic disorders such as 
cystic fibrosis (Dekkers et al., 2013). These 3D cultures have also shown great 
promise in understanding host pathogen interactions (Leslie and Young, 2016). 
Within the field of infection and immunity alone, the clinical promise of 3D cultured 
postnatal SCs is wide ranging. Already, postnatal SC organoids have been used 
to culture immune cells which could ultimately be reintroduced therapeutically into 
patients (Nozaki et al., 2016). These early studies into the clinical applications of 
3D cultured tissues have shown promising results across many tissue types. It 
has been the retention of characteristics from the tissue of origin, by organoid 
cultured SCs has also been a key factor in the successful engrafting of organoids 
back into a donor following in vitro expansion (Yui et al., 2012). 
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1.1.3 Mesenchymal stem cells 
Mesenchymal tissue is derived from the embryonic mesoderm (and neural Crest 
in some tissues (Noden, 1988)) and develops into blood, connective tissues and 
skeletal tissues (Figure 4).  
 
Mesenchyme is characterised by its loosely organised stromal cell structure 
surrounded by abundant extracellular matrix. Within many mesenchyme derived 
tissues, mesenchymal stem cells (MSCs) have been discovered and isolated. 
The first such tissue identified as containing MSCs was the bone marrow (Caplan, 
1991). Haematopoietic stem cells (HSCs) had previously been identified in the 
 
Figure 4. The three germ layers and their derivatives  
Within the early developing embryo three predominant germ layers develop (in addition to the germ 
cell precursors). From these three germ layers all adult tissues are derived (Kiecker et al., 2016). 
The neural crest is a specialised group of cells found in certain vertebrates. Cells derived from the 
neural crest include those which make up many mesenchymal like tissues such as those of the 
craniofacial bone, cartilage, neural tissue and muscle (Hall, 2018). 
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bone marrow and found to give rise to the cells of the blood. For many years 
previously, experiments using bone marrow had shown a propensity for 
osteogenesis within the cells of the marrow (Tavassoli and Crosby, 1968). The 
stromal cells from within the bone marrow were later identified as being the 
causative cells and were also shown to be able to differentiate into bone, cartilage 
and adipose (Friedenstein et al., 1987) (Figure 5). The isolation of these stromal 
bone marrow cells (BMCs) lead to the resultant derived cells being termed as 
MSCs when referring to them ex vivo (Bianco et al., 2008).  
 
The term “mesenchymal stem cell” has caused much controversy (Bianco et al., 
2008). One of the most largely debated issues with the nomenclature is that not 
all mesenchymal like tissues are in fact derivatives of the early mesoderm, for 
 
Figure 5. Within the bone marrow, two well described stem cells pools have been identified 
Within the bone marrow, BMSCs are a form of MSCs which are capable of giving rise to the skeletal 
tissues including (but not limited to) adipocytes, chondrocytes and oligodendrocytes. The 
hematopoietic stem cells are also found within the bone marrow and are able to differentiate into the 
cell types which make up the blood, including the red and white blood cells.  
Figure adapted from (Yin and Li, 2006).  
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example the bones of the craniofacial region are of a neuroectodermal origin 
(Olsen et al., 2000).  
Since the discovery of bone marrow mesenchymal stem cells (BMSCs) , pools of 
mesenchyme derived SCs have been identified and characterised in many 
tissues including, bone, muscle and fat (Ba et al., 2012, Caplan, 1991, Gopinath 
et al., 2014, Beltrami et al., 2007, Jiang et al., 2002). Although these cells are 
committed to differentiate into tissue specific lineages in vivo, they have been 
shown to have the potential to differentiate along many mesenchymal lineages 
when given appropriate cues to do so experimentally.  
In order to identify isolated cells as true MSCs, their stemness, multipotency and 
self-renewal properties must be assessed (Bianco et al., 2008). Isolating and 
expanding MSCs has posed a technical issue to researchers. In part due to the 
fact that they often behave similarly to non-SCs within the same tissues, when 
cultured. For example, BMSCs have been shown to always be clonogenic, 
frustratingly many other non-stem cell cells within the bone marrow are also 
capable of forming colonies. However, when these cells are transplanted into a 
host, only the true BMSCs are multipotent (Gronthos et al., 2003). Following the 
discovery of MSCs, the signature of expression of cell surface antigens has been 
widely used as a method of distinguishing BMSCs from their haematopoietic 
neighbours (Simmons and Torok-Storb, 1991, Boxall and Jones, 2012, Ramos et 
al., 2016). Primarily the expression of CD44, CD73 and CD90 identified BMSCs 
from their CD45 expressing HSC counterparts within the marrow. In addition to 
these marker proteins being expressed within MSCs, they also play an important 
role in maintaining the pluripotent state of the cells and regulating differentiation 
(Moraes et al., 2016). 
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Within solid tissues, many of these antigens are harder to identify and so other 
marker profiles have been investigated to aid in the identification of MSCs within 
these tissues. An effort to consolidate the vast array of work done to identify MSC 
specific marker genes has been undertaken. It was found that across different 
MSC models, similar signalling pathways are at work, including those involved in 
coordination of the cell cycle, mitochondrial function and transcriptional regulation 
(Cheung and Rando, 2013). Interestingly many of the genes identified in this 
study were linked to cell cycle regulation, with those involved in promoting 
progression being downregulated in quiescent MSCs, while genes known to 
negatively regulate the cell cycle were upregulated. 
 
1.2 Stem cells and the cell cycle 
Postnatal SCs often exist in a state of quiescence, where the cells still have the 
potential to divide but are not in an active state of mitosis (Figure 6) (Oki et al., 
2014). It is believed that by maintaining mitotic quiescence, SCs are protected 
from deoxyribonucleic acid (DNA) damage that is likely to occur through the cell 
cycle process. Therefore, allowing the cells to persist within the tissue until they 
are required to activate to participate in growth and repair.  
The quiescent SCs differ from other non-dividing cells, such as TDCs, which do 
not readily re-enter the cell cycle (Serrano, 2010). Quiescent cells are slow 
cycling or resting in a G0 state, which then can be activated to exit mitosis, given 
the correct cues and favourable biological conditions (Larsson et al., 1985, 
Cheung and Rando, 2013).  
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Once quiescent SCs re-enter the cell cycle, the daughter cells can be quiescent 
themselves or may be mitotically active Transit Amplifying Cells (TACs) (Watt, 
2001, Clayton et al., 2007).  The process of SCs, TACs and TDCs becoming 
activated and fated is illustrated in Figure 7., which follows the mostly accepted 
SC concept (Bachor and Suburo, 2012, Alison et al., 2010). Quiescent MSCs 
have distinct signatures as they express specific cell cycle genes such as Cdkn1a, 
p21 & Ccnd3 and transcription regulators Zbtb20 & Thra (Cheung and Rando, 
2013). TACs self-renew to increase cell number within the tissue and also have 
the potential to give rise to lineage differentiated cells (Fuchs et al., 2004). Some 
TACs are multipotent and can give rise to a number of differentiated cell types, 
 
Figure 6. The cell cycle consists of phases of growth, synthesis, mitosis and rest 
Stages G1, S and G2 are defined as interphase. G1 represents the initial growth phase during which 
time the cell prepares for DNA synthesis. S represents the phase of DNA replication, G2 represents 
the second growth phase where the cell prepares for mitosis. M represents mitosis, this phase is 
made up of 4 mitotic phases, prophase, metaphase, anaphase and telophase. G0 represent the cells 
exit from the cell cycle and a subsequent rest period. During G0 a cell may be able to re-enter the 
cell cycle again at G1 phase if the biological conditions are favourable and the cell is capable. Not 
all cells pass through a G0 stage before continuing onto G1 following mitosis. 
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while others can only give rise to one cell type in addition to self-renewing (Slack, 
2000).  
Normally TACs are transiently present within a tissue, often they are lost after 
development has been completed (Zhang and Hsu, 2017) but can be replenished 
via the activation of SCs within certain tissues following wounding (Xin et al., 
2016). In tissues where constant replenishment of TDCs is required, such as in 
the skin and intestinal epithelium, TACs persist and reside as neighbours to the 
SCs within the niche (Clevers, 2013, Kretzschmar and Watt, 2014). 
 
In hESCs, cell division is required in order to produce sufficient cell numbers for 
development, this is achieved by having mitotically active SCs with a shortened 
G1 phase (Becker et al., 2006). However, in postnatal tissues cell division is 
required for homeostasis rather than tissue genesis. Consequently postnatal SCs 
are less mitotically active than their embryonic counterparts (Orford and Scadden, 
2008). Studies of the HSC system, have shown that up to 75% of these cells 
 
Figure 7. Stem cell differentiation occurs in stages, distinguishable by differences in the rate 
of mitosis 
SCs are defined by their ability to self-renew. When conditions are appropriate the SC is cued to 
begin the process of differentiation. Initially SCs often transition into a TAC type. TACs can also self-
renew, but are more mitotically active, thus increasing the pool of available cells within the tissue. 
Once again, when cued to do so, the TACs can further differentiate and become TDCs. TDCs 
generally make up the majority of the cells within the adult tissue. They are mitotically inactive as 
they have acquired characteristics which allow them to fulfil their function, but which also prohibit 
mitosis. 
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reside in a G0 or G1 state in vivo (Cheshier et al., 1999). Further work in this SC 
model has found that mice deficient of important cell cycle inhibitors such as p21, 
exhaust their HSC pools through over proliferation (Cheng et al., 2000, Hock et 
al., 2004).  
In addition to controlling SC number, the regulation of the cell cycle also provides 
a platform for fate determination to be regulated. During the early G1 phase, cells 
are particularly sensitive to the cues which determine commitment and survival 
decisions (Massague, 2004). The expression levels of genes which regulate cell 
cycle progression may therefore act both as markers of SC quiescence, and also 
as regulators of maintenance and differentiation in these cells. 
 
1.3 Commitment of stem cells 
While a SC is defined in part by its multipotent state and ability to self-renew, it is 
the cell’s capacity for differentiation which allows it to become a TDC in the 
postnatal or regenerated tissue. The process of a SC differentiating along a 
specific lineage is a tightly regulated and dynamic process (Zhang and Wang, 
2008). Initial cell fate determination is multifactorial, with influences from genetic, 
epigenetic and environmental factors all contributing to fate determination 
(Vincent and Van Seuningen, 2009, Wagers et al., 2002). Commitment of cells to 
a specific fate had long been believed to be an irreversible process, however it 
has since been shown that cells can be manipulated to return to a more potent 
state in vivo (Tata et al., 2013) and in vitro through the invention of induced 
pluripotent stem cells (iPSCs)(Takahashi and Yamanaka, 2006). 
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Some of the most famous work in the field of differentiation was published by 
Conrad Hal Waddington in the 1940’s. His theoretical frameworks outlined the 
concepts of genes and the environment organising the development of an embryo 
(Waddington, 1940). A major concept from this work, which has become a 
foundation stone to many theories on commitment, is that of a marble rolling down 
a hill (Figure 8) (Waddington, 1957). As the marble rolls down the hill, it is directed 
down valleys and ultimately will reach the bottom of the hill. The final resting point 
of the marble is resultant from the path which it travelled; a path determined by 
the environment that it encounters as it rolls. Likewise, a cell will follow a path of 
commitment based on the spatial and temporal cues which it receives from its 
environment. 
 
The signals which cue cells to begin the process of lineage commitment include 
chemical and physical signals. It has been shown that the stiffness of the 
substrate on which cells are grown can influence differentiation along specific 
skeletal tissue lineages (Engler et al., 2006). Further research in this field has 
also shown that the shape of the cell, the area of the cell in contact with the 
 
Figure 8. The process of stem cell fate determination is likened to a marble rolling through a 
landscape 
The analogy of an object rolling down a hill is commonly used to depict the concept of cell fating. As 
the marble rolls down it is funnelled along certain valleys, which restrict its ability to travel down 
another path (Waddington, 1940). This metaphor mirrors the way in which a SC is committed to a 
lineage based on the cues it has received from the local environment as it differentiates. 
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substrate and the components of the extracellular matrix, all influence the fate 
determination of cultured SCs (Trappmann et al., 2012, McBeath et al., 2004).  
The specific molecular mechanisms which underpin the process of SC fate 
determination are largely tissue specific, and so are not well defined as a broad 
universal mechanism. One common element to all SCs as they differentiate is 
that they must overcome their propensity to maintain self-renewal. In order to 
maintain an appropriate pool of SCs whilst also allowing differentiation for 
development and repair, a fine balance between maintaining cell cycle arrest and 
lineage commitment must be achieved (Zhang and Wang, 2008). 
 
1.4 Maintenance of self-renewal in stem cells 
Homeostasis of postnatal tissues requires regulated mechanisms of cell 
proliferation and differentiation in order to govern repair and regeneration 
(Simons and Clevers, 2011). This regulation is important to maintain tissue 
integrity and avoid aberrant growth or loss of cells. To ensure that SCs are not 
depleted with time it is vital that a pool of SCs remain within the tissue. This is 
achieved through either population asymmetry or by a process of singe cell 
asymmetric division (Watt and Hogan, 2000). In population asymmetry strategies, 
proliferation occurs and while some SCs produce two SC daughters others will 
produce two cells which will both differentiate, these two divisions occur at an 
equal ratio in order to maintain the SC pool. The method of asymmetric cell 
division is perhaps more commonly described, whereby a SC creates two 
daughters, one a SC itself and the other committed to differentiate (Figure 9). 
These two asymmetric SC proliferation strategies both work to maintain SC pools 
while still contributing to the cells available for repair and regeneration of the 
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tissue. The mechanisms which determine which of these strategies are employed 
are unclear. However, links to cell polarity, intrinsic cues and signals from the 
surrounding tissue have all been identified (Morrison and Kimble, 2006, 
Yamashita et al., 2010). 
 
In recent years the concept of microenvironmental influences on SC behaviour 
has come in vogue (Scadden, 2006). With regards to the maintenance of SCs, it 
has been proposed that when daughter cells are physically removed from the 
 
Figure 9. Stem cells employ asymmetric division strategies in order to maintain the stem cell 
pool while also producing more differentiated progeny 
Two different asymmetric division strategies have been shown to be employed by stem cells. The 
process which decides the fate of the daughters is often linked to the orientation of the SC mother 
and the cues received from the surrounding microenvironment. 
A Single cell asymmetric division (as shown in the top part of this figure) is a process whereby each 
individual SC divides to give rise to one TAC daughter and one SC daughter. 
B Population asymmetry (outlined in the lower portion of this figure) describes the process whereby 
the SC pool is maintained through some SCs producing only SC daughters, while other SCs produce 
all of the TACs (Watt and Hogan, 2000).  
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anatomical region of the niche, they may then lose their self-renewal properties 
(Simons and Clevers, 2011). This is due to the loss of contact with the 
surrounding cells which may provide contact activation/inhibition, regulating the 
cell’s behaviour. Much of this work has been undertaken through the study of 
gametogenesis, where the niche architecture is well defined and self-contained, 
however similar mechanisms have been observed in other tissues (Simons and 
Clevers, 2011). In the gonads, SCs leave the microenvironment as they divide 
and transform through a process of TAC divisions. A similar process has been 
observed in the skin and intestines (Diaz-Flores et al., 2006). The specific 
mechanisms regulating SC self-renewal in different postnatal tissues are largely 
tissue specific, however there are many common molecular signals which have 
been discovered which control self-renewal, the cell cycle and fate determination.  
 
1.5 Signalling pathways in mesenchymal stem cells 
SCs receive a range of cues and signals from their micro-environment and the 
other cells within the niche. These signals often coordinate in a complex feedback 
mechanism with the SCs themselves to drive SC maintenance or differentiation 
(Morrison and Spradling, 2008). In postnatal tissues, many developmentally 
active signalling pathways have been found to be reutilised in the regulation of 
postnatal SCs, such as the Sonic Hedgehog (Shh), Wingless (Wnt) and Notch 
pathways (Ahn and Joyner, 2005, Reya and Clevers, 2005, Perdigoto and Bardin, 
2013, Lim et al., 2013). The Notch pathway specifically has been known to be 
involved in a wide array of developmental and SC processes (Artavanis-
Tsakonas et al., 1999) from organ patterning to cell fate determination. Such 
signalling pathways often rely upon a crosstalk between the mesenchyme and 
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epithelial structures during development and repair (Blanpain et al., 2007). In 
addition to signalling between different embryonic lineages within the niche, intra-
lineage signalling, from TACs for example, also plays an important role in SC 
regulation (Hsu et al., 2014). Efficient signalling is required to maintain correct SC 
function and disruption can cause aberrant growth or faulty repair. 
Wnt signalling is a highly conserved pathway which is utilised throughout 
development in a range of processes, including cell fate determination and 
differentiation (Logan and Nusse, 2004). The Wnt proteins themselves are a large 
group of molecules which can act as secreted hydrophobic ligands, these ligands 
can often interact with the plasma membrane to maintain prolonged signalling 
within the SC niche (Nusse, 2008). Within MSCs, Wnt signalling has been shown 
to be a regulator of proliferation and differentiation in a number of MSC containing 
tissues, including adipose, bone, cartilage and muscle (Van Camp et al., 2014). 
As with many signalling pathways there is a great deal of cross talk. Wnt 
signalling has been linked to Shh signalling in the regulation of SC fate 
determination (Ouspenskaia et al., 2016). Shh itself is an evolutionarily 
conserved pathway which plays a vital role in embryonic development and 
patterning (Wu et al., 2010). Hedgehog proteins are powerful morphogens which 
can act both locally and distally to create patterning gradients. In hESCs, Shh 
signalling is particularly important in the regulation of lineage specific 
differentiation (Wu et al., 2010). In postnatal SCs the role of Shh is widely 
contested and appears to be strongly tissue specific. In dental SCs, Shh has been 
suggested as an important regulator of SC quiescence in both epithelial and 
mesenchymal SCs (Ishikawa et al., 2017, Zhao et al., 2014). However in the 
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postnatal pituitary, Shh induces SC proliferation within the gland (Pyczek et al., 
2016).  
A third highly conserved developmental signalling pathway, which has a strong 
regulatory role within SCs is the Notch pathway. Of course there are many other 
signalling pathways at play in SCs which act independently and in conjunction 
with these pathways (Bhaskar et al., 2014, Tanavde V.M., 2009). 
 
1.6 The Notch pathway 
The canonical Notch pathway is an important signalling pathway found in many, 
if not all, metazoans as homologues between vertebrates are highly conserved 
(Gazave et al., 2009). Notch signalling has a range of functions in development 
and regeneration including a key role in cell fate determination. Central to this 
pathway is the presentation of Notch receptors on the plasma membrane, these 
receptors can be activated canonically by ligands or independent of traditional 
ligand binding, through non-canonical activation (Kopan and Ilagan, 2009).  
Canonical Notch signalling was first described in the development of the 
Drosophila nervous system as a mechanism of lateral inhibition (Simpson, 1990). 
This method of activation of the Notch receptor involves binding of a 
complementary ligand (D'Souza et al., 2008). The first of these ligands were 
identified as being bound to adjacent cells and so Notch signalling was believed 
to be a juxtracrine pathway, however diffusible ligands have since been 
discovered (Kopan and Ilagan, 2009). The binding of ligand to receptor triggers 
a multi-step cleavage of the intracellular domain of the Notch receptor (NICD). 
The NICD then translocates to the nucleus, where it interacts with the RBP-
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Jκ/CSL complex, causing a reversal of transcriptional repression and so 
transcriptional activation occurs. This process is summarised in Figure 10.  
 
In mammals there are four known Notch receptors and an array of canonical 
ligands (Figure 11). The expression patterns of these receptors and ligands differ 
between tissues; as such the function of each receptor is largely context 
dependent. These canonical ligands can be divided into distinct groups based on 
their homology to the serrate and delta ligands of the drosophila and the 
conserved domains they possess (Kopan and Ilagan, 2009, D'Souza et al., 2010).  
The downstream effectors of canonnical Notch activation have important roles in 
regulation of proliferation, differentiation and cell fating. Hes1, for example 
controls proliferation through the repression of cell cycle inhibitor Cdkn1b (Murata 
 
Figure 10. The canonical Notch receptor activation pathway involves the use of proteolytic 
enzymes and intranuclear mediators 
Upon activation by a ligand the Notch receptor undergoes a second cleavage (S2) (after S1 which 
occurs during synthesis). A further 2 cleavage steps (S3 & S4) release the NICD into the cytoplasm. 
From the cytoplasm NICD translocates to the nucleus. In the nucleus RBP-Jκ (aka. CSL in humans) 
is ordinarily part of a complex with co-repressors (Co-R). Once the NICD interacts with the Rbp-Jκ 
complex a conformational change occurs and with the co-activators (Co-A) transcription is activated. 
Adapted from (Kopan and Ilagan, 2009, Yu et al., 2015).  
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et al., 2005). While Notch effectors Hey1 and Hey2 have been linked to cell fate 
determination in arterial development (Fischer et al., 2004).  
 
Non-canonical Notch signalling was identified when differentiation of myoblasts 
was inhibited by Notch, even when the NICD was unable to interact with the RBP-
Jκ complex (Shawber et al., 1996). Further work went to on to show that 
modulation of Notch receptors could cause an effect even in the absence of RBP-
Jκ (Rusconi and Corbin, 1998). These findings, which predominantly focussed on 
progenitor and SC populations (Andersen et al., 2012), highlighted the potential 
for Notch receptors to have a function independent of canonical Notch signalling. 
The mechanisms of non-canonical Notch signalling have yet to be fully explained, 
 
Figure 11. Mammalian Notch receptors and ligands show high levels of inter and intra species 
conservation 
The Notch receptor family of proteins are identified as containing multiple extracellular EGF-like 
repeats. The number of repeats differ between the four mammalian Notch paralogues, some of which 
are known to regulate ligand binding. Within the extracellular domain of the receptor there is also a 
cysteine rich negative regulatory domain. The transmembrane and intracellular domains (NICD) of 
the different mammalian Notch receptors are more highly conserved in their gross structure, each 
containing an RBP-Jκ association domain and nuclear localisation sequences, which are important 
for canonical Notch function after ligand binding and NICD cleavage. 
Notch ligands are grouped based on the domains which they contain. Classical ligands contain both 
a Delta/Serrate/Lag_2 (DSL) and a Delta & OSM-11 like (DOS) domain. Other classes of ligands 
contain only one of these two motif types. The DSL ligands have been shown to be able to function 
alone or in conjunction with the DOS ligands. Adapted from (Kopan and Ilagan, 2009)  
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however one interesting action which has been identified is the antagonistic effect 
of ligand independent Notch signalling on the Wnt pathway (Andersen et al., 
2012). Work into the interplay between Wnt and Notch signalling has revealed a 
Notch-ligand independent role of the Wnt-Notch axis in the regulation of SC 
lineage progression (Chavali et al., 2018), while canonical Notch signalling has 
been shown to crosstalk with Wnt to promote expansion of SCs (Hayward et al., 
2008). 
 
1.6.1 Notch function in stem cells 
There is a great deal of debate over the specific role of Notch in different SC 
groups, however it is often the case that Notch signalling (whether canonical or 
ligand independent) is an important regulator of SC maintenance and 
differentiation (Liu et al., 2010a). 
In BMSCs, data suggests that Notch activity has a role in promoting differentiation 
along an osteogenic lineage through inhibiting cells from residing in a G0 state 
(Tian et al., 2017, Cao et al., 2017). A similar differentiation promoting action of 
Notch has been observed in SCs of the hair follicle and inter-follicular epidermis 
(Williams et al., 2011, Estrach et al., 2008). However in muscle SCs, genetic 
ablation of RBP-Jκ causes premature differentiation of the cells, suggesting a role 
in SC maintenance for canonical Notch signalling (Mourikis et al., 2012, Luo et 
al., 2005). Likewise, in neural SCs the Notch pathway is a key regulator of the 
maintenance of quiescence and also in fate determination (Chapouton et al., 
2010). Furthermore, once SCs have begun to differentiate into TACs, Notch is 
still an important player in the cell fate progression of these cells (Artavanis-
Tsakonas et al., 1999). Part of the reason for these discrepancies may lie in the 
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method of Notch signalling activation utilised in these different cell types. Due to 
the RBP-Jκ knock out phenotype observed, it appears that it is canonical Notch 
signalling which is maintaining the SC pool in such neural tissues (Chapouton et 
al., 2010). The role of the non-canonical Notch pathway is yet to be elucidated, 
however work on adipose derived MSCs may elude to a role for this type of 
signalling in these cells. 
In adipose MSCs the SC pool is maintained by Notch dependent regulation of 
cell cycle progression (Perdigoto and Bardin, 2013, Moriyama et al., 2014, 
Osathanon et al., 2012). Through the inhibition of differentiation the SCs are kept 
from beginning their lineage differentiation towards adipogenesis. A key regulator 
of adipogenesis is Delta-like Homologue 1 (Dlk1), also known as Preadipocyte 
Factor 1 (Pref1). This molecule is long since been known to promote 
adipogenesis in BMSCs (Sul, 2009, Wang et al., 2010). In BMSCs, Dental Pulp 
Stem Cells (DPSCs) and even cancer SCs elevated Dlk1 expression has been 
linked to the highly proliferative cells within the lineages, sugegsting that this 
molecule may also have a role in TACs maintenance (Xu et al., 2012, Qi et al., 
2017, Kluth et al., 2010). Dlk1 functions both as a membrane bound ligand and 
can be cleaved to act as a diffusible signalling molecule. The role of Dlk1 in its 
diffusible and membrane bound forms in SC regulation have been found to exert 
different effects (Mirshekar-Syahkal et al., 2013). Of particucular interest is the 
fact that Dlk1 is a well known Notch ligand, which has been identified as a 
negative regulator of Notch1 possibly through competition with the classical 
ligands (Baladron et al., 2005, Nueda et al., 2007, Falix et al., 2012). Therefore it 
is possible that while canonical Notch signalling maintains the SC pool, the action 
of Dlk1 may be to promote the progression of SCs towards differentiation.  
28 
 
 
1.7 Epigenetic regulation of stem cells & the cell cycle 
The term epigenetics was first coined in the 1940’s by C. Waddington, to refer to 
the field of biology investigating how a phenotype is brought about by the causal 
interactions between genes and their products (Waddington, 1968). Since this 
definition was first introduced, the boom in molecular biological research has 
allowed many fields to fall under this banner. Consequently this definition has 
since been refined to refer only to the way in which gene function is heritably 
changed without a DNA sequence alteration (Wu and Morris, 2001). At present 
the description of epigenetic modifications is used to refer to histone modifications 
and covalent alterations of the DNA itself (Figure 12) (Dupont et al., 2009, 
Bernstein et al., 2007). 
Histone modifications have been strongly implicated in the epigenetic regulation 
of chromatin structure, thus altering the accessibility of the DNA for transcription. 
The amino acid tails of histones are vulnerable to histone modifying enzymes, 
which can cause posttranslational modifications on selected arginine, lysine and 
serine residues. The wide array of possible histone modifications and phenotypic 
outcomes have been extensively investigated in order to determine patterns in 
expression changes, giving rise to the histone code hypothesis (Strahl and Allis, 
2000). The acetylation of many histone 3 and 4 lysine residues, have been 
associated with transcriptional activation of local genes (e.g. H3K9 & H3K27 
(Goda et al., 2013, Marinho et al., 2017)). While methylation of the same (and 
other) lysine residues are associated with transcriptional repression (Dupont et 
al., 2009). The targeted modification of specific histone amino acids is believed 
to be regulated by both the recognition of specific DNA sequences and by the 
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interaction of intermediate proteins, such as the polycomb group proteins (Kohler 
and Villar, 2008). While histone modification is a widely studied part of epigenetic 
research, the presence and mechanism of heritability of such alterations to 
histones in not clear. Some have argued that during cellular division histones are 
semi-conservatively distributed during duplication (Tagami et al., 2004). However 
this is a widely contested mechanism, and consensus on an alternative method 
is yet to be reached (Dupont et al., 2009).  
 
The other focus of epigenetic study is that of covalent modification of the DNA 
itself. DNA bases were first observed to be covalently modifiable in the 1940’s 
(Hotchkiss, 1948). The majority of these modifications were found to be 
methylation events of cytosine, adenine and to some extent guanine bases 
(Hotchkiss, 1948). 20 years later it was found that such modifications can regulate 
gene expression levels (Griffith and Mahler, 1969). The inheritance of DNA 
methylation through mitotic events is regulated by DNA methyltransferase 
DNMT1, which stabilises and replicates the modifications during replication 
 
Figure 12. Potential sites of epigenetic modification occur through interaction with the DNA, 
histones or assembled chromatin 
Epigenetic regulation of transcription can occur at different levels within the chromatin, as indicated 
by the yellow shapes. Covalent modification of the DNA bases (often through the methylation of 
cytosine residues) alters the accessibility of the DNA to transcription factors and other DNA binding 
molecules, thus regulating transcription levels. or through mRNA interactions with the chromatin 
(Deaton and Bird, 2011). The modification of histone structure, again through the covalent addition 
or removal of methyl moieties, alters the structure of chromatin thus making the DNA more or less 
accessible to transcriptional machinery (Wu and Morris, 2001). More recently, the role of mRNAs in 
modulating these other forms of epigenetic marks, has led to some including mRNA mediation as a 
further form of epigenetic regulation (Holoch and Moazed, 2015).  
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(Dupont et al., 2009, Reik et al., 2001). Key regulators of de novo methylation 
include DNA methyltransferases DNMT3A & DNMT3B. The targeted binding of 
these enzymes is site and developmental stage specific, but can involve the 
action of RNA interference and recognition of specific DNA sequences (Dupont 
et al., 2009). 
While methylation of cytosine can occur throughout the genome (Woodcock et 
al., 1987), one well documented epigenetic regulation process is the methylation 
of cytosine at CpG dinucleotides (Deaton and Bird, 2011). CpG islands are a 
common feature of the promotor sequences of many transcribed genes. Current 
findings in the field of DNA epigenetic modification have shown that CpG 
methylation in promotor sequences causes transcriptional repression (Deaton 
and Bird, 2011). This repression occurs due to two effects of the DNA 
modification. Firstly, the binding site of transcription factors can be blocked by the 
covalent modification of the bases within the promotor sequence. The second 
repressive event which can occur, is that the methylation of the DNA can attract 
chromatin and histone remodelling proteins which in turn repress transcription. 
When considering the role of epigenetic regulation in SCs, it is important to take 
note of the array of cellular processes within SCs which can be modulated. For 
example, the necessity of SCs and TACs to undergo proliferation, and ultimately 
differentiation, requires robust genomic stability. The loss of DNA methylation has 
been shown to allow inappropriate recombination and mutagenesis, which can 
lead to immortalisation and thus inhibited differentiation (Dupont et al., 2009, 
Dodge et al., 2005). 
One such important cellular process which SCs utilise is the maintenance of 
cellular quiescence. H3K9 methylation has been shown to be important in the 
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regulation of quiescence in muscle precursor cells (Cheedipudi et al., 2015). 
Specifically, PRDM2 associates with promoters in quiescent myoblasts and 
colocalises with methylation at H3K9. This molecule has also been found to be 
able to further modulate quiescence by regulating the transcription of TAC marker 
genes such as CCNA2 (Cheedipudi et al., 2015). DNA methylation has also been 
shown to be an important regulator of the G0 state, through the modification of 
promoter sequences for genes which modulate quiescence (Gu et al., 2011). 
In postnatal SCs, self-renewal is a vital cellular process, which is tightly regulated. 
The loss of specific chromatin modifiers has been shown to impair the ability of 
cells to self-renew (Xi and Xie, 2005, Rinaldi and Benitah, 2015). For example, 
the loss of Ring1A in intestine has been found to cause tissue failure through 
impaired self-renewal. Histone modifiers have also been found to have a 
profound impact on self-renewal. Over expression or knock out of EZH1, a H3K27 
methyltransferase, has been shown enhance or impair mammary gland cell self-
renewal respectively (Avgustinova and Benitah, 2016). In addition to chromatin 
and histone modifications affecting the ability of SCs to self-renew, DNA 
methylation is also an important regulator. In HSCs, knock out of DNMT1 inhibits 
the mitotic inheritance of DNA modifications and results in impaired self-renewal. 
Meanwhile, ablation of DNMT3A and DNMT3B in the same cell type has been 
shown to enhance self-renewal (Challen et al., 2014). 
With changes in self-renewal being observed when epigenetic modifications are 
externally manipulated, changes in lineage commitment have also been 
observed (Avgustinova and Benitah, 2016, Srinageshwar et al., 2016). Changes 
in the methylation of DNA in HSCs have given rise to impaired lymphoid 
differentiation, indicating a role for covalent DNA regulation in determining the 
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fate of these cells (Broske et al., 2009). Similarly, loss of histone deacetylation 
modifiers such as HDAC1 in the epidermis cause a loss of lineage specificity 
(Winter et al., 2013). 
Further to lineage determination being affected by epigenetic modification, 
regulation of differentiation is also impacted. Knock out of other H3K27 
methyltransferases (e.g. JARID2) have been shown to affect the timing of 
differentiation of epidermal SCs (Mejetta et al., 2011). Meanwhile, 
overexpression of another H3K27 methyltransferase, EZH2, has been found to 
cause premature differentiation of mammary gland SCs (Li et al., 2009). 
Mammary gland SCs have also been shown to have limited differentiation 
capability, leading to impaired terminal end bud development, when de novo DNA 
methylation is inhibited (Pathania et al., 2015). 
The role of different epigenetic modifications in different SC types are largely cell 
type specific. As with most cellular events and regulations there is no one-size-
fits-all hypothesis which would determine the effect of a specific regulatory event 
on the phenotype of all SCs. However, it is clear that both histone and DNA 
epigenetic modifications play an important role in the regulation of SC quiescence, 
self-renewal and differentiation. 
 
1.7.1 Epigenetic regulation of Notch signalling 
When considering the way in which epigenetic regulations affect cellular 
phenotypes, it is important to bear in mind the specific molecular pathways that 
are being modulated. The epigenetic modulation of the Notch pathway has been 
studied in terms of the synergistic function of epigenetics on Notch target gene 
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expression, and in terms of the expression of Notch pathway components 
themselves. The downstream effect of the Notch pathway is the expression of 
target genes, which is often epigenetically modulated (Schwanbeck, 2015).  
A number of the key interaction partners of RBP-Jκ are histone acetyl 
transferases, which are vital for appropriate targeting of the binding complex 
(Wallberg et al., 2002). Furthermore, research into the binding partners of the 
NICD have identified other known epigenetic regulators, including ATP-
dependent chromatin remodellers (such as SmarcA2 of the SWI/SNF complex) 
and polycomb repressing complexes (Schwanbeck, 2015). The effect of 
chromatin remodelling and Notch target gene promoter occupation, on Notch 
target gene expression is an area of much study within epigenetics. Specifically, 
in ESCs, some 95% of studied Notch target genes were identified as having 
histone methylation events in the promoter region (Meier-Stiegen et al., 2010). 
Chromatin modifying proteins are important epigenetic regulators. KDM5A, a 
lysine demethylase, has been identified as a highly conserved, essential 
component of the RBP-Jκ repressor complex (Liefke et al., 2010). In cancer cells, 
the polycomb repressor complex and KDM5A interact to remove histone 
methylations in order to regulate Notch target genes including Hes1 (Liefke et al., 
2010). The regulation of Notch target genes by polycomb group proteins is further 
supported following the identification of polycomb repressor complex proteins at 
Notch target gene promoter regions (Schwanbeck et al., 2011). Specifically, 
Ring1B and EZH2 have been shown to be enriched at the promoter regions of 
Notch target genes, suggesting a role for polycomb repressive complexes as 
antagonists to Notch signalling (Yatim et al., 2012).  
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In addition to potentially regulating levels of downstream Notch effects, a role for 
polycomb group proteins has also been investigated in “reading” epigenetic 
histone marks and thus targeting or preventing intracellular Notch pathway 
components from binding to specific chromatin regions (Kutateladze, 2011). 
Notch signalling pathway components have also been shown to interact with 
chromatin remodelling factors, including those of the SWI/SNF complex 
(Schwanbeck, 2015). This complex is an ATP-dependent chromatin remodelling 
complex, which allows DNA to be more accessible to transcription, replication 
and repair machinery, by restructuring the nucleosome (Tang et al., 2010). 
Chromatin remodelling complexes have also been identified as having histone 
acetyl transferase interaction capabilities, thus allowing the acetylation of 
histones (Schwanbeck, 2015). Components of chromatin remodelling complexes 
have been identified as being able to interact with Notch receptors and act as 
vital mediators of NICD – RBP-Jκ binding (Yatim et al., 2012, Takeuchi et al., 
2007). Of particular note is the findings that ATPases of the SWI/SNF complex, 
SmarcA2 and SmarcA4, can interact strongly with RBP-Jκ and NICD (Kadam and 
Emerson, 2003, Yatim et al., 2012). SmarcA2 and SmarcA4 are exclusively and 
interchangeably expressed within the SWI/SNF complex, and the role of each 
complex type is believed to be distinct. In cancer cells the interaction of SmarcA4 
with the core Notch effector complex is necessary for endogenous Notch effector 
gene expression (Takeuchi et al., 2007, Yatim et al., 2012). However, in retinal 
SCs, SmarcA2 interactions have been shown to have inhibitory effects on Hes1 
and Hes5 expression (Das et al., 2007). 
As with all cellular pathways, the expression of the ligands, receptors and 
effectors of the Notch pathway can be epigenetically regulated. Epigenetic DNA 
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modification has been shown to both regulate and be regulated by the Notch 
Pathway. Methylation of cytosine, 5mC, is a well characterised inhibitory 
epigenetic change which occurs often within the DNA in regulatory elements, 
gene bodies and CpG islands. RBP-Jκ has been found to bind strongly to 5mC 
motifs, suggesting a role for DNA methylation in increasing RBP-Jκ binding to 
certain areas of chromatin (Bartels et al., 2011). Notch target genes themselves 
have been shown to have different levels of DNA methylation in their promoter 
regions in progenitor and differentiated cells (Reister et al., 2011, Martini et al., 
2013). Further suggesting that the effect of Notch signalling is modulated 
epigenetically throughout a cell’s life. In addition to methylation changes in Notch 
target genes, the components of the Notch pathway themselves are also 
upregulated by hypomethylation (Terragni et al., 2014). 
A further important epigenetic event when considering the regulation of 
expression of Notch pathway components through DNA methylation is genomic 
imprinting. Since the 1980’s it has been known that mammalian embryogenesis 
requires both paternal and maternal genetic contributions (McGrath and Solter, 
1984). The epigenetic silencing of specific parental alleles occurs through the 
modification of the DNA in the oocyte or spermatozoon. Whether a gene is 
madumnally or padumnally expressed conveys different heritable fitness to the 
offspring (Wilkins and Haig, 2003). Some genes remain imprinted throughout an 
organism’s life, while others are temporally and spatially transient. Similar to the 
way in which X chromosome inactivation occurs at some loci during 
gametogenesis, autosomal genomic imprinting can occur during germ cell 
development (Dupont et al., 2009). 
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The gene of Notch ligand Dlk1 lies within a region of the genome which is well 
documented as paternally imprinted in mammals (Wallace et al., 2010). 
Consequently, Dlk1 is expressed from the maternal allele in early development 
(Schmidt et al., 2000). This imprinting occurs through the methylation of DNA in 
a series of CpG rich regions within the loci. The Dlk1 gene sits within a well 
characterised, epigenetically regulated locus. In the region of the genome 
containing the Dlk1 gene, there are two areas of CpG islands. One sits upstream 
and the other downstream of the gene. These islands are referred to as the 5’ 
and 3’ islands respectively (Figure 16 B). Methylation of these sites has been 
linked to transcriptional repression of Dlk1. Targeting of DNA methylation has 
been linked to the modification of histone proteins in the region (Rose and Klose, 
2014). The imprinting is maintained and inherited through the function of DNTPs 
which can be used to modify levels of repression of the gene (Schmidt et al., 
2000). The modification of levels of epigenetic imprinting of Dlk1 have been linked 
to levels of potency in embryonic and iPSCs (Liu et al., 2010b). Thus, suggesting 
an important role for the levels of epigenetic regulation of this Notch ligand in SC 
maintenance and differentiation. 
 
1.8 The tooth as a model for mesenchymal stem cell research 
Since the first description of vertebrate tooth development (Owen, 1840), the 
processes and mechanisms at work have been studied in depth. Research has 
been conducted using animal models including reptiles, fish and mammals 
(Jernvall and Thesleff, 2012), with many commonalities and conserved pathways 
being identified. 
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1.8.1 Development of the tooth 
The morphological stages of tooth development are defined as initiation, bud, cap, 
bell and mineralisation (as shown in Figure 13). The stages are assigned 
predominantly by the morphology of the tissues and not by the age of the animal, 
as the teeth of different species develop at different rates and in different formula 
(Cobourne and Sharpe, 2010).  
The gross stages of tooth development are common to many mammals and to 
some animals of other classes. Rodents are often used as mammalian models of 
tooth development, as although their postnatal dentition is markedly different from 
our own, many of the developmental processes and gross morphology 
throughout development have been shown to often be conserved (Hu et al., 2013).  
 
 
Figure 13. The stages of tooth development are described primarily based on the morphology 
of the molar tooth 
The stages of tooth development are characterised morphologically. This schematic outlines the 
process in the molar teeth. During initiation the dental epithelium thickens. This thickening begins to 
invaginate into the mesenchyme as the mesenchymal cells condense around it in the bud stage. 
The cap stage begins as the early cusps are patterned with the interaction of the condensed 
mesenchyme and the epithelium above. During bell stage odontoblasts and ameloblasts differentiate 
from the mesenchyme and epithelium respectively. Following this, mineralisation and eruption 
begins, whereby the hard tissues of the tooth are deposited, and the tooth migrates into the oral 
cavity. Adapted from (Tucker and Sharpe, 2004, Hugnot and Franzen, 2011)  
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1.8.1.1 Murine molar development 
The general process of molar development in mice is conserved between 
strains, however the precise timing of these events can differ (Pugach and 
Gibson, 2014). Within the field of research into dental development, and in the 
research presented here, strains with a background of ICR (CD-1®) and BL6 
are commonly used (Caton and Tucker, 2009). The combined work on multiple 
mouse strains has allowed for a broad understanding of the overall process of 
dental formation, patterning and development. 
1.8.1.1.1 Initiation 
During the initiation phase (generally E11.5 in mice 1st molar (M1)) there are two 
tissue layers, the mesenchymal tissue and the epithelial tissue. While the 
epithelial tissue is derived from the ectoderm and endoderm as expected, the 
mesenchymal tissue is not mesodermal in origin, but is derived from the neural 
crest (Soukup et al., 2008).  
The dental epithelium proliferates to a two-layer thickness during initiation. The 
layer of cells contacting the mesenchymal tissue then begins to polarise and 
press towards the mesenchyme. The mesenchyme then condenses around this 
newly formed placode. Once initiated, early dental development is controlled by 
the interaction of the epithelial and mesenchymal tissues (Balic and Thesleff, 
2015).  
In many developing organs within vertebrates, the mesenchyme initiates 
developmental signalling though cross-talk with the epithelium. However in the 
tooth it has been shown that the epithelium is the instigator of signalling which 
acts upon the mesenchyme causing condensation (Moss, 1969, Thesleff et al., 
1995). This may suggest that the different origin of the tooth mesenchymal tissue 
39 
 
may lead to different functionality. These recombination experiments also 
identified a range of transcription factors and growth factors which are key players 
in the development of mammalian teeth, including BMPs, TGFβs and FGFs 
(Thesleff et al., 1995). 
1.8.1.1.2 Bud 
The bud stage (generally E12.5-E13.5 in mice M1) is identified by the invasion of 
the epithelial tissue into the mesenchyme. By this stage there is increased cross 
talk between the epithelium and the underlying mesenchymal tissue. Effective 
budding requires BMP4 signalling from the epithelium to act though Msx1 to 
induce BMP4 expression in the mesenchyme (Saadi et al., 2013). It is at this 
stage that development is often halted in the absence of the necessary signalling 
molecules. In the diastema region of the mandibles of the mouse, the reduction 
of Shh signalling inhibits the further development of early tooth buds in this area 
(Kangas et al., 2004). This effect has been shown to be rescued by mutations 
which cause elevated Wnt signalling (Ahn et al., 2010). These findings suggest a 
complementary role whereby reduction of Wnt and restriction of Shh results in a 
reduced postnatal murine dentition, while vestigial teeth remain undeveloped in 
the diastema of these adults. 
1.8.1.1.3 Cap 
By the cap stage (generally E14.5-E15.5 in mice M1) the epithelium begins to 
differentiate into two distinct layers, the inner enamel epithelium (at the convexity 
of the cap) and outer enamel epithelium (at the concavity). These layers are 
separated from the underlying mesenchymal tissue by a basement membrane, 
which has also been implicated in the crosstalk between the epithelium and 
mesenchyme (Thesleff and Hurmerinta, 1981). At the cervical loop (CL) the cells 
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between these two epithelia begin to take on a star-shaped phenotype, while still 
maintaining contact to one another. The dental epithelial stem cells (EpSCs) are 
located in the stellate reticulum and surrounding outer enamel epithelium (Li et 
al., 2012). 
During the cap stage, the enamel knot is first visible. The enamel knot is an 
epithelia derived structure which contains densely packed cells (Jernvall and 
Thesleff, 2012), In multi-cuspid teeth a secondary enamel knot later forms from 
non-proliferative cells of the primary knot (Coin et al., 1999), thus allowing for an 
increase in cusp complexity in these teeth. The enamel knots are transient 
developmental structures which are later apoptosed once the enamel knot has 
performed its function of establishing the future cusp pattern (Vaahtokari et al., 
1996). In addition to the dense clustering of epithelial cells at this time, the 
underlying mesenchymal tissue can also be observed condensing. In the mouse 
incisor capillaries are seen to begin forming within the mesenchyme (Kerley, 
1975).  
By late cap stage one side of the forming bell elongates before the other follows 
suit. This elongation is marked by increased Shh expression in the Inner Dental 
Epithelium (IDE) (Hu et al., 2013). The expression pattern of Shh has also been 
observed in the developing human dentition, showing the inter species 
conservation of signalling mechanisms in ontogenesis (Hu et al., 2013). 
1.8.1.1.4 Bell 
During the bell (generally E16.5-E18.5 in mice M1), the tissue is said to be 
undergoing histodifferentiation (Phinney and Halstead, 2003). The cells of the 
inner enamel epithelium begin to differentiate into preameloblasts, while the 
mesenchymal cells contacting the basement membrane become preodontoblasts. 
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As the cells differentiate and undergo different rates of mitosis, the epithelium 
folds into a bell shape. By the late bell stage (E19) the developing dental organ 
loses its attachment to the ectoderm (Kerley, 1975).  
1.8.1.1.5 Differentiation 
During the process of differentiation (generally perinatally in mice M1) the TACs 
of the teeth begin to differentiate into the terminally differentiated odontoblasts 
and ameloblasts (Yildirim, 2013). During this process the cells polarise and align 
along the basement membrane between the mesenchyme and epithelium. This 
process is tightly regulated though reciprocal signalling between these two 
tissues and through interaction with the extracellular matrix (He et al., 2010). 
1.8.1.1.6 Mineralisation & Eruption 
During the process of eruption (generally postnatal day 0-2 in mice M1) crown 
formation is finalised. The now mature ameloblasts secrete enamel while the 
odontoblasts secrete dentine. The ameloblasts on the cusps of the tooth begin to 
deposit enamel, starting at the tips and slowly developing down the sides of the 
tooth. The last remnant of the attachment between the surface epithelium and the 
enamel organ is degraded concurrently with increased proliferation of the enamel 
organ itself (Lungova et al., 2011). The dental mesenchyme is also active during 
this stage of development, displaying increased proliferation and remodelling.  
By postnatal day 2, ameloblasts of the crown are no longer proliferating but rather 
are utilised in the production of enamel. The ameloblasts of the rest of the tooth 
slowly begin to reduce their proliferation and increase secretion in a wave towards 
the CLs, until all of the dental epithelium is no longer mitotically active.  
Alongside the mineralisation of the crown, the root is beginning to form and 
remodel (Lungova et al., 2011). This involves not only dental, but bone 
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remodelling. By postnatal day 4, bone turnover is increased along the base of the 
tooth crypt (Villarino et al., 2005). In rooted teeth, the epithelial cells of the CL 
begin to differentiate into the Hertwig’s Epithelial Root Sheath (HERS) which then 
secretes cementum (Jernvall and Thesleff, 2012). After the formation of the root, 
the HERS loses its ability to continue to grow and the SC containing Stellate 
Reticulum is lost (Baratella et al., 1999). Molar teeth erupt into the oral cavity 
around postnatal day 14 (Lungova et al., 2011). By this stage the teeth are 
beginning to locate into their functional position and can be seen within the cavity 
fully by postnatal day 16. 
1.8.1.2 Murine incisor development 
The development of the mouse incisors follows a generally similar process to that 
of their molar counterparts. The key differences are observed at the later stages, 
as the continuously growing mouse incisor maintains its proliferative potential and 
does not develop a classical root (Juuri et al., 2013). 
In the development of the murine dentition, the initiation phase of the incisor is 
morphologically very similar to that of the molar teeth (Harada et al., 2002). 
However the molecular cues which determine the fate of the developing tooth are 
already being put into place at this early stage (Caton and Tucker, 2009). 
By bud stage early differences between molars and incisors can be observed. 
Within the incisors the condensation of the mesenchyme begins to cause 
asymmetry in the epithelium, causing the bud to begin to tilt away from being 
entirely perpendicular to the ectoderm above (Harada et al., 2002). 
This asymmetry continues into the cap stage. By the end of the cap stage the 
morphological features of the developing incisor are distinct from the molar teeth. 
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It has been observed that the time taken to reach this stage of development may 
be slightly swifter in incisors than the molar teeth, further differentiating this tooth 
from the molars. The tilting of the dental epithelium and the beginnings of the bell 
shape form so that the region which will ultimately go on to become the dental 
pulp forms a chamber parallel to the developing oral cavity (Harada et al., 2002). 
Enamel knot, which is a prerequisite structure of cusp formation is notably absent 
from the rodent incisor. 
Throughout the bell stage the patterning of the incisor teeth clearly demarks this 
tooth as being different from the non-continuously growing molars. The tooth lies 
almost horizontal within the mandible with the crown at the distal tip of the jaw. 
Within the epithelium of the incisor the two CLs which have formed are also 
beginning to be distinct from one another (Suomalainen and Thesleff, 2010). The 
lingual CL is notably smaller than the larger labial CL below (Harada et al., 2002). 
Both CLs begin to grow deeper into the mesenchyme, thus elongating the tooth 
and ultimately coming to rest closer to the angle of the mandible (Kerley, 1975). 
While differentiation and polarisation of the cells within the tooth still occur within 
the incisor, it is notable that many of the cells of the CL maintain their proliferative 
capability. As no traditional root is forming it is ameloblasts rather than 
cementoblasts which differentiate from the epithelial tissue (Kawano et al., 2004). 
Similarly, to molars the odontoblasts which have differentiated from the 
mesenchymal cells go on to produce the dentine during mineralisation, while the 
ameloblasts secrete enamel. 
In the mouse incisor and other continuously growing teeth, the process of 
eruption is associated with increased vascularisation (Balic and Mina, 2010), this 
is vital to provide an adequate oxygen and nutrient supply to the tooth which will 
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grow throughout life. As the tooth elongates the incisor tooth passes through the 
external epithelium of the oral cavity and erupts early after birth (Lungova et al., 
2011). 
 
1.8.2 Stem cells in the non-continuously growing teeth 
In humans the deciduous teeth are typically lost before adolescence and replaced 
by the permanent dentition (Cobourne and Sharpe, 2010). After this time the teeth 
are increasingly limited in their ability to repair after injury (Volponi et al., 2010). 
However a population of reactive mesenchymal DPSCs has been identified, 
these cells can be activated upon injury to produce a reparative dentine that 
strengthens the damaged hard tissue (Gronthos et al., 2002, Huang et al., 2009).  
In teeth which do not continuously grow, including all human teeth and rodent 
molars, the epithelium is lost by the time of eruption. Not only does this limit the 
regenerative capacity of the enamel, it also has a profound impact on the 
mesenchymal cell lineages and dentine production, due to the loss of epithelial-
mesenchymal communication. However the mesenchymal dental pulp is a 
dynamic tissue which can still contribute to the reparation of dentine in these teeth 
(Sloan and Smith, 2007, Yu et al., 2015). 
In teeth which do not continuously grow there is no CL, as the corresponding 
structure during development differentiated into the HERS  (Jernvall and Thesleff, 
2012) and the remaining epithelium is differentiated into ameloblasts by 
adulthood. The apical papilla of the postnatal tooth has been shown to contain an 
EpSC niche (Morotomi et al., 2005), while the dental pulp within the postnatal 
45 
 
tooth has been shown to contain a non-terminally differentiated cell population 
which can be activated upon injury (Gronthos et al., 2000). 
Dental SCs were first isolated from the dental pulp (Gronthos et al., 2000) in 2000. 
Since then, dental SCs have also been harvested from exfoliated deciduous teeth 
after they have been shed (Bluteau et al., 2008). The characterisation of true 
dental pulp SCs (DPSCs) has been much debated. Currently the most accurate 
method of characterisation is though the presence or absence of cell surface 
antigens. DPSCs have been found to express a number of markers that are 
common to many MSCs (i.e. CD44, CD29, CD105 & Stro-1) (Kawashima, 2012), 
while being low for haematopoietic antigens (i.e.. CD45 & CD34) (Lindroos et al., 
2008, Mitsiadis et al., 2011). Dental SCs have been shown to be multipotent and 
can be cultured to differentiate into cardiomyocytes (Gandia et al., 2008), 
chondrocytes and adipocytes (Patil et al., 2013). Induced pluripotency assays 
have also shown that DPSCs can be reverted to a pluripotent state (Yan et al., 
2010). However, unlike embryonic SCs, the dental SCs have a finite mitotic 
potential and with each division the risk of genetic alterations within the cells 
increases (Gronthos et al., 2002). 
 
1.8.3 Stem cells in the continuously growing teeth 
Unlike human teeth, the incisors of rodents and lagomorphs, continue to grow 
throughout adulthood and are worn down by gnawing (Derrell-Clark, 2013). The 
murine incisor is an elegant model for the study of SCs.  By nature, it grows 
continuously throughout the lifetime of the animal and the tooth is worn down 
through friction. If this process does not occur, aberrant overgrowth can occur 
which carries with it high levels of morbidity and mortality.  
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The incisor tooth of rodents is by far the largest of its teeth (Figure 14). The 
exposed tip, which is visible, is only a fraction of the entire organ.  Within the 
mandible the incisor takes up large proportion of the jaw.   
 
The hard, exposed portion of the incisor is comprised of two hard tissues, dentine 
and enamel. The epithelium and mesenchyme at the apical end of the incisor 
provide precursors, these precursors then go on to become the terminally 
differentiated enamel secreting ameloblasts, and dentine producing odontoblasts 
respectively (Seidel et al., 2010). Enamel is produced by TDCs specific to the 
tooth, known as ameloblasts.  Meanwhile dentine is produced by mesenchymal 
odontoblasts (Smith, 1980).  
 
 
Figure 14. The sagittal view & sectioning of the mouse mandible shows the extent of the 
incisor 
The top image is an Illustration of the mouse mandible after sagittal sectioning has exposed the tooth 
chambers. M1, M2 & M3 denote the 1st, 2nd and 3rd molars respectively. “In” denotes the incisor. Cut 
out shows cervical loop region of the incisor tooth as seen in a histological sagittal sectioned 
preparation. The epithelial tissue is marked in blue, containing regions of EpSCs, ETACs and 
ETDCs. Mesenchymal tissue is coloured pink, containing the MTAC and MTDC pools. 
Neurovascular bundles (NVBs) are also depicted. 
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It is known that ameloblasts originate from an epithelial structure located at the 
apical end of the incisor called the CL (Baker et al., 2009). Within the CL a pool 
of well characterised EpSCs has been documented. The CL epithelium 
expresses a range of growth factors, including FGFs 3, 7 & 10, alongside a range 
of SC markers such as Sox2, BMI1 & LGR5 (Kettunen et al., 2000, Biehs et al., 
2013, Juuri et al., 2012, Suomalainen and Thesleff, 2010). These SCs persist 
within the adult, and commit to differentiate through a TAC state before terminally 
differentiating (Smith and Warshawsky, 1975, Harada et al., 1999).  The origins 
of odontoblasts however are less well characterised.  
 
1.8.4 Mesenchymal stem cells in the mouse incisor tooth 
In the incisor mesenchyme there is a highly proliferative region, adjacent to the 
TAC region of the epithelium (Lapthanasupkul et al., 2012). This region of 
mesenchyme highly expresses a number of polycomb genes including 
transcriptional regulator Ring1b and cell cycle controller Skp1 (Lapthanasupkul 
et al., 2012). The cells from this population have since been shown to be capable 
of migrating to the mesenchymal odontoblast layer within the incisor (Feng et al., 
2011, Zhao et al., 2014). 
Contrary to the mesenchymal transit amplifying cells (MTACs), the origin of MSCs 
in the mouse incisor model has yet to be fully confirmed. Recently published 
findings indicate a glial origin for dental MSCs, having identified a population of 
label retaining cells around the neurovascular bundles (NVB) of the mouse incisor 
(Kaukua et al., 2014a). A periarterial slow cycling cell population, which is Gli1 
and Thy1 positive has also recently been identified (Zhao et al., 2014, An et al., 
2018). Both of these NVB associated populations of MSCs (NVB-MSCs) have 
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been shown to be capable of migrating to areas of the odontoblast layer and 
participating in repair of the tooth’s hard tissues after damage. However, lineage 
tracing data was not able to link either of these cell populations to the native 
MTACs of the incisor. Additionally, these cells also did not express known MSC 
markers. Therefore, the endogenous incisor MSCs have not been identified so 
far. 
At least in the epithelium, the SCs, TACs and TDCs of the epithelium can all be 
visualised on the same sagittal plane, alongside their mesenchymal counterparts 
(Naveau et al., 2014), (Figure 14), this is observed in relatively few tissue niches 
(Li and Clevers, 2010) making the murine incisor an exciting model for studying 
the interactions and transitions between each of the cell groups.  
The continuously growing mouse incisor provides a potential model for better 
understanding the regulation of SC maintenance and renewal. It is hoped that by 
providing further insight into the regulation of mesenchymal cells within this tissue, 
further advances in the MSC field could be made. In order to utilise the mouse 
incisor for this purpose, a series of research questions were posed and 
addressed. The question of whether the mesenchyme contains a similar SC, TAC, 
TDC axis to the epithelial cells remains. An equivalent SC population within the 
mesenchyme which gives rise to the odontoblasts has yet to be identified. If such 
cells are present, novel methods of identifying and distinguishing them from the 
other cells of the tissue will need to be employed. Further research questions 
about these cells will also need to be addressed, including the molecular control 
of these cells in both development and regeneration. 
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1.8.5 Dentine regeneration 
In humans, tooth damage is most commonly caused by erosion of the enamel 
through physical, chemical or bacterial assault. Dental caries is the most common 
dental pathology among humans and is caused by bacterial infection of 
compromised teeth (Bjorndal, 2008). The infection causes demineralisation and 
damage to all the hard tissues of the dentition. As caries is such a common 
complaint, a wealth of research has been conducted into preventative and 
reparative strategies.  
Upon dental injury there is initial apoptosis of odontoblasts. The surviving 
odontoblasts begin to secrete a reactive dentine to counteract the damage. The 
apoptosis of neighbouring odontoblasts causes an activation of the DPSCs, 
which proliferate, migrate and differentiate into odontoblasts-like cells and begin 
producing a reparative dentine. Ordinarily this repair response occurs so rapidly 
that there is little recruitment of inflammatory markers to the site of injury. Part of 
the reason why the repair mechanisms are so quick to initiate is that during 
physiological conditions, signalling molecules and growth factors (such as TGF-
beta (Baker et al., 2009)) are secreted by pulp cells and sequestered by the 
dentine (Silva et al., 2004). Upon injury these molecules are released from the 
dentine and are free to induce wound healing, differentiation and proliferation 
responses in the surrounding tissue. 
In order for efficient regeneration (and continued tooth growth) a pool of stem like 
cells is required. In the tooth there are two broad classes of dental SCs, those of 
epithelial origin and those which originate from the mesenchymal tissue. 
While the SC niches of developing teeth (and continuously growing teeth) have 
a great potential to differentiate and proliferate, the fully formed dentine and 
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cementum have very little regenerative ability and the enamel has not been 
observed to have any. However the presence of postnatal SC niches in the dental 
pulp and the CL of the murine incisor, have led many to believe that reactivating 
these SCs could provide a regenerative therapy to counteract demineralisation 
and possibly whole tooth loss (Bluteau et al., 2008). In addition to advances in 
clinical dentistry, dental SCs have been suggested as a potential pool of postnatal 
SCs that could be utilised in regenerative medicine systemically (Huang et al., 
2009). 
 
1.8.6 Notch function in the tooth 
In the tooth, Notch signalling has a number of regulatory roles (Mitsiadis et al., 
2005, Campa et al., 2008). Notch signalling has been shown to be indispensable 
for tooth development (Mitsiadis et al., 2010). Furthermore, the Notch pathway 
has been shown to be important in tooth pulp reparation (Mitsiadis et al., 2011, 
Mitsiadis and Rahiotis, 2004). However, how the Notch pathway is activated and 
how the level of Notch activation contributes to tooth SC behaviour is not yet 
understood. 
Throughout murine dental development, the expression pattern of Notch 
receptors and ligands are temporally and spatially regulated (Cai et al., 2011). 
The epithelial cells of the developing tooth broadly express the Notch receptor 
proteins. However, within the dental mesenchyme Notch transcription has been 
identified within the pre-odontoblast regions but is absent from the odontoblasts 
(Mitsiadis et al., 1995), suggesting a potential role for Notch signalling in 
maintaining the pool of odontoblast precursors. 
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During early murine molar development, the Notch receptors 1, 2 and 3 are 
expressed broadly within the dental epithelial tissue. As development progresses 
through to the bell stage, the localisation of each receptor is restricted into distinct 
compartments as the fate of each of the epithelial cell types are adopted (Cai et 
al., 2011). Initially Notch receptor mRNA (messenger ribonucleic acid) is not 
detected within the developing molar tooth mesenchyme, however by late bell 
stage Notch receptor genes 2 and 3 are being transcribed in this tissue. By 
eruption, each of the three major Notch receptors are expressed transiently within 
the dental mesenchyme, however the differentiated mesenchymal cells remain 
absent of Notch expression (Mitsiadis et al., 1995). Classical ligands of Notch 
signalling, Jag1 and Jag2 are also expressed within the developing mouse molar. 
During early development, Jag1 is highly expressed within the condensing 
mesenchyme and epithelial stellate reticulum (Mustonen et al., 2002). This 
expression pattern is strongly correlated with the expression of Notch receptors. 
As the molar develops, the expression of Jag1 in the mesenchyme becomes 
more restricted to the regions of mesenchyme which contain the developmental 
dental pulp SCs. Jag2 conversely is most highly expressed within the epithelial 
tissues throughout development of the mouse molar (Mitsiadis et al., 2005). This 
initially broad expression is restricted as development progresses until by the time 
of eruption, Jag2 is expressed almost exclusively in the IDE and ameloblasts 
(Harada et al., 2006). 
During early incisor development in the mouse, the Notch receptor gene 
expression patterns have been shown to be similar to that of their molar 
counterparts (Mitsiadis et al., 1995). Of note is the differential expression of 
Notch2, which has been shown to be expressed in the condensing mesenchyme 
of incisor teeth during the bud/cap stage (Mucchielli and Mitsiadis, 2000). By bell 
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stage, the rotation of the incisor has begun and so the pattern of Notch receptor 
gene expression is no longer symmetrical within the tooth, thus highlighting the 
difference in expression to molar teeth. However, the majority of the expression 
of Notch1, 2 and 3 at this stage, is restricted to the epithelial tissue. By the time 
that the incisor tooth is erupting, Notch1 mRNA is once again detectable in the 
region of mesenchyme containing odontoblast precursors (Harada et al., 2006). 
Much of this work has been carried out using In-situ hybridisation techniques 
some 20 years ago. With the development of modern techniques such as laser 
capture microdissection, more accurate assessment of the expression patterns 
of these genes may show more accurately the precise regions of expression. 
The expression of classical Notch ligands within the developing incisor is almost 
entirely restricted to the epithelial compartment throughout. However Dll1 has 
been shown to be expressed in the mesenchymal tissue around the labial CL by 
late bell stage (Mitsiadis et al., 1998). The apparent lack of Notch ligands within 
the mesenchyme has led to the suggestion that cross talk between the epithelium 
and mesenchyme, and the interaction with other molecular pathways, may play 
an important role in incisor development (Harada et al., 1999). Together this 
dynamic spatiotemporal Notch receptor and ligand expression pattern shows the 
potential for Notch signalling to be utilised by the tooth in order to direct cell fate 
determination, and the maintenance of precursor cell pools within the developing 
tooth.  
Within the adult dentition, Notch pathway gene expression is largely absent from 
the differentiated cells which make up the teeth. Primarily the expression of these 
proteins are restricted to the SC containing CL region of the incisors (About and 
Mitsiadis, 2001). However, following injury, the adult teeth require the reactivation 
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of SCs in order to undertake repair and regeneration. Work on molar teeth has 
shown that this reactivation correlates with the triggering of Notch signalling within 
the dental mesenchyme and preodontoblasts adjacent to the injury (About et al., 
2000, Mitsiadis et al., 1999). Notch receptor activity is greatly upregulated in the 
reactive dental pulp, specifically Notch2 protein is strongly expressed (Mitsiadis 
et al., 1999). While Notch1 is upregulated in the mesenchymal tissue local to the 
injury, and adjacent to the surrounding NVBs, Notch2 has also been shown to be 
upregulated more distally, in the odontoblast precursor pool (Mitsiadis et al., 
1999). This Notch2 upregulation correlates with increased expression of ligand 
protein Dll1, and a drive towards differentiation of these precursor cells (About 
and Mitsiadis, 2001). It is believed that Notch signalling in the injured tooth 
mesenchyme may indicate pools of reactive dental pulp SC. Notch signalling has 
already been shown to be required for the survival of dental epithelial SCs, and 
so it is possible that the same signalling pathway plays a similarly vital role in the 
mesenchymal SCs of the teeth (Felszeghy et al., 2010). 
Postnatal dental SCs, including DPSCs, Notch signalling has been shown to 
regulate differentiation and maintenance of the SC pool (Bray, 1998, Carlesso et 
al., 1999). The presence of Notch signalling has also been used to identify the 
presence of undifferentiated dental cells in organ culture conditions (Morsczeck 
et al., 2005). Once identified the fate determination of these DPSCs in vitro is 
modifiable through the manipulation of Notch signalling, suggesting a role for 
Notch in the differentiation of reactive dental SCs in vivo (Grottkau et al., 2010).  
The perivascular cells of the dental pulp have been found to contain a population 
of DPSCs (Machado et al., 2016, Shi and Gronthos, 2003). Notch 3 is an 
established marker for the identification of these cells and the upregulation of this 
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protein following injury indicated a further role for the Notch pathway in fate 
determination of reactive SCs (Lovschall et al., 2005). 
As Notch signalling is an important and well documented regulator of 
developmental and reparative SCs within many mesenchymal tissues, the 
question of whether Notch activity may indicate pools of SCs within the mouse 
incisor, and how the same pathway may function in these cells, is an interesting 
basis for further study. 
  
55 
 
 
 
  
56 
 
2 Aims & Objectives 
The primary hypothesis of this research is that within the mouse incisor 
mesenchyme, there is a novel endogenous MSC population which gives rise to 
the MTAC and ultimately odontoblast cells. It is also hypothesised that Dlk1 will 
have a regulatory role on the maintenance and transition of MSC and MTACs. 
This work therefore aims to investigate the molecular mechanisms underpinning 
the behaviour of these mesenchymal cells, specifically to determine the role of 
Notch signalling in this process. 
Specific objectives are therefore as follows: 
2.1 Classification of an endogenous mesenchymal stem cell pool 
To identify the location of novel MSCs in the incisor, regions will be examined for 
MSC marker gene expression, at a protein and mRNA transcription level. It is 
expected that the MSC and MTAC regions will display distinct molecular 
expression signatures. 
Qualification that the identified cells of the endogenous MSC pool are capable of 
differentiating into MTACs and ultimately odontoblasts will also be determined. 
This will initially be investigated though microinjection and lineage tracing 
methodologies. Secondly, an ex vivo model will be developed. This will involve 
the resection and culture of MSC containing incisor tissue with mature devitalised 
dentine, in order to display the ability of these cells to reproduce a mature 
odontoblast like phenotype and functionality. 
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2.2 Determination of the role of Notch signalling in the maintenance 
and transition of mesenchymal cells of the incisor 
To investigate the role of Notch signalling in the behaviour of MSC and MTAC 
cells in vivo Dlk1 conditional overexpression transgenic mouse line, Collagen 1 
a1 Dlk1 overexpression, and Dlk1 knock out mice will be characterised. The 
expression of MSC marker proteins in the potential cervical loop MSC (CL-MSC) 
region of these animals will be determined, to define the effect of mediation of the 
Notch signalling pathway through Dlk1 modulation. 
To further investigate the role of Notch signalling pathway members (with a focus 
on Dlk1) on MSC behaviour, an in vitro model of MSCs will be developed. Both 
primary cells and established cell lines will be utilised. Cell cycle synchronisation 
of the cultured cells will be performed to model quiescent MSC and MTAC cells. 
The effect of the addition or silencing of Dlk1 and MSC markers on the cell cycle 
status and expression profiles of the cells will be investigated. 
2.3 Investigation into the translational potential of findings to clinical 
applications 
Finally, to investigate the translational potential of this study, in terms of 
regenerating a non-continuously growing teeth, a dental injury model will be 
employed. This will be used to investigate the mouse incisor MSC/MTAC 
regulating proteins at sites of dental injury in a rat model. 
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3 Materials & Methods 
3.1 Animal models 
Mouse strains used included ICR (CD-1®) Mice (CD1) mice from The University 
of Plymouth, UK; Collagen 1 α2 Cre x Rosa26 mice and Collagen 1 α2 Cre x 
Rbp-Jκ flox/flox and Transgenic Notch Reporter mice both obtained from The 
University of Lausanne, Switzerland; Collagen 1 α1 Dlk1 overexpression mice 
from The University of Southern Denmark, Denmark; and Dlk1 -/- mice from the 
University of Castilla-La Mancha, Ciudad Real, Spain. 
All in vivo and in vitro experiments used mice at postnatal ages of day 0, day 7, 
day 14 and day 30. 
Six female Wistar rats were used at age 30-45 days, which were raised at Peking 
University, China. 
All animals used in this work were humanely euthanized using cervical dislocation 
in accordance to Home Office regulation under the UK Animals Scientific 
Procedures Act 1986 (ASPA). Plymouth University Animal Welfare and Ethical 
Review Board granted ethical approval for all mice experiments. Experiments 
using rats were conducted at Peking University under local ethical approval. 
 
3.2 Rat molar capping animal experiment 
Wistar rats aged 30 days were used. Bilateral 0.5mm wounds were created in the 
first molar to open up the pulp chamber. One wound was capped with a control 
calcium hydroxide substance (Dycal®), while the contralateral wound was treated 
by being capped with the same substance containing Dlk1 protein. Rats were 
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sacrificed 14 days after the procedure. Mandibles were fixed in 10% Formalin 
(Sigma, HT50-128) for 24 hours before being embedded as formalin fixed paraffin 
embedded (FFPE) blocks (see section 3.3 Fixation & embedding of formalin fixed 
paraffin embedded animal tissues). FFPE blocks were sectioned at 10μm 
thickness and mounted on Superfrost slides (Sigma Aldrich, Z692255). Slides 
were processed for immunofluorescent staining (see section 3.22 
Immunofluorescent staining of frozen tissue, formalin fixed paraffin embedded 
tissue & cultured cells), or Haematoxylin & Eosin staining (see section 3.23 
Haematoxylin & eosin staining of formalin fixed paraffin embedded tissue). 
 
3.3 Fixation & embedding of formalin fixed paraffin embedded animal 
tissues 
FFPE tissue blocks were prepared by initially fixing the tissue in formalin (Sigma, 
HT50-128). Where appropriate, tissue was decalcified in 14% 
Ethylenediaminetetraacetic acid (EDTA) (Thermo Fisher, BP2482-100), for 30 
days at 4°C prior to processing. Samples were then processed using a Leica 
HistoCore Pearl through the following program of solutions (Table 1); 
 
After processing tissue was formed into blocks using Leica EG1150H and Leica 
EG1150C embedding instruments. Blocks were then stored for processing as 
Table 1. Reagents used for formalin fixation of tissue 
Reagent Company Catalogue 
Number 
Time in 
solution 
Temperature 
Ethanol 70% VWR Chemicals 20821.321 90 seconds Room Temperature 
Ethanol 70% VWR Chemicals 20821.321 45 seconds 37°C 
Ethanol 80% VWR Chemicals 20821.321 45 seconds 37°C 
Ethanol 95% VWR Chemicals 20821.321 45 seconds 37°C 
Ethanol 100% VWR Chemicals 20821.321 135 seconds 37°C 
Xylenes Sigma Aldrich 534056 120 seconds 37°C 
Paraffin wax PFM Medical 9000R2010 180 seconds 62°C 
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outlined in section 3.22 Immunofluorescent staining of frozen tissue, formalin 
fixed paraffin embedded tissue & cultured cells. 
 
3.4 Freeze embedding of fresh and cultured animal tissues 
Fresh tissue was immediately submerged in dry ice cooled 2-methylbutane 
(Sigma Aldrich, M32631) for 10 minutes. Frozen tissue was then removed and 
stored at -80°C. 
For incisor samples from p30 mice, CL regions were dissected first under a Leica 
M80 stereo microscope then embedded in Tissue-Tek® O.C.T.™ (Sakura, 4583) 
and stored at -80°C before sectioning. 
Cultured tissues were initially fixed in 10% Formalin (Sigma, HT50-128) for 20 
minutes before being embedded in Tissue-Tek® O.C.T.™ and stored at -80°C, 
as fully described in section 3.22 Immunofluorescent staining of frozen tissue, 
formalin fixed paraffin embedded tissue & cultured cells. 
 
3.5 Organ culture of murine tissues 
Incisors of postnatal day 0-7 mice were extracted by microdissection under a 
Leica M80 stereo microscope. The dentine of the incisor was isolated, and the 
dentine washed and stored in Hank's balanced salt solution (HBSS) (Gibco, 
14175-053) for 24 hours. From further mice, the incisors were again extracted 
and the CL region isolated. The tissue was placed into dispase (Roche, 
4942078001) for 1 hour at 37°C. After which the dispase was neutralised by 10ml 
of Dulbecco modified Eagle’s medium (DMEM) (Gibco, 31966021) containing 10% 
foetal bovine serum (FBS) (Sigma, F7524) and 1% penicillin-streptomycin 
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(Hyclone, SV30079.01). The epithelial tissue was then removed mechanically by 
microdissection under a Leica M80 stereo microscope.  
The dentine slides were placed on sterile cell strainers (Corning 431750) in a 6 
well plate (Fisher Scientific, 140685) containing Dulbecco modified Eagle’s 
medium/F12 (DMEM/F12) (Gibco, 31331-028) with 20% FBS, 1% penicillin-
streptomycin and 1% L-Ascorbic acid (w/w) (Sigma, A4403). The extracted 
incisor mesenchyme was then placed on top of the dentine and cultured for 4-7 
days. 
The dentine-mesenchyme samples were removed from culture and placed 
directly into 4% paraformaldehyde (PFA) (Sigma Aldrich, 158127) solution in 
10mM phosphate buffered saline (PBS) (Sigma, 4417) for 20 minutes at room 
temperature. After fixation the samples were washed twice in PBS. Samples were 
then passed through serial solutions of 10%, 20% and 30% sucrose (Sigma, 
S0389) in PBS for 20 minutes each, before being embedded in Tissue-Tek® 
O.C.T.™ (Sakura, 4583) and snap frozen by plunging into liquid nitrogen. Once 
frozen samples were stored at -80 before being sectioned at 15μm and stained 
for immunofluorescent analysis (see section 3.22 Immunofluorescent staining of 
frozen tissue, formalin fixed paraffin embedded tissue & cultured cells).  
Alternatively, sections were used to visualise the actin cytoskeleton. Samples 
were cryosectioned at 15µm thickness on a Leica CM1850 cryostat onto 
Polysine™ Microscope Adhesion Slides (Thermo Scientific, J2800AMNZ). The 
tissue was fixed in ice cold Acetone (Sigma Aldrich, 34850) for 30 minutes. Slides 
were washed three times in PBST (PBS containing 0.1% Triton-X100, (Sigma, 
X100)) for 5 minutes per wash, and then incubated for 30 minutes in 0.1µg/ml 
4’,6-diamidino-2-phenylindole (DAPI) (Sigma Aldrich, D9542) with 1:200 DyLight 
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554 Phalloidin (Cell Signalling, 13054) in PBS. Stained slides were processed as 
outlined in section 3.24 Three-dimensional reconstruction of the mouse incisor 
and cultured tissues following immunofluorescent staining. 
 
3.6 Cell culture from established cell lines & primary culture of human and 
mouse cells  
Immortalised odontoblast cell lines MO6-G3 cells (MacDougall et al., 1995) were 
obtained from Professor Shou Chen, at UT Health San Antonio. Cells were 
cultured in DMEM (Gibco, 31966021) containing 10% foetal bovine serum (FBS) 
(Sigma, F7524), 1% penicillin-streptomycin (Hyclone, SV30079.01) and 
300μg/ml Geneticin (Gibco, 10131019). 
Human BMC’s were extracted and cultured in DMEM/F12 (Gibco, 31331-028) 
containing 20% FBS and 1% penicillin-streptomycin. 
CL mesenchyme cells were isolated as follows; Incisors were dissected from 
postnatal day 30 CD1 mice shortly after death. The CL region was dissected 
under a Leica M80 stereomicroscope. The explants were incubated for 60 
minutes in 1% Collagenase I (Sigma, C0130) in HBSS (Gibco, 14175-053) with 
1% penicillin-streptomycin and 1% Fungizone® Antimycotic (Gibco, 15290-018). 
Following incubation collagenase was neutralised with DMEM/F12 containing 10% 
FBS and 1% penicillin-streptomycin. The resulting cell suspension was 
centrifuged at 1000 RCF, at room temperature for 5 minutes. Supernatant was 
discarded, and the pellet resuspended in complete AmnioMax Media, which 
combines AmnioMAX™ C-100 Basal Medium (Gibco, 17001-07) and 
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AmnioMAX™ C-100 Supplement (Gibco, 12556-023) before being cultured on 
Poly-D-Lysine CELLCOAT® dishes (Greiner Bio One, 628940). 
 
3.7 Synchronisation of cell cycle of cultured cells 
Adapting the protocol from(Chen et al., 2012a), cultured cells UT Health San 
Antonio were grown under different culture conditions in order to induce cell cycle 
synchronisation. Twenty-four hours after initial seeding and culture under normal 
cell culture conditions, cells were grown in basal or fully supplemented media as 
described in Figure 15. After the defined amount of time under this treatment, 
cells were replenished with new media, either maintaining the current supplement 
positive or negative condition or returning the appropriate supplements to the 
culture (Figure 15). 
 
 
Figure 15. A quiescent mesenchymal stem cell in vitro model system utilises serum 
starvation to model quiescence 
Cultured incisor mesenchyme, when grown under mesenchymal selective conditions displays 
heterogeneity in cell cycle state. Cells are deprived of serum to induce starvation conditions and so 
promote cell cycle arrest, producing a largely quiescent cell population. When serum is returned to 
the culture conditions, cells are encouraged to re-enter the cell cycle, thus producing a more TAC-
like population. 
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Cells were cultured in their standard conditions and classified as “fed” cells, within 
this population the mixed expression of quiescent MSC and MTAC marker genes 
was observed. By removing serum supplementation from the culture media cells 
were considered “starved”. The third culture regimen was also undertaken 
whereby the cells were starved initially before having serum replenished before 
analysis, thus encouraging the cells to re-enter the cell cycle and mimic TAC-like 
cells, termed “recovered” cells. 
 
3.8 Cell culture confluency assay 
Cells were seeded at equal densities of 1x105 into a 6 well plate (Fisher Scientific, 
140685). Wells were synchronised as described in section 3.7 Synchronisation 
of cell cycle of cultured cells. In certain conditions siRNA was added to the culture 
at the point of replenishing the supplements to the media (see section 3.11 
Transfection of cultured cells with short interfering RNA). 
Cells were fixed in 10% Formalin (Sigma, HT50-128) for 30 minutes at room 
temperature before being washed 3 times for 5 minutes each in HBSS (Gibco, 
14175-053). Cells were visualised using 0.01% Crystal Violet solution (Sigma, 
V5265). Images were taken of four areas of each well on a Leica DM1000 LED 
microscope. Confluency was measured using FIJI (Image J 1.51n). 
 
3.9 Infection of cultured cells with Ki67-FUCCI cell cycle indicator 
Ki67-mCherry-BSD and Ki67-mAG-NEO plasmids were gifted by Alexander 
Zambon. Human BMCs were incubated with the plasmid containing viral 
containing supernatant with 10μg/ml polybrene (Millipore, TR-1003-G) for 2 hours. 
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Following the incubation, the supernatant was replaced with normal growth media. 
Infected cells were definitively selected using 10µg/ml blasticidin (Sigma Aldrich, 
15205) and 250µg/ml Geneticin (Gibco, 10131019). 
 
3.10 Flow cytometric analysis of cultured cells 
FUCCI infected BMCs (see section 3.9 Infection of cultured cells with Ki67-FUCCI 
cell cycle indicator) were harvested (see section 3.7 Synchronisation of cell cycle 
of cultured cells), fixed in 4% PFA (Sigma Aldrich, 158127) solution in 10mM PBS 
(Sigma, P4417) for 30 minutes at room temperature, and analysed using the BD 
FACSCanto II SOR (Beckman Coulter). Data was acquired using blue laser (488 
nm) for mAzamiGreen signal and yellow-green laser (561 nm) for mCherry. 
Results were analysed using the FlowJo software v10.3 (Tree Star Inc.).  
For flow cytometry analysis of stained cultured cells, the cells were collected and 
stained using the Mouse Mesenchymal Stem Cell Marker Antibody Panel (R&D, 
SC018). Cells were harvested and fixed in flow staining buffer (R&D, FC001) for 
15 minutes at room temperature. After 30 minutes of incubation with the primary 
antibodies provided in the kit, the cells were washed and incubated for 30 minutes 
with secondary antibodies appropriate to the primary antibodies used (Alexa 488 
donkey anti-mouse IgG (Life Technologies, A21202) or Alexa 488 donkey anti-
rat IgG (Life Technologies, A21208). 
Cells were analysed on a BD Accuri C6 (Beckman Coulter) Data was acquired 
using the blue laser (488nm) to detect the Alexa 488 signal from the bound 
secondary antibodies. Analysis was performed in the BD Accuri C6 Software 
(Accuri Cytometers Inc, version 1.0.264.21) 
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3.11 Transfection of cultured cells with short interfering RNA 
Short interfering RNA was added to cells in accordance with the protocol as 
outlined in the information sheet provided by polyplus INTERFERin kit (Polyplus, 
409-10).  
 
In brief, siRNA was complexed with interferin reagent in DMEM (Gibco, 31966021) 
containing 1% penicillin-streptomycin (Hyclone, SV30079.01) for 15 minutes. The 
media on the cells is then replaced with fresh complete media and 100μl of each 
siRNA complex was added per well of a 24 well plate. Cells were collected or 
fixed after 48 or 72 hours as appropriate. siRNAs used are listed in Table 2. 
 
3.12 Treatment of cultured cells with recombinant proteins 
Cells were treated with recombinant proteins either through direct addition of the 
protein to fresh media (without the use of carriers) or via an indirect coating 
method. 
Direct protein treatment involved the addition of the protein into fresh un-
supplemented or fully supplemented media as appropriate to the cell line. This 
fresh media was then placed onto the cells which had been cultured previously 
for 24 hours. Media containing the protein was replaced every 48 hours. 
Table 2. siRNA constructs used for cell culture transfection 
Target ConcN Company siRNA 
Code 
Mm_SmarcA2_4 10μM Qiagen 2182015 
Mm_SmarcA2_3 10μM Qiagen 2182014 
mDlk1 10μM Invitrogen 39 
mDlk1 10μM Invitrogen 38 
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The indirect binding method involved passaging cells onto pre-prepared dishes 
which had already been coated with protein. Dish preparation was performed as 
follows; 6 well plate (Fisher Scientific, 140685) plates were coated by placing 
10μg/ml of Goat anti-human IgG (Sigma, I1886) or Goat anti-Mouse IgG (Sigma, 
M8642) in HBSS (Gibco, 14175-053) into the dish. The dish was then incubated 
for 30 minutes at 37°C. Dishes were quickly washed five times in HBSS and then 
blocked by incubating with a 2% solution of bovine serum albumin (BSA) (Sigma, 
A2153) in HBSS over night at 4°C. Following blocking 10μg/ml of the recombinant 
Human Dlk1 protein (R&D, 144-PR/CF, lot HNE041302) was added to the 
blocking solution and incubated for 2 hours at 37°C. Following preparation of the 
dishes they were washed quickly in HBSS 5 times and immediately cells are 
plated into them. 
 
3.13 Treatment of cultured cells with synthetic probe, PFI3 
Cells were treated with PFI-3 (Sigma, SML 0939) by adding PFI-3 directly to fresh 
cell culture media. As PFI-3 was dissolved in Dimethyl sulphoxide (DMSO) Hybri-
Max (Sigma, D2650) as stock, the 50mM stock was diluted 1:1000 in media 
before being used at final concentrations of 5μM 2μM or 1μM. 
After culture cells were collected for crystal violet staining and RNA as described 
in section 3.8 Cell culture confluency assay. 
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3.14 Chromatin immunoprecipitation of cultured cells  
ChIP was performed on cells using the ChIP-IT high sensitivity kit (Active Motif, 
53040) in accordance with the provided protocol. In summary the procedure was 
as follows; 
Cells were fixed using Complete Cell Fixation Solution added directly to the 
culture media for 15 minutes at room temperature. Fixation was quenched using 
Stop Solution. Cells were scraped and collected by centrifugation for 3 minutes 
at 1250 RCF at 4°C. The pellet was resuspended and washed in ice-cold PBS 
Wash Buffer twice via centrifugation. The resultant pellet was resuspended in 
Chromatin Prep Buffer supplemented with protease inhibitor cocktail (PIC) and 
phenylmethylsulphonyl fluoride (PMSF) and incubated for 10 minutes on ice. 
Using a Dounce homogeniser the cells were homogenised, collected by 
centrifugation and resuspended in fresh ChIP Buffer supplemented with PIC and 
PMSF. 
Chromatin was sheared using a Diagenode Bioruptor Pico (Diagenode) by 
sonicating for 15 seconds followed by 30 seconds of rest for four cycles. Cell 
debris was removed by pelleting this out by centrifugation. 
Antibodies or control IgG was mixed with Blocker as outlined in Table 3; 
 
Table 3. Antibodies used in ChIP assays 
Antibody Company Catalogue  
Number 
Amount IgG Company Catalogue  
Number 
h,mRBPSUH(D10A4) 
Cell 
Signalling 
5313 100ng 
rabbit IgG 
from serum 
Sigma-
Aldrich 
I5006 
H3K27me3 Diagenode pAb-069-050 1μg 
rabbit IgG 
from serum 
Sigma-
Aldrich 
I5006 
H3K9me3 Diagenode pAb-056-050 1μg 
rabbit IgG 
from serum 
Sigma-
Aldrich 
I5006 
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This antibody mix was mixed with ChIP Buffer, PIC and sonicated chromatin and 
incubated over night at 4°C. 
Immunoprecipitation was performed by washing Protein G agarose beads in TE 
pH 8.8 and then mixing the washed beads to the antibody/chromatin mixture and 
incubating for 3 hours at 4°C. Following incubation with the beads the solution 
was passed through a ChIP filtration column to collect the bound chromatin. The 
bound chromatin was washed and eluted using the provided solutions. The cross-
links within the eluted sample was reversed and the DNA purified by overnight 
incubation at 37°C in Proteinase K. The DNA was collected by heating the sample 
to 95°C for 8 minutes and then plunging into ice for 1 minute to deactivate the 
Proteinase K function. DNA Purification Binding Buffer and Sodium Acetate was 
added to the sample which was then passed through a DNA Purification Column 
using centrifugation. The column was washed in DNA Purification Wash Buffer 
and finally eluted from the column using DNA Purification Elution Buffer. 
 
 
 
 
Figure 16. The regions of the genome targeted by ChIP assay primers  
A A schematic showing the location of RBP-Jκ binding sites within 10000 base pairs of the SmarcA2 
transcript variant 1 start codon (numbered 1-20) with the target region of primers designed to cover 
these (marked a-k & z-v) B Illustration of the Dlk1 loci with CpG islands as presented on USCS 
genome browser (2011). 
 
 
71 
 
Input DNA was prepared in the same manner, however rather than column-based 
purification.  Following proteinase K treatment, the DNA was immunoprecipitated 
in 2-Propanol (Fluka Analytical, 34965) with 1ul GlycoBlue (Ambion, AM9515), 
before washing in 70% ethanol (VWR Chemicals, 20821.321) and resuspended 
in 0.1% diethylpyrocarbonate (Sigma Aldrich, D5758) treated water (DEPC). 
Regions of the genome targeted by primers designed for ChIP as described in 
3.19 Real-time PCR & data analysis, to target the regions of CpG islands 
associated with the Dlk1 gene loci, and the Promotor region of the SmarcA2 gene 
containing Rbp-Jκ binding sites (Figure 16). 
 
3.15 Laser capture microdissection of frozen & formalin fixed paraffin 
embedded tissues 
Frozen tissue was prepared in OCT then frozen at -80°C before being sectioned 
using a Leica CM1850 cryostat at a thickness of 20μm. Sections were mounted 
onto PEN Membrane Glass Slides (Applied Biosystems, LCM0522).  
FFPE blocks were sectioned on a Microm HM320 microtome at a thickness of 
10μm and placed onto PEN Membrane Glass Slides. After drying overnight, 
deparaffinisation was performed. Slides were heated to 55°C for 20 minutes 
before being twice washed in xylenes (Sigma Aldrich 534056) for 10 minutes. 
Slides were then washed in 100% industrial methylated spirits (IMS) (VWR, 
23684.360) for 5 minutes, before being washed for 2 minutes in 95% IMS, then 
70% IMS and finally in distilled water. 
All prepared slides were stained using 1% Methyl Green (Fluka Analytical, 67060) 
in 0.1% DEPC (Sigma Aldrich, D5758), then washed three times for 30 seconds 
72 
 
in 0.1% DEPC before being allowed to dry for 5 minutes in order to make 
visualisation of the structures clear. An ArcturusXT™ LCM instrument was used 
to perform LCM onto CapSure® Macro LCM Caps (Applied Biosystems, 
LCM0211). Capture was performed utilising the ultraviolet laser to cut around 
regions of interest, particularly the CL-MSC, MTAC, Odontoblast and NVB 
containing dental pulp. The infrared laser was then deployed to fix the cap 
material to the section allowing the region to be lifted from the slide. 
Captured tissue to be used for RNA analysis was stored in Tri-Reagent (Sigma, 
T9424) at -80°C within 30 minutes of initial sectioning.  Captured tissue to be 
used for gDNA analysis was processed immediately (see section 3.18 Extraction 
of genomic DNA from laser capture microdissected tissue). 
 
3.16 Extraction of mRNA from cultured cells & LCM captured tissue 
Samples were collected from tissue using LCM (see section 3.15 Laser capture 
microdissection of frozen & formalin fixed paraffin embedded tissues). 
Alternatively, from cultured cells by washing the cells in HBSS (Gibco, 14175-
053) briefly before covering the cells in Tri Reagent (Sigma, T9424) for 5 minutes 
at room temperature, before scraping the cells, collecting 500ul of cell suspension. 
RNA was extracted and purified using an acid guanidinium thiocyanate-phenol-
chloroform extraction protocol. Briefly, the total RNA was extracted using Tri-
Reagent. The samples were vortexed and incubated for 5 minutes at room 
temperature before addition of Chloroform (Sigma Aldrich, C2432) at a ratio of 
5:1 (lysate: chloroform). The samples were then incubated for a further 5 minutes 
before centrifugation for 10 minutes at 13000rpm. The aqueous phase was then 
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collected and added 1:1 with 2-Propanol (Fluka Analytical, 34965) with 1ul 
GlycoBlue (Ambion, AM9515). The sample was incubated at -20°C overnight 
before centrifugation at 13000rpm for 45 minutes at 4°C. The subsequent pellet 
was then washed in 1ml 70% Ethanol (VWR Chemicals, 20821.321) and 
centrifuged for 10 minutes at room temperature at 9000rpm. The resulting pellet 
was resuspended in 10ul of 0.1% DEPC (Sigma Aldrich, D5758). 
Purified RNA was quantified on a NanoDrop 2000 UV-Vis Spectrophotometer 
(Thermo Scientific). Quality control was assessed by analysis of the 260/230 ratio, 
which highlights phenol contamination and 260/280 ratio more than 1.8 which can 
be used as an indicator of DNA contamination. 
 
3.17 Reverse transcription of mRNA extracted from cultured cells & laser 
capture microdissected tissue 
Reverse transcription polymerase chain reaction (RT-PCR) was performed using 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 4368814) 
in accordance with the manufacturers protocol on a Veriti™ Thermal Cycler 96 
well (Applied Biosystems) using manufacturers program of 25°C for 10 minutes, 
37°C for 120 minutes, 85°C for 5 minutes and 4°C indefinitely thereafter. Samples 
were diluted in 180μl of 0.1% DEPC (Sigma Aldrich, D5758) and stored at -20°C. 
 
3.18 Extraction of genomic DNA from laser capture microdissected tissue 
LCM was used to capture regions of tissue of interest (see section 3.15 Laser 
capture microdissection of frozen & formalin fixed paraffin embedded tissues). 
CapSure® Macro LCM Caps (Applied Biosystems, LCM0211) with captured 
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tissue attached, were placed into 30μl of DNA lysis buffer. Lysis buffer contained 
10mM TrisCL ph8 (Sigma Aldrich, T1503), 1mM EDTA (Thermo Fisher, BP2482-
100), 1% Tween-20 (Sigma Aldrich, P9416), 0.04% Proteinase K (RPROTK-RO 
ROCHE, 03115836001). Samples were inverted and incubated at 58°C overnight. 
Caps were inspected visually to confirm that the tissue had been removed into 
the reagents. The sample was heated to 95°C for 8 minutes, before being 
plunged into ice for 1 minute. DNA concentration of the sample was measured 
on a NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific). Analysis 
was performed by real-time PCR (see section 3.19 Real-time PCR & data 
analysis) followed by gel electroporation (see section 3.21 Electroporation of 
PCR produced amplicons). 
 
3.19 Real-time PCR & data analysis 
Real-time RT-PCR analysis was performed on a LightCycler 480 Real-Time 
system (Roche) for 45 cycles, using a SYBR Green I MasterMix (Roche) and 
primers listed below. Internal control primers were used to determine relative 
quantification of gene expression using the 2-ΔΔCt method. Analyses were 
performed using three technical replicates. 
Real Time PCR was performed in triplicate.  Samples were combined with 
LightCycler 480 SYBR Green I master kit (Roche Life Science, 4887352001) 
(diluted 1:1 with the water provided in accordance with the manufacturer’s 
instructions) and appropriate primers in a ratio of 1:8:1 totalling 10µl. This equates 
to a final primer concentration of 1µM. The samples were analysed with each 
primer in triplicate as a technical control.  
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A panel of genes known to be upregulated or down regulated within quiescent 
MSCs in a number of tissues was identified as potential targets for analysis using 
real time polymerase chain reaction (PCR). This panel was made up of a 
selection of genes identified in Cheung & Rando’s 2013 paper (Cheung and 
Rando, 2013). These genes were identified as being involved in many cellular 
processes which govern self-renewal, cell cycle arrest/progression and 
differentiation (Figure 17). 
Primers for mRNA transcription analysis were designed against the CDS 
sequence for each gene, provided by NCBI gene 
(http://www.ncbi.nlm.nih.gov/gene/). Primers for the assessment of genomic DNA 
(gDNA) were designed against the gDNA sequence. All primers were generated 
using Primer 3 website (http://biotools.umassmed.edu/bioapps/primer3_www.cgi) 
and validated on UCSC In-SilicoPCR (http://genome.ucsc.edu/cgi-
bin/hgPcr?command=start) assembly Dec11(GRCm38/mm10). 
 
 
Figure 17. Molecular markers, differentially expressed in quiescent mesenchymal stem cells 
and mesenchymal transit amplifying cells, are involved in diverse cellular processes 
Schematic representation of a panel of genes identified as being up or down regulated in quiescent 
MSCs adapted from (Cheung and Rando, 2013). Genes are grouped by cellular function/role. Green 
arrows indicate genes which are commonly upregulated in quiescent MSCs. Red arrows denote 
downregulation is commonly observed in quiescent MSCs, thus genes which are more commonly 
associated with mitotically active MTAC-like cells. 
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Table 4. Primers used for mRNA assessment 
Gene for mRNA Analysis Product 
Size 
Forward Primer 
Reverse Primer 
Anln anillin, actin binding protein 153 
Anln-F, 5'-ATTTTGTGCAAGACGCAACA-3’;  
Anln-R, 5'-ATCCAGAGATCCCGCTCTTC-3’; 
Ccna2 cyclin A2 164 
Ccna2-F, 5'-CATTGGCACAACAGACTGGA-3’;  
Ccna2-R, 5'-TGTCTCTGGTGGGTTGAGAA-3’; 
Ccnb1 cyclin B1 159 
Ccnb1-F, 5'-TTCCTGTTATGCAGCACCTG-3’;  
Ccnb1-R, 5'-CGGCCTTAGACAAATTCTGA-3’; 
Ccnd3 cyclin D3 164 
Ccnd3-F, 5'-GCGATGTATCCTCCATCCAT-3’;  
Ccnd3-R, 5'-GCAGCTTCGATCTGTTCCTG-3’; 
Cdh1 cadherin 1 245 
Cdh1-F, 5’-CAGCTGCCCCGAAAATGAAAAGG-3’; 
Cdh1-R, 5’-TCCACCGCTTCCCCATTTGATG-3’; 
Cdkn1A cyclin-dependent kinase inhibitor 1A (P21) 142 
Cdkn1A-F, 5'-CTTGTCGCTGTCTTGCACTC-3’;  
Cdkn1A-R, 5'-TCTCTTGCAGAAGACCAATCTG-3’; 
Cdkn1B cyclin-dependent kinase inhibitor 1B 152 
Cdkn1B-F, 5'-TTGGGTCTCAGGCAAACTCT-3’;  
Cdkn1B-R, 5'-TCTGTTGGCCCTTTTGTTTT-3’;  
Cdkn1C cyclin-dependent kinase inhibitor 1C (P57) 146 
Cdkn1C-F, 5'-TCTAGGGGAATGGTTGTTGA-3’;  
Cdkn1C-R, 5'-GATTTTTGTTGGGCCTCTTT-3’; 
Ctdsp1 
carboxy-terminal domain, RNA polymerase 
II, polypeptide A, small phosphatase 1 
149 
Ctdsp1-F, 5'-CGCCTCCTATGTCTTCCATC-3’;  
Ctdsp1-R, 5'-GCCTAGGCTGTCTGAGCACT-3’; 
Cycs cytochrome c, somatic 159 
Cycs-F, 5'-AAATCTCCACGGTCTGTTCG-3’;  
Cycs-R, 5'-GCGAAGATCATTTTTGTTCCA-3’; 
Dlk1 delta like non-canonical Notch ligand 1 276 
Dlk1-F, 5'-GCGTGGACCTGGAGAAAG-3’;  
Dlk1-R, 5'-GGAAGTCACCCCCGATGT-3’; 
Ezh1 
enhancer of zeste 1 polycomb repressive 
complex 2 subunit 
149 
Ezh1-F, 5’-ACCCCAACTGTTATGCCAAA-3’; 
Ezh1-R, 5’-CCTCTCGATGCCCACATACT-3’; 
Foxo3 forkhead box O3 130 
Foxo3-F, 5'-ACAAACGGCTCACTTTGTCC-3’;  
Foxo3-R, 5'-CTGTGCAGGGACAGGTTGT-3’; 
GapDH 
glyceraldehyde-3-phosphate 
dehydrogenase 
148 
GapDH-F, 5'-ATCACTGCCACCCAGAAGAC-3’;  
GapDH-R, 5'-CAGTGAGCTTCCCGTTCAG-3’; 
Hat1 histone aminotransferase 1 164 
Hat1-F, 5'-TTCGACTGCTGGTGACTGAC-3’;  
Hat1-R, 5'-TGGTCTCAGGCATTTCTTCA-3’; 
Hes1 hes family bHLH transcription factor 1 148 
Hes1-F, 5’-CCAAGCTAGAGAAGGCAGACA-3’; 
Hes1-R, 5’GTCACCTCGTTCATGCACTC-3’; 
Hes5 hes family bHLH transcription factor 5 164 
Hes5-F, 5’-AGGGTAGCAGCTTTCAGGAT-3’; 
Hes5-R, 5’-AGCCTCTGGGATCTCCTCTA-3’; 
Heyl 
hairy/enhancer-of-split related with YRPW 
motif-like 
141 
Heyl-F, 5’-TTTGAGAAACAGGGCTCCTC-3’; 
Heyl-R, 5’-CCCAATACTCCGGAAGTCAA-3’; 
K14 keratin 14 190 
K14-F, 5’-CCTGCTGGATGTGAAGACAA-3’; 
K14-R, 5’-ATCGTGCACATCCATGACCT-3’; 
Ki67 
antigen identified by monoclonal antibody 
Ki 67 
194 
Ki67-F, 5'-AGCAAACCAGCTGCAGAAAT-3’;  
Ki67-R, 5'-TTCTTGGTGCATACAATGTCTT-3’; 
Notch1 notch 1 150 
Notch1-F, 5’-TGTTGTGCTCCTGAAGAACG-3’; 
Notch1-R, 5’-TCCATGTGATCCGTGATGTC-3’; 
Notch2 notch 2 157 
Notch2-F, 5’-GAGGCGACTCTTCTGCTGTT-3’; 
Notch2-R, 5’-CCATGTGGTCAGTGATGTCC-3’; 
Pcna proliferating cell nuclear antigen 167 
Pcna-F, 5'-GAAGAGGAGGCGGTAACCAT-3’;  
Pcna-R, 5'-TGTCCCATGTCAGCAATTTT-3’; 
PdgfrВ 
platelet derived growth factor receptor, 
beta polypeptide 
210 
PdgfrВ-F, 5'-CAGAAATGCTGGGAAGAAAA-3’;  
PdgfrВ-R, 5'-AACAGAGCTGGTGTCCAGAG-3’; 
Pdk1 
pyruvate dehydrogenase kinase, 
isoenzyme 1 
153 
Pdk1-F, 5’-TACGGGACAGATGCGGTTAT-3’; 
Pdk1-R, 5’-GGTCATGTCTTTCGGCTCTC-3’; 
Prdm5 PR domain containing 5 166 
Prdm5-F, 5’-AGTGCTCAGAGTGCAGCAAG-3’; 
Prdm5-R, 5’-ATCGGACGGTTAGGATTGTG-3’; 
Ptov1 prostate tumour over expressed gene 1 145 
Ptov1-F, 5'-CGCCTGGTACAGTTCCACTT-3’;  
Ptov1-R, 5'-TCCGAGGAGTACAGGAGCAT-3’; 
Rbp-Jκ 
recombination signal binding protein for 
immunoglobulin kappa J region 
166 
Rbp-Jκ-F, 5'-GACAAGGCCGAGTACACGTT-3’;  
Rbp-Jκ-R, 5'-CATCCCCAAACCACACTCTT-3’; 
Sgol1 shugoshin 1 145 
Sgol1-F, 5'-CCAGCAGTGGCTCTGACTAA-3’;  
Sgol1-R, 5'-TCATACCCTTTTCTGCTTGA-3’; 
SmarcA2 
SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, 
subfamily a, member 2 
172 
SmarcA2-F, 5'-AGGCGAAATCTGTGAAGGTG-3’;  
SmarcA2-R, 5'-TCAGTTCCACTTGCTTCTGACT-3’;  
Tef thyrotroph embryonic factor 147 
Tef-F, 5'-AGCTCTTCAACCCTCGGAAG-3’;  
Tef-R, 5'-GAGCGTTTAGCTGCCACATT-3’; 
Thra thyroid hormone receptor alpha 155 
Thra-F, 5'-GGCTGTGCTGCTAATGTCAA-3’;  
Thra-R, 5'-TCACCTTCATCAGCAGCTTG-3’; 
Top2a topoisomerase (DNA) II alpha 147 
Top2a-F, 5'-GAACAGTCGCAAAAGGAAGC-3’;  
Top2a-R, 5'-GCTCGAGGAGCTATCGTGTC-3’; 
Vimentin vimentin 148 
Vim-F, 5'-CCAACCTTTTCTTCCCTGAA-3’;  
Vim-R, 5'-GGTCATCGTGATGCTGAGAA-3’; 
Zbtb20 zinc finger and BTB domain containing 20 169 
Zbtb20-F, 5'-CAAGGCGACAAAAAGCCTTA-3’;  
Zbtb20-R, 5'-GCGTCACCATGTGCTTGATA-3’; 
Zfp30 zinc finger protein 30 154 
Zfp30-F, 5'-GGCTGAGAAGAGAAGGTGGA-3’;  
Zfp30-R, 5'-TTTCCCCAAAAGGGAGTCTT-3’; 
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Primers were designed to give an amplicon length that reduces the risk of dimers 
and hairpins. Primers for the assessment of mRNA levels were also designed to 
cross an exon to negate the problems of gDNA contaminants being amplified. To 
reduce the risks posed by RNA degradation leading to non-binding of primers, 
primers were designed to bind towards the 3’ end of the cDNA. Primers were 
validated against cDNA extracted from mouse embryonic fibroblasts, to ensure 
that they detect cDNA and the amplicons produced are of the anticipated length. 
Mouse and human primers used in this study are shown in Table 5.  
 
 
Table 5. Primers used for gDNA assessment 
Experiment  Product Size Forward Primer 5’-3’ Reverse Primer 5’-3’ 
Dlk1 methylation ChIP 5' CpG island site 1 CTTTTCGTGGTGGTTTTCGT GCAAGTCTCAGGAACCAAGC 
Dlk1 methylation ChIP 5' CpG island site 2 GTGCAACCCTGGCTTTCTT AAGAAAGCCAGGGTTGCAC 
Dlk1 methylation ChIP 5' CpG island site 3 GTGGTTTTCGTGTGTGCATC GCAAGTCTCAGGAACCAAGC 
Dlk1 methylation ChIP 5' CpG island site 4 ACCCGTCTAGCCAAAGAGTG AAGAAAGCCAGGGTTGCAC 
Dlk1 methylation ChIP 5' CpG island site 5 GTGCAACCCTGGCTTTCTT GGCTCACCATAGGTGCTGTG 
Dlk1 methylation ChIP 3' CpG island site 1 CTAACCCATGCGAGAACGAT GCTTGCACAGACACTCGAAG 
Dlk1 methylation ChIP 3' CpG island site 2 GGATTCGTCGACAAGACCTG TCGGTGAGGAGAGGGGTACT 
Dlk1 methylation ChIP Non-CpG island control site 1 AAACACAAGCTCACAGCCTCT TGCAGTTTCAAGAGCACCAG 
Dlk1 methylation ChIP Non-CpG island control site 2 CCCATCTAAAAATCCCAACATC AAAACCCCAGGTTCAGTTCC 
Dlk1 methylation ChIP Non-CpG island control site 3 GGAACTGAACCTGGGGTTTT CCCCACACGGTAGAAGAAGA 
Rbp binding SmarcA2 ChIP Non-Rbp-Jκ binding control Site GACACATGGTTCACATTCTCC AGTCACTTGATGGCACCTGT 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 3 CCACCAATGGCATCCTTAAC CAGGGAACATTGGGCATATT 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 3 GCACACTGGAAAAGGACCTC TTCTGGGGATTCCATTCATC 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 4 & 5 CTGAGCCCTGTGACAGATCA GCACACTGGAAAAGGACCTC 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 6 & 7 CGCATGGAAGCCTAAATGTT TTAGGCTGCTGGCCATAAAT 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 8 TCACCTTTGCAGGTCCCTAT CACTCCCACAGAACCCTGAG 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 9 & 10 CAAGGCTTATCGCTCTCCTG ACCTCCAAAACTGCCCTTCT 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 11 GAGGCTTAGGCTGACTGTGG TCCCTGCCACATTACTCTCC 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 12 & 13 TGGAGGGGGTCTTTGTGATA TCTGGGTCATGTCGATAGGG 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 14 TTGGAGATCACCCATCATCA GGAAATGGGAAGTGATGGAA 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 15 GGCTGGCTGGTCTAATTTCA TTCCGGCAGAAATCAAAGAT 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 16 GACCAATTCTGGGGCCTAGT ATGCCTGAGAAGACGGGTAA 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 17 GGGCTGGTCTTTCCTCATTT TGGTTAAAGTGGCACATGGA 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 18 TCCATGTGCCACTTTAACCA CTCCAGCAAACAAACAAGCA 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 19 CCCCACTTTTGCTTGTTTGT TGTCAAGGTGTCACCCCATA 
Rbp binding SmarcA2 ChIP Rbp-Jκ binding site 20 GAGGGAAAATGTGGAGGACA GGAAGCACACAAGCTCAAAA 
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Real-time PCR was performed using a Roche Lightcycler 480 Instrument II 384-
well block real-time PCR machine (Roche), in accordance with the 
manufacturer’s instructions. Program details are outlined in Table 6. 
 
Results were analysed using comparative Ct methods. PCR amplification was 
checked to ensure appropriate amplification curves and annealing temperature 
was obtained. Results were exported into Microsoft Excel. 
 
3.20 Statistical analysis of real-time PCR data 
Experimental data was analysed using PRISM 5 software (Graph Pad Software). 
For Real-Time PCR analysis data is shown as mean with standard error of mean, 
a Two-way ANOVA followed by Bonferroni correction was performed. Statistical 
significance was set at * p < 0.05, ** p<0.01 & *** p<0.001. Experimental n 
numbers are shown in figure legends. 
 
3.21 Electroporation of PCR produced amplicons 
Amplicons were run on an agarose gel (2% Agarose (Thermo Fisher BP160-100) 
in TAE buffer (Life Technologies, 15558-042)). Once microwaved and cooled 
20μl of Sybr Safe DNA gel stain (Invitrogen, PIN533102) was added to the molten 
Table 6. Program used for Real-Time PCR 
Program Step Temperature Time (hh:mm:ss) Repeats 
Pre-Incubation 95°C 00:05:00 1 
Amplification 95°C 
60°C 
72°C 
00:00:10 
00:00:20 
00:00:10 
45 (from cultured cell sample) 
55 (from LCM sample) 
Melting Curves 95°C 
65°C 
97°C 
00:00:05 
00:01:00 
Until reached 
1 
Cooling 95°C 00:00:01 1 
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gel before being cast. Following pouring the gel was allowed to set for 30 minutes 
at room temperature. 
The gel was submerged in TAE buffer and the comb removed. 20μl of PCR 
product was mixed with 4μl of loading dye (Thermo Scientific, R0611) and loaded 
into each well. The gel was electroporated for 15 minutes at 125 volts at room 
temperature. The gel was then imaged using a UV light chamber. 
 
3.22 Immunofluorescent staining of frozen tissue, formalin fixed paraffin 
embedded tissue & cultured cells 
Preparation and fixation of cells to be used for immunofluorescent (IF) analysis 
was performed. Cells were washed in HBSS (Gibco, 14175-053). Then fixed in 
ice cooled 4% PFA (Sigma Aldrich, 158127) solution in 10mM PBS (Sigma, 
P4417) for 30 minutes.  
Preparation and fixation of frozen tissue is as follows; Frozen tissue was 
cryosectioned at 15µm thickness on a Leica CM1850 cryostat. Sections were 
mounted onto Polysine™ Microscope Adhesion Slides (Thermo Scientific, 
J2800AMNZ) and allowed to air dry for 30 minutes before were fixed in ice cold 
Acetone (Sigma Aldrich, 34850) or freshly made ice cooled 4% PFA (Sigma 
Aldrich, 158127) solution in 10mM PBS (Sigma, P4417) for 30 minutes. 
Preparation of FFPE samples is performed as described here; FFPE samples 
were sectioned on a manual microtome at a thickness of 10μm, and placed onto 
Superfrost slides (Sigma Aldrich, Z692255). After drying overnight, 
deparaffinisation was performed. Slides were heated to 55°C for 20 minutes 
before being twice washed in xylenes (Sigma Aldrich 534056) for 10 minutes. 
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Slides were then washed in 100% IMS (VWR, 23684.360) for 5 minutes, before 
being washed for 2 minutes in 95% IMS and then 70% IMS. Antigen retrieval was 
performed by microwaving the slides in a 0.01M citrate buffer solution (citric acid 
(Sigma Aldrich, C2404) & 0.05% Tween (Sigma Aldrich, P9416)) for 1 minute. 
 
Once prepared all sample types were washed three times in PBST (PBS 
containing 0.1% Triton-X100, (Sigma, X100)) for 5 minutes per wash. Non-
Specific binding was blocked by incubation for 60 minutes with PBST containing 
5% Donkey Serum (Sigma, D9663), 0.25% cold water fish gelatine (Sigma, 
G7765) and 0.25% BSA (Sigma, A2153).  
Table 7. Antibodies used in immunofluorescence assays 
Primary 
Antibody 
Company 
Catalogue 
number 
Secondary antibody (catalogue number, company) 
Dlk1 Abcam 21682 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Dmp1 R&D Systems AF4386 Alexa 488 donkey anti-sheep IgG (A11015, Life Technologies) 
Dsp 
Gifted by Dr Larry 
Fisher (NIH) 
 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
GFP Abcam ab6673 Alexa 488 donkey anti-goat IgG (A11055, Life Technologies) 
Gli1 Novus NBP1-78259 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
H3k9me3 Diagenode 
pAb-056-
050 
Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
H3k27me3 Diagenode 
pAb-069-
051 
Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Hes1 Cell Signalling 11988s Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Jag1 Cell Signalling 2620 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Jag2 R&D Systems MAB4748 Alexa 488 donkey anti-rat IgG (A21208, Life Technologies) 
K14 Covance 
PRB-155P-
100 
Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Ki67 R&D Systems AF7649 Alexa 488 donkey anti-sheep IgG (A11015, Life Technologies) 
Notch1 eBioscience 14-5785 
Alexa 488 donkey anti-mouse IgG (A21202, Life 
Technologies)  
Notch2  
NICD 
Sigma 410353 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Notch2 Cell Signalling 5732 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Notch3 R&D Systems AF1308 Alexa 488 donkey anti-goat IgG (A11055, Life Technologies) 
Pdgfrβ eBioscience 16-1401 Alexa 488 donkey anti-rat IgG (A21208, Life Technologies)  
Smarca2 AbCam 15597 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
Thy-1 eBioscience 11-0903-82 Alexa 488 donkey anti-rat IgG (A21208, Life Technologies) 
Zbtb20 Sigma HPA016815 Alexa 568 donkey anti-rabbit IgG (A10042, Life Technologies) 
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Primary antibodies were incubated overnight. Slides were washed three times in 
PBST at room temperature before incubation with secondary antibodies for 2hrs 
at room temperature. Secondary antibodies were incubated for 2 hours. Nuclei 
were counterstained with 2µg/ml DAPI (Sigma Aldrich, D9542) for 10 minutes.  
An overview of antibody concentrations and secondary pairings is summarised in 
Table 7. 
IF images were captured using a Leica DMI6000 confocal microscope with a 
Leica TCS SP8 attachment at a scanning thickness of 1μm per section. The 
microscope is running LAS AF software from Leica. Images for comparison were 
taken using the same settings and post imaging processing was conducted using 
Adobe Photoshop CC also in parallel between comparable samples. 
 
3.23 Haematoxylin & eosin staining of formalin fixed paraffin embedded 
tissue 
Slides of FFPE sectioned tissue are stained using Haematoxylin and Eosin 
histological dyes according to the following protocol. FFPE samples were 
sectioned on a manual microtome at a thickness of 10μm, and placed onto 
Superfrost slides (Sigma Aldrich, Z692255). After drying overnight, 
deparaffinisation was performed.  Slides were heated to 55°C for 20 minutes. 
Subsequently slides were washed twice in xylenes (Sigma Aldrich, 534056) for 5 
minutes. The tissue is then rehydrated through 2 changes of 100% alcohol, 
followed by a wash in 95% alcohol and then 70% alcohol (VWR, 23684.360), 
each for 2 minutes. The slides were briefly washed in distilled water before being 
stained for 8 minutes in Harris haematoxylin (Sigma, HHS16). After staining was 
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sufficient the slides were washed in tap water for 5 minutes. Differentiation of the 
stain was achieved by placing the slides in 1% Acid alcohol (Sigma Aldrich, 56694) 
for 30 seconds, before a further 5-minute tap water wash. Subsequent 
counterstaining was performed by washing the slides briefly in 95% alcohol, 
followed by a 1-minute incubation in 0.25% eosin Y solution (Sigma, 230251). 
After staining was complete, the tissue was dehydrated by passing the slides 
through two 5-minute washes in 95% alcohol, then 100% alcohol. In order to clear 
the sample, the slides were washed twice more in xylenes for 5 minutes before 
being mounted using Eukit, xylenes based mounting medium (Fluka, 03989). 
 
3.24 Three-dimensional reconstruction of the mouse incisor and cultured 
tissues following immunofluorescent staining 
For dentine culture assay, IF images were captured using A Leica DMI6000 
confocal microscope with a Leica TCS SP8 attachment at a scanning thickness 
of 1μm per section. The microscope is running LAS AF software from Leica. 
These images were used to reconstruct the growth of the cells into the dentine 
tubules using Imaris 9 (Bitplane).  
The 3D reconstruction of the CL and surrounding transit amplifying mesenchyme 
region was performed by taking serial immunofluorescently labelled cryosections. 
The epithelium was outlined from approximately 20 consecutive 20-µm-thick 
sagittal sections of the apical end of the mouse incisor. The corresponding TAC 
region was defined by the location of ki67 positive nuclei in the mesenchyme 
adjacent to the basement membrane. Computational reconstruction using BioVis 
software (version: 3.1.1.11) (http://www.biovis3d.com) was used to calculate the 
volume of the TAC region.  
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4 Results 
4.1 There is a novel endogenous pool of mesenchymal stem cells 
within the murine incisor 
In order for the mouse incisor to continuously grow throughout an animal’s life, it 
is necessary for a pool of SCs to reside within the tissue. 
Within the epithelium there is a pool of well characterised quiescent epithelial SCs 
in a structure called the CL at the apical end of the mouse incisor. The epithelial 
CL is surrounded by mesenchymal tissue. Within the dental mesenchyme of the 
incisor there is a known region of MTACs. These cells can differentiate to 
populate the odontoblast layer and participate in the production of dentine. The 
hypothesis of this body of work is that within the mesenchyme of the continuously 
growing mouse incisor there is a quiescent, cervical loop adjacent, MSC 
population which provide the pool of cells which go on to populate the MTAC 
region. 
 
4.1.1 The region of incisor mesenchyme adjacent to the epithelial stem cell 
region displays a quiescent mesenchymal stem cell marker signature 
The mesenchyme contacting the EpSC region of the CL has been highlighted by 
Gli1 reporter studies (Seidel et al., 2010, Zhao et al., 2014). This region’s 
proximity to the MTAC region of the incisor tooth, adjacent position to the EpSCs 
of the CL, indicated that this may be a region of interest in the identification of 
MSCs within the incisor tooth. Using immunofluorescent analysis, the expression 
of Thy1 and Gli1 was indeed expressed within the region of interest in addition to 
being expressed within the NVB-MSCs (Figure 18). 
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Laser capture microdissection (LCM) followed by mRNA extraction and analysis 
was conducted in order to confirm if the region of interest expresses known 
quiescent MSC markers.  Regions of tissue captured included the known MTAC 
region, the proposed CL adjacent MSC region and the region containing the 
NVBs (Figure 19).  
 
 
Figure 18. Confirmation of stem cell marker gene expression in the region of mesenchyme 
adjacent to the cervical loop 
Postnatal day 7 CD1 mouse incisor cervical loop region cryosectioned and immunofluorescently 
stained with antibody specific to A Gli1 & B Thy1, counterstained with DAPI. Representative images, 
n=2 
 
 
Figure 19. Regions of incisor mesenchyme can be located and captured by Laser Capture 
Microdissection 
A Representative postnatal day 7 CD1 mouse incisor sectioned onto Laser Capture Microdissection 
(LCM) membrane slide & stained with methyl green. (n=11) B The same preparation of tissue as 
shown in panel A, following LCM to capture the region of mesenchyme proposed to contain a 
Cervical Loop associated Mesenchymal Stem Cells (CL-MSC) region, Neurovascular Bundle (NVB) 
region, Odontoblast (Ods) region and the region of known Mesenchymal Transit Amplifying 
Cells.(MTACs) C Captured tissue sections taken from the section shown in panel A 
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The CL-MSC region displayed high expression of transcripts of quiescent marker 
genes compared to the expression of these genes in the neighbouring MTACs 
(Figure 20 A). The pattern of increased expression was not limited to genes which 
regulate only one cellular pathway, but included genes involved in chromatin 
assembly, cell cycle arrest and transcriptional control. 
In addition, this region also had reduced expression of genes expected to be 
down regulated in quiescent MSCs (Figure 20 B). Most notably a reduction in 
proliferation and cell cycle progression markers, was observed in the MSC region. 
 
 
Figure 20. The markers gene expression profile of known quiescent mesenchymal stem cells 
is observed within the proposed mesenchymal stem cell region of the mouse incisor 
Real Time PCR analysis of the mRNA expression levels of quiescent MSC marker genes in tissue 
captured by LCM from the MTAC region & the proposed MSC region of the p7 CD1 incisor tooth. A 
Genes with upregulation of expression in other known quiescent MSC pools are more highly 
expressed in the proposed incisor MSC region than in the MTAC region. B Genes which are 
downregulated in quiescent MSC populations are less highly expressed in the Notch active region 
than in the MTAC region. * p<0.05, ** p<0.01, *** p<0.001 Representative data, n=4 
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Of this panel of markers, two genes that were significantly upregulated in the CL-
MSC region, SmarcA2 and Zbtb20, were selected for additional investigation.  
 
These markers displayed high levels of consistency between experimental data 
sets, the antibodies were readily available, and the functions of these genes are 
not fully understood, making them interesting and accessible research targets. 
Immunofluorescent analysis of these two marker genes supported the real time 
PCR data and showed stronger immunoreactivity within the MCS region than in 
 
Figure 21. Quiescent mesenchymal stem cell marker proteins are expressed in the 
mesenchymal stem cell region of the mouse incisor 
Postnatal day 7 CD1 mouse incisor cervical loop region cryosectioned and immunofluorescently 
stained using antibody specific to A SmarcA2, B Zbtb20, C SmarcA2 with Ki67 & counterstained 
with DAPI. Representative images, A n=14, B n=14, C n=6 
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the MTAC region (Figure 21). The expression pattern of SmarcA2 is distinct from 
that of Ki67, with a transitional zone of dual expressing cells at the boundary of 
the MTAC region (Figure 21 C).   
Further analysis of the erupted and functional postnatal tooth is hampered by the 
tooth’s hard tissue structure. However, immunofluorescent analysis was 
undertaken at postnatal day 30. It is clear that once the incisor tooth has erupted 
and become functional, the profile of protein expression within the incisor 
mesenchyme persists (Figure 22). Immunoreactivity of Ki67 and Zbtb20 
antibodies were distinctly localised, with Zbtb20 expression restricted within the 
mesenchyme to the CL-MSC region. SmarcA2 immunoreactivity was observed 
within the MTAC region at this time, however the expression remained highest in 
the Ki67 negative, CL-MSC region. 
 
Together this data shows that the region of incisor mesenchyme adjacent to the 
CL epithelial SCs displays a quiescence MSC marker gene signature which is 
 
Figure 22. Quiescent mesenchymal stem cell marker expression patterns persist within the 
functional murine incisor 
Postnatal day 30 CD1 mouse incisor cervical loop region cryosectioned and immunofluorescently 
stained using antibodies specific to A Zbtb20 & Ki67 and B SmarcA2 & Ki67, counterstained with 
DAPI. Representative images, n=8 
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maintained into adulthood.  Consequently, this region is a likely location of an 
endogenous MSC pool. 
 
4.1.2 The endogenous mesenchymal stem cells of the incisor mesenchyme 
are progenitors of odontoblasts and differentiate through a transit 
amplifying lineage 
In order to prove that the novel pool of endogenous quiescent CL-MSCs identified 
within the mouse incisor are the progenitors of those within the odontoblast layer, 
lineage tracing is required.  
To circumnavigate the issues associated with in vivo and in vitro lineage tracing, 
examination of transgenic mice post mortem was undertaken. In previous work 
carried out within the research group of Dr Bing Hu, LacZ staining was 
undertaken on Colagen1a2 Cre x Rosa26 mice, which were therefore identified 
as having the Cre recombinase expressed in some of cells within the proposed 
CL-MSC region. However, no such expression was observed in the MTAC or 
odontoblast areas. The unpublished data here in (Figure 23 A) was kindly given 
by Dr Bing Hu (The University of Plymouth) and is printed here with his permission.  
Cre recombinase was found to be expressed primarily in the bone, but also at 
low levels in the MSC region, at embryonic, postnatal and adult aged mice (Figure 
23 A). By crossing this mouse line with RBP-Jκ flox/flox mice, their offspring could 
be assessed to determine the location of the progeny of cells where Cre 
recombinase has acted to excise RBP-Jκ. Assessment of the MTAC and 
odontoblast regions of these mice by LCM and genomic DNA analysis was 
undertaken. 
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Primers were designed against the second exon of the RBP-Jκ gene which is 
unaffected by the action of Cre recombinase on the DNA, and also against exon 
 
 
Figure 23. Transgenic mouse line Collagen 1a2Cre x RBP-Jκ flox/flox shows that cells of the 
MSC region go on to populate the MTAC and odontoblast regions 
A Collagen 1a2Cre x Rosa26 postnatal day 1 mouse mandible, lac z stained. Representative image 
from Dr Bing Hu, unpublished data. Within the mesenchyme, the MSC region shows some cells of 
positive lac z staining. (n=2) B Real time PCR undertaken on LCM samples from Collagen 1a2Cre 
x RBP-Jκ flox/flox mice of a range of ages (embryonic day 18.5 (E18.5), postnatal day 6 (p6), 
postnatal day 14 (p14) & 2 months (2M)), and from the pooled mesenchymal LCM sample from a 
control mouse of age p6. (ND denoted not detected, NA denotes non-capturable region) (n=1 for 
each age)) C Gel image of real time PCR showing RBP-Jκ and βActin (control) gDNA within the 
dental pulp of WT mouse LCM dental pulp sample and Collagen 1a2Cre x RBP-Jκ flox/flox 
odontoblast sample. RBP-Jκ is not present within the odontoblasts of the KO mouse(n=3). 
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6/7 which is cleaved from the DNA. Comparison between the levels of exon 2 
and exon 6/7 in each LCM gDNA sample was performed. 
RBP-Jκ exon 6/7 was removed from the gDNA of the cells within the CL-MSC 
region of the postnatal day 6 transgenic mouse. There was also a reduction in 
the presence of this gDNA within the MTAC and odontoblast samples. By 
postnatal day 14, the levels were still reduced within the CL-MSC region and are 
more strongly reduced in the MTAC and odontoblast samples. In the 6-month-old 
mouse, levels of the floxed gDNA were reduced in all three LCM samples (Figure 
23 B). Confirmation using traditional PCR showed that RBP-Jκ was not present 
within the odontoblasts of the Collagen 1a2Cre x RBP-Jκ flox/flox adult mouse 
(Figure 23 C). 
 In this work there appears to have been Cre-recombinase activity in the cells 
which gave rise to the odontoblasts at all ages, suggesting that the CL-MSC 
region continues to give rise to odontoblast layer cells throughout the animals’ 
life. 
The ability of the CL mesenchyme to give rise to dentine producing cells was 
further investigated to support the hypothesis that the cells of this region contain 
SCs which are capable of differentiating into odontoblasts. Microdissection of the 
CL region was undertaken. The resected tissue was enzymatically and 
mechanically dissociated to allow discard of the epithelial tissue. The isolated 
mesenchyme was placed on devitalised dentine and cultured in organ culture 
conditions. Histological analysis showed that the cells of the mesenchyme were 
able to align with the dentine slice and begin to project into the existing dentine 
tubules. These projections showed a typical odontoblastic branching phenotype 
(Figure 24 A). Continuing culture for a further 3 days showed that the projections 
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were able to produce new DSPP and DMP1 protein, indicating that the cells are 
beginning to become functional odontoblast like cells (Figure 24 B-D). 
 
Together this data has shown that cells from within the CL-MSC region are 
capable of populating the MTAC and odontoblast cell regions. In addition, these 
cells have the capacity to differentiate into odontoblast like cells when in a 
permissive environment. 
 
 
Figure 24. Dental mesenchyme from the cervical loop mesenchymal stem cell region of the 
mouse incisor can form odontoblast like cells when cultured on devitalised dentine slices in 
vitro 
Postnatal day 7 CD1 mouse incisor CL-MSC tissue, cultured on devitalised p30 CD1 incisor dentine 
slides. A Tissue cultured on dentine slice for 4 days, frozen, cryosectioned, stained with phalloidin 
and counterstained with DAPI. Image shows actin cytoskeleton of cultured cells protruding into the 
dentine tubules, 3D rendered on IMARIS software. B-C Tissue cultured on dentine slice for 7 days, 
frozen, cryosectioned, stained with (B) DMP1 & (C) DSP antibodies and counterstained with DAPI.D 
Merged image of B&C with phase contrast image overlaid (n=2). 
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4.2 Development of an in vitro model to use in investigating the 
molecular mechanisms of dental mesenchymal stem cell 
maintenance 
In order to further investigate the molecular mechanisms underpinning SC 
maintenance and transition, accurate in vitro cell culture model systems were 
employed. Initial attempts at producing a primary cell-line based approach were 
moderately successful. However, the cells showed limited propensity to survive 
after passage 7 and were not sufficiently robust to survive transfection and 
infection manipulations. Consequently, established cell lines were also used in 
order to better understand the molecular mechanisms governing quiescence, 
self-renewal and differentiation is dental mesenchymal cells. 
 
4.2.1 Primary mesenchymal cell culture can be utilised to propagate dental 
mesenchymal cells from the mouse incisor 
Development of an adherent primary-cell system in order to better understand 
the nature of the mesenchymal cells of the mouse incisor was undertaken.  
 
 
Figure 25. Mouse incisor mesenchymal stem cell region tissue can be cultured in vitro 
A Microdissected cervical loop tissue following enzyme digestion and mechanical dissociation of the 
surrounding mesenchyme from the epithelial tissue. Illustrates the accuracy of microdissected area 
and the completeness of dissociation of epithelium and mesenchyme possible by this method. scale 
bar 200nm.  B Phase contrast image of the mesenchymal cells at passage 2 following extraction 
from the mouse incisor and culture under mesenchymal permissive conditions.  
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Microdissection of the CL of the mandibular incisors was undertaken. The apical 
region containing the CL and surrounding mesenchyme was collected and 
enzymatically digested (Figure 25 A). The resultant single cell suspension was 
then applied to precoated culture dishes and grown under mesenchymal or 
epithelial permissive conditions. In poly-d-lysine coated dishes and with culture 
conditions utilising a SC permissive media, AmnioMax, the cells which grew were 
able to survive and expand in culture and exhibited a mesenchymal like 
morphology (Figure 25 B).  
In order to determine if cells grown in these permissive conditions were exhibiting 
mesenchymal and epithelial specific behaviours, the mRNA expression of known 
mesenchymal and epithelial specific markers were assessed. K14 and CDH1 are 
well documented epithelial markers, with K14 expression being entirely epithelial 
specific in the incisor tooth (Figure 26 A).  
Meanwhile PDGFRβ and Vimentin are common mesenchymal markers, the 
former being almost exclusively expressed in the mesenchymal compartment of 
the mouse incisor (Figure 26 B). Analysis of the mRNA expression of these 
cultured cells, showed that when cultured in mesenchymal culture conditions, the 
cells exhibited high expression of known mesenchymal marker genes, and 
negligible expression of epithelial markers (Figure 26C&D). Suggesting that the 
culture system is capable of selectively culturing mesenchymal cells. 
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Further validation of the mesenchymal cell culture model was undertaken using 
flow cytometry. In BMSCs a number of cell surface antigens have been shown to 
be routinely expressed. These markers include Sca1, CD29, CD73, CD105 and 
CD106. Antibody kits for flow cytometric analysis of MSCs are commercially 
available.  
 
Figure 26. Cultured incisor mesenchymal cells have a mesenchymal expression signature 
A & B Representative Postnatal day 7 CD1 mouse incisor cervical loop region cryosectioned and 
immunofluorescently stained using antibodies specific to A  K14 (n=2) and B  PDGFRβ (n=4), 
counterstained with DAPI. Scale bars 100nm. C & D Representative Real Time PCR analysis of the 
mRNA expression of dental epithelial specific markers (C) and dental mesenchymal specific markers 
(D) in the cultured mesenchymal and epithelial cells grown from the mouse incisor. * p<0.05, ** 
p<0.01, *** p<0.001 n=3 
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Preliminary work found that when the cells of the incisor were cultured under 
mesenchyme permissive conditions, the population contained cells which 
displayed many of these antigens on their surface (Figure 27). Indicating that the 
cultured cells may contain MSC-like cells. 
The mesenchymal cells cultured from the resected tissues expressed many 
genes which are known to be both up regulated and down regulated when MSC 
are in a state of quiescence (Figure 28). The heterogeneity of the cultured cells 
may be owing to the imprecise nature of the initial tissue extraction, capturing 
both MTAC and quiescent MSCs.  
 
Figure 27. Flow cytometric analysis suggests that cultured incisor mesenchyme cells contain 
cells expressing some known mesenchymal stem cell marker genes 
Flow cytometric analysis using a commercially available panel of MSC marker genes. A-E 
Representative histogram data of the flow cytometry analysis. Black lines indicate the background 
fluorescence of cells having been incubated with IgG protein. Coloured lines indicate the distribution 
of fluorescent cells within the sample following incubation with the antibody indicated. F For all MSC 
markers tested observable peak shift in fluorescence was noted (n=2).  
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In addition, the culture conditions are high in nutrients which may have 
encouraged formerly quiescent cells to begin cycling again once they were placed 
into culture. In order to better model the MSC and MTAC populations 
synchronisation of the cell cycle within these cells was required.  
 
4.2.2 The cell cycle status of cultured cells can be synchronised through 
adjusting culture conditions 
Using an established cellular synchronisation protocol, serum deprivation was 
used to encourage the cells to enter into quiescence (Figure 15) (Chen et al., 
2012a).  
Initial analysis of cells under these three regimens was undertaken through an 
immunofluorescence (IF) based approach. Fed cultures showed a great deal of 
heterogeneity with populations of cells which were positive for known quiescent 
MSC marker genes, Zbtb20 and SmarcA2, while other cells within the same field 
 
 
Figure 28. Heterogeneity within the cultured incisor mesenchymal cells indicates a mixed 
population of quiescent mesenchymal stem cell like and proliferative transit amplifying cell 
like cells 
A Representative Real time PCR analysis indicating raw data (CT values) of MSC and MTAC marker 
gene expression from two batches of cultured incisor mesenchymal cells. Both MSC and MTAC 
marker gene transcripts are detectable within the cells (n=2). B Cultured incisor mesenchymal cells 
fixed and immunofluorescently stained using antibodies specific to MSC marker Zbtb20, 
counterstained with DAPI. Representative image, n=2. White arrow indicates two adjacent cells each 
with markedly different levels of immunoreactivity to the MSC marker antibody. 
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were negative (Figure 29 A&D). Cells which were recovered from starvation 
displayed fewer cells positive for these markers (Figure 29 B&E) and an overall 
more homogenous pattern of expression. While starved cells maintained the 
expression of Zbtb20 and SmarcA2 in some cells possibly with a modest increase 
in expression of these markers although this was not able to be quantified through 
IF (Figure 29 C&F).  Synchronisation does not produce entirely positively or 
negatively immunoreactive, homogenous populations. However starved culture 
conditions appear to encourage more cells to adopt a quiescent MSC-like 
expression pattern. 
 
 
Figure 29. Synchronisation of the cell cycle through serum starvation produces a population 
of cells which express more quiescent mesenchymal stem cell marker proteins 
Cultured incisor mesenchymal cells, grown under fed, recovered or starved conditions, fixed and 
immunofluorescently stained using antibodies specific to MSC markers Zbtb20 & SmarcA2, 
counterstained with DAPI. yellow arrows indicate cells with nuclear localisation n=1 
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Following from the immunofluorescent analysis, a molecular transcript 
expression approach was undertaken in order to allow for accurate quantification. 
Molecular profiling of cells cultured under each regimen showed that mRNA 
expression of the cells under each condition was quite different (Figure 30).  
 
When compared to the expression profile of fed cells, starved cells upregulated 
quiescent SC marker genes and downregulated MTAC markers. Conversely 
recovered cells downregulated quiescent MSC markers and upregulated MTAC 
markers respectively.  
 
 
 
Figure 30. Synchronisation of cultured incisor mesenchyme cells produces populations of 
cells which exhibit more quiescent stem cell like transcription signatures 
Representative Real Time PCR analysis of the mRNA expression levels of quiescent MSC marker 
genes in cultured incisor mesenchymal cells which have been subjected to fed, starved and 
recovered conditions. *** p<0.001 n=3 
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4.2.3 Established dental mesenchymal cell lines are capable of being 
synchronised into a state of quiescence  
While incisor culture cells were capable of being manipulated into quiescent 
MSC-Like and MTAC-like behaviours, these cells are limited by their nature. 
Being primary cells, they are not capable of being passaged repeatedly, nor are 
they robust enough to withstand manipulations such as infection or transfection. 
Consequently, and alternative model was sought. 
 
 
Figure 31. Established dental pulp cell lines display a similar morphology, expression profile 
and response to synchronisation as cultured incisor mesenchyme cells 
A&B Representative phase contrast image of the established dental pulp cell line (MO6 G3). C Gel 
image of PCR products in mouse embryonic fibroblasts (MEF) and MO6 G3 cell sample, against a 
selection of quiescent MSC and MTAC marker genes. (n=1) D Representative Real time PCR 
analysis of MO6 G3 cells following synchronisation (n=3) data not significant. 
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In the 1990’s MacDougall et al, established a pre-odontoblast like cell line 
(MacDougall et al., 1995). These cells, MO6 G3, are an immortalised cell line 
which can be grown in vitro and are sufficiently robust (Figure 31 A&B). PCR 
analysis revealed that these cells expressed many of the quiescent MSC and 
MTAC marker genes which were identified in the mouse incisor mesenchyme 
(Figure 31 C). Both MSC and MTAC marker transcripts were detectable in MO6 
G3 cells, suggesting a similar heterogeneity to fed cultured incisor mesenchyme 
cells. Furthermore, when exposed to the synchronisation regimens used on the 
incisor culture primary cells, starved cells showed an upregulation of MSC marker 
genes and a downregulation of TAC gene expression. Conversely, recovered 
cells displayed upregulation of TAC genes and a downregulation of MSC genes 
(Figure 31 D). 
 
4.3 CL-MSCs & MTACs display distinct patterns of Notch pathway 
utilisation 
 
4.3.1 Notch signalling activity in the incisor tooth mesenchyme is spatially 
restricted 
Notch signalling has long been connected to quiescent SC maintenance and 
activation. It is well documented that Notch activity can indicate the presence of 
quiescent SCs in mesenchymal tissues.  
Transgenic Notch Reporter (TNR) mice were employed to determine if Notch 
activity is present within the CL-MSC region. Indeed, at postnatal day 0 and 
persisting at postnatal day 14, the CL-MSC region is strongly immunoreactive 
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when anti-GFP is applied (Figure 32 A&B). This indicates that RBP-Jκ binding 
sites are occupied in this region (Figure 32 C), which in turn is indicative of Notch 
pathway regulation occurring here. 
 
Immunofluorescent analysis of the localisation of Notch receptors within the 
mouse incisor was undertaken, to confirm previous reports. Within the mouse 
incisor mesenchyme, Notch receptors 1 and 2 were widely expressed throughout 
the tissue, while Notch receptor 3 was largely undetectable by IF analysis (Figure 
33 A-C). With Notch2 displaying enhanced immunoreactivity in the known MTAC 
region of the mesenchyme (Figure 33 B). The Notch1 antibody shown here 
(Figure 33 A) is specific to the intra cellular domain and therefore indicates not 
 
Figure 32. Transgenic Notch Reporter mice indicate the presence of Notch signalling 
regulation within the cells of the cervical loop mesenchymal stem cell region 
A Representative postnatal day 0 TNR mouse incisor cervical loop region cryosectioned and 
immunofluorescently stained using antibodies specific to GFP, counterstained with DAPI. (n=2) B 
Representative postnatal day 14 TNR mouse incisor cervical loop region cryosectioned and 
immunofluorescently stained using antibodies specific to GFP, counterstained with DAPI. Yellow 
arrows indicate the positive staining regions. (n=2) C Schematic of the TNR construct, showing the 
expression of GFP under the control of RBPj binding sites. 
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only ubiquitous expression but also the presence of the cleaved ICD, suggestive 
of active Notch signalling.  
 
Using LCM as previously described, the expression of Notch1 and Notch2 
indicated a greater expression of both receptors in the CL-MSC region (Figure 33 
D). The presence of Notch receptors indicates a potential for active Notch 
 
Figure 33. Notch1 & Notch2 receptors are expressed within the incisor mesenchyme 
A-C Representative postnatal day 7 CD1 mouse cervical loop region of the incisor, cryosectioned 
and immunofluorescently stained using antibodies specific to A) Notch1, n=15 (ICD), B) Notch2 n=14 
& C) Notch3 n=5, counterstained with DAPI. Yellow arrows indicate the immune-unreactive CL-MSC 
region. D Representative Real Time PCR analysis of the mRNA expression levels of Notch receptor 
genes in LCM captured populations of p7 CD1 mice cells. *** p<0.001 n=4 
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signalling to take place, however assessment of the prevalence of active Notch 
signalling can be undertaken though identification of cleaved Notch receptor 
intracellular domains. 
Immunofluorescent detection of cleaved Notch1 and Notch2 ICDs is another 
powerful tool used to determine the regions of Notch receptor activation.  As the 
intracellular domain is only cleaved once the Notch receptor is activated, 
presence of the cleaved domain is indicative of canonical Notch signalling. Within 
the mouse incisor mesenchyme, Notch1 ICD antibodies showed very low levels 
of immunoreactivity throughout the mesenchyme (Figure 33 A). Notch2 
intracellular domain antibodies displayed elevated immunoreactivity in the 
mesenchyme known to contain MTACs (Figure 34). Thus, supporting the 
suggestion that Notch signalling is an important regulator of SC activation and 
maintenance.  
 
 
Figure 34. Cleaved Notch2 intracellular domains localise to the nuclei of cells within the 
mesenchymal transit amplifying region 
Representative postnatal day 7 CD1 mouse incisor cervical loop region cryosectioned and 
immunofluorescently stained using antibody specific to cleaved Notch2 intracellular domain (Notch2 
ICD) & counterstained with DAPI. Dotted line marks the basement membrane, separating the 
epithelial CL from the mesenchymal tissue. Boxes B & C depict area expanded and shown in panels 
to the right, CL-MSC and MTAC regions respectively. yellow arrow heads indicate nuclei with nuclear 
Notch2ICD staining n=3 
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Analysis of nuclear localisation of cleaved Notch2 intracellular domains  showed 
that Notch2 ICD was expressed within the CL-MSC and MTAC regions, it was in 
the MTAC region where the localisation was most strongly within the nucleus 
(Figure 34). Thus, indicating a contrasting role for Notch2 receptor within the 
incisor mesenchyme in these two areas. 
The combination of Notch2 expression and activation being highest in the MTAC 
region, coupled with enhanced TNR activity in these cells, suggest that Notch 
signalling is active in this region. In order to confirm this, immunostaining of the 
mouse incisor for down-stream Notch target Hes1 was carried out. While Hes1 
expression was most striking in the epithelial tissue of the incisor tooth, there was 
a modest upregulation of this protein in the MTAC region over that of the CL-MSC 
area (Figure 35 A). Suggesting that Notch signalling is truly most abundant in the 
MTAC region. Furthermore, mRNA expression analysis of LCM captured CL-
MSC and MTAC tissue, found that Notch effector genes were more highly 
upregulated in the CL-MSC region. 
 
 
Figure 35. Notch downstream target protein (Hes1) are highly immunoreactive in the 
mesenchymal transit amplifying cell region 
A Representative postnatal day 7 CD1 mouse cervical loop region of the incisor, cryosectioned and 
immunofluorescently stained using specific antibodies for Hes1, counterstained with DAPI. Arrows 
indicate low reactivity in the CL-MSC region. n=13 B Real Time PCR analysis of the mRNA 
expression levels of Notch effector genes in LCM captured populations of p7 CD1 mice cells. 
**p<0.01, *** p<0.001 
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Canonical Notch signalling is ordinarily activated by Notch ligands binding to the 
receptors.  In order to determine if this is likely to be the case in this system, 
immunofluorescent analysis was undertaken to investigate the location of 
expression of Notch ligands Jag1, Jag2 and Dlk1. 
 
In the case of classical ligands Jag1 and Jag2 immunoreactivity was detected 
throughout the incisor mesenchyme at relatively homogeneous levels however 
there was a clear increase in expression within the incisor epithelium (Figure 36 
 
 
Figure 36. Expression of Notch ligands occurs in distinct locations within the mouse incisor 
Representative postnatal day 7 CD1 mouse incisor cervical loop region cryosectioned and 
immunofluorescently stained using antibody specific to A Jag1 n=11, B Jag2 n=8 and C Dlk1 n=14 
& counterstained with DAPI. Arrows mark the CL-MSCs. D Real Time PCR analysis of the mRNA 
expression levels of Notch effector genes in LCM captured populations of p7 CD1 mice cells. (N.D. 
denotes not detected, Ods = Odontoblasts, DPs = Dental Pulp cells) n=1 *** p<0.001 
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A&B). DSL ligand Dlk1 however is most highly expressed within the MTAC region 
(Figure 36 C).  Dlk1 mRNA expression was also found to be upregulated in the 
MTAC region (Figure 36 D).   
 
4.4 Notch signalling modulation affects the maintenance of the 
mesenchymal transit amplifying cells and the transition of the 
endogenous mesenchymal stem cell pool 
Notch pathway components are spatially restricted within the mouse incisor 
indicating that they may have a role in maintaining and regulating this tissue. 
Notch signalling is known to be important in the maintenance and transition of 
SCs. As Notch receptor, Notch2, and ligand, Dlk1, are each most highly 
expressed and possibly functional in the MTAC region, the modulation of Notch 
signalling could have profound effects on the mitotic potential of the MTACs and 
the endogenous CL-MSC pool. 
 
4.4.1 In vivo modulation of Notch signalling affects the terminally 
differentiated progeny of the mesenchymal transit amplifying cell pool 
The effect of removing canonical Notch signalling from the incisor tooth was 
investigated using mice which are conditionally deficient of RBP-Jκ within the 
mesenchymal compartment of the incisor. These Collagen 1 α2 Cre x RBP-Jκ 
flox/flox mice display a significant dentine disorganisation phenotype (Figure 37). 
Histologically the odontoblast layer is disorganised, and the dentine produced is 
similarly disorganised (Figure 37 C&D). In the Collagen 1 α2 Cre x Rbp-Jκ 
flox/flox the odontoblast layer is disrupted to the point of almost entire loss. The 
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dentine is disorganised, and dentine tubule orientation is eccentric. Similarly, 
scanning electron microscopy, (performed by Dr Bing Hu (The University of 
Plymouth) and printed here with his permission) reveals that the hydroxyapatite 
crystals of the dentine have lost their characteristic organisation and density 
pattern (Figure 37 E&F).  
 
Fluorescent immunohistochemical analysis of the RBP-Jκ conditional knock out 
mouse incisor highlights that the dental mesenchyme displayed more 
immunoreactivity for markers of terminally differentiated odontoblasts, DSP and 
DMP1 (Figure 37 A&B). This phenotype suggests that in the absence of Notch 
 
Figure 37. In vivo, dental mesenchymal specific knock out of RBP-Jκ gives rise to disruption 
of normal dentine organisation and maturation 
A&B Representative Collagen 1 α2 Cre x Rbp-Jκ flox/flox mouse incisor dentine, frozen, 
cryosectioned, stained with DMP1 & DSPP specific antibodies and counterstained with DAPI (n=2) 
C&D Representative Haematoxylin and eosin staining of sectioned wildtype and Collagen 1 α2 Cre 
x Rbp-Jκ flox/flox incisor dentine (n=4) E&F Scanning electron microscopy images of wildtype and 
Collagen 1 α2 Cre x Rbp-Jκ flox/flox mouse incisor dentine (n=1).  
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signalling, the lineage of cells responsible for the production of odontoblasts, and 
thus dentine, is dysregulated. The presence of increased differentiation markers 
indicates that premature differentiation has occurred, potentially due to inability 
to maintain the self-renewal of the progenitor cells. 
 
4.4.2 In vivo modulation of Notch ligand, Dlk1, affects mesenchymal transit 
amplifying cell maintenance and mesenchymal stem cell transition 
Notch ligand, Dlk1 was identified as being highly upregulated in the MTAC region 
of the incisor. In order to investigate the function of Dlk1 in these cells, 
microscopic phenotypic analysis of Dlk1 null mice (Raghunandan et al., 2008) 
and of mice overexpressing Dlk1 in a tissue specific manner (Abdallah et al., 2011) 
was undertaken.  
 
 
Figure 38. Incisors of mice deficient of Dlk1 display a pattern of expression of MTAC and MSC 
marker genes consistent with an increase in quiescent cells and a decrease in proliferating 
cells 
Representative Postnatal day 7 Dlk1 KO and wildtype mouse incisor cervical loop regions 
cryosectioned and immunofluorescently stained using antibodies specific to Ki67 & SmarcA2, n=5 
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Initial immunofluorescent analysis of the CL region of Dlk1 knock out mice was 
undertaken. The expression of MTAC and MSC marker genes, Ki67 and 
SmarcA2, were similar in pattern in the knock out and wild type mice. SmarcA2 
immunoreactivity is observed in the CL-MSCs region in both wildtype and knock 
out mice, while Ki67 immunoreactivity is most prevalent in the MTACs region 
within the mesenchyme (Figure 38). However there appeared to be a greater 
level of immunoreactivity for the MSC marker, SmarcA2, within the MTAC region 
of the knock out incisor (Figure 38). This was coupled with a reduced level of Ki67 
immunoreactivity throughout, indicating a reduction in proliferative cells (Figure 
38 A&D). 
In order to quantify if there is a reduction in the MTAC marker genes in the MTAC 
region of the knock out incisor compared to the wildtype, LCM and PCR was 
undertaken. The expression pattern of upregulation of quiescent MSC marker 
genes in the CL-MSC region was observed in both the wildtype and knock out 
(Figure 39). There is no statistically significant difference between the expression 
of the quiescent MSC and MTAC marker genes in the knock out, the two 
mesenchymal cell populations are more similar to one another than in the 
wildtype.  
In order to determine if the MTAC region had indeed been diminished by the loss 
of Dlk1, 3D remodelling was undertaken. By digitally analysing serial sections of 
the incisor, having been cryosectioned and immunofluorescently stained, a 3D 
model of the tissue has been reproduced (Figure 40 A&B). The CL was defined 
using the basement membrane as a boundary, while the MTAC region was 
determined through the location of Ki67 positive cells adjacent to the basement 
membrane. The volume of the MTAC region was calculated using Biovis3D 
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software, which showed that the relative volume of the MTAC region was reduced 
by 22.5% (Figure 40 D). In addition, the number of Ki67 positive cells within the 
region was also reduced (Figure 40 C). Further suggesting the Dlk1 is necessary 
for MTAC maintenance. 
 
 
Figure 39. The mesenchymal stem cell and transit amplifying regions of Dlk1 null mice display 
more similar expression of mesenchymal stem cell marker genes than in wildtype incisors 
Representative Real Time PCR analysis of the mRNA expression levels of quiescent MSC marker 
genes in samples of incisor CL-MSC and MTAC regions collected by LCM from A Dlk1 WT mice 
(n=3) and B Dlk1 KO mice (n=2). *** p<0.001 
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Similar immunofluorescent and 3D modelling analysis of Collagen 1 α1 Dlk1 
overexpression mice was also conducted. Preliminary work was undertaken to 
microscopically analyse the incisor phenotype of these mice which overexpress 
Dlk1 under the promotor for rat collagen 1. Interestingly the expression of 
quiescent MSC marker gene, SmarcA2, was found to be widespread throughout 
the mesenchyme of the incisor (Figure 41 A). This quiescent marker was 
observed within the region usually described as the MTAC location, which itself 
displayed a modest decrease in Ki67 immunoreactivity (Figure 41 B).  
 
 
Figure 40. The mesenchymal transit amplifying cell region of incisors of mice deficient in Dlk1 
are reduced in volume 
A&B Representative 3D reconstruction of immunofluorescently stained serial cryosections form Dlk1 
WT and Dlk1 KO incisors, stained with antibodies specific to Ki67 and counter stained with DAPI. 
Computational reconstruction produces models as show, with volume calculations for the MTAC 
regions in apple-blue-sea-green. C Number of Ki67 positive cells observed within the mesenchyme 
of the CL structure, based on quantification of cells from serial immunofluorescently stained 
cryosections. D Relative volume of WT and KO MTAC regions following computational analysis of 
3D models. WT; n=3, KO; n=3 data not found to be significant 
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Due to the limited availability of these mice, this work is only preliminary and 
requires more investigation before these findings can be proven. It is unclear 
however, if the depletion of the MTAC is primarily due to a loss of maintenance 
of self-renewal in these cells, or due to enhanced transition of MTACs to 
odontoblasts.  
 
Additional work has been undertaken within the research group of Dr Bing Hu, 
which indicates that these mice have increased dentine deposition (Walker et al, 
in review). Together this indicates a potential mechanism whereby constitutive 
expression of Dlk1 in the incisor enhances MTAC proliferation and subsequent 
differentiation to the point of exhausting the MTAC pool.  
 
 
Figure 41. Incisors of mice overexpressing Dlk1 within the incisor mesenchyme show an 
apparent reduction of the MTAC region and increased quiescent MSC marker gene 
expression 
Postnatal day 7 Collagen 1 α1 Dlk1 overexpression mouse incisor cervical loop region cryosectioned 
and immunofluorescently stained using antibody specific to A SmarcA2 (n=1) and B Ki67 (n=1) & 
counterstained with DAPI  
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4.4.3 In vitro manipulation of Dlk1 reveals that Dlk1 is necessary for 
mesenchymal transit amplifying cell maintenance 
In order to further consolidate the in vivo findings of Dlk1 modulation in the mouse 
models, in vitro analysis was also carried out.  
 
Following the finding that Dlk1 deficient mice appear to have a reduction in the 
MTAC phenotype within the mouse incisor, the effect of interfering with Dlk1 in 
vitro was assessed. Mesenchymal cells cultured from the mouse incisor were 
transfected with siDlk1 constructs. The level of Dlk1 reduction was modest. 
However, it was clear that with the reduction of Dlk1, other MTAC marker genes 
were also downregulated (Figure 42). 
Using the MO6 G3 cell line model, the effect of removing endogenous Dlk1 
through the use of siRNA transfection was more pronounced. Using two different 
siRNA probes, Dlk1 transcription could be downregulated in these cells (Figure 
43 A). Simultaneously, other MTAC region marker genes, Ki67 and Top2A 
 
Figure 42. In vitro reduction of Dlk1 reduces expression of genes commonly downregulated 
in quiescent mesenchymal stem cells in cultured incisor mesenchyme cells 
Representative Real Time PCR analysis of the mRNA expression levels of genes which are 
downregulated in MSCs in cultured incisor mesenchyme cells transfected with siRNA, before mRNA 
samples were collected 24hours later. Scrambled siRNA used as control. siDlk1 treatment 
successfully reduced Dlk1 expression levels within the sample. In this sample all four tested MTAC 
marker genes also displayed reduced transcription. *p<0.05, *** p<0.001 n=2 
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indicate a trend of downregulation (Figure 43 A). The growth of the cells was 
reduced in the transfected cells, with a modest reduction in the area covered by 
the cells in sparse cell culture conditions (Figure 43 B). 
 
When considered together, it appears that dental mesenchymal cells in culture 
reduce their MTAC-like phenotype in the absence of Dlk1. Thus, highlighting a 
potential role for Dlk1 as a necessary factor in the maintenance of MTACs.  
 
4.4.4 In vitro, Dlk1 is sufficient for quiescent mesenchymal stem cells to 
transition to a transit amplifying like state and functions to maintain this 
status 
In addition to Dlk1’s role as a maintainer of MTACs, the in vivo data also indicates 
that the overexpression of Dlk1 may encourage differentiation throughout the 
lineage. To investigate this further, Dlk1 protein was added to cultured dental 
mesenchymal cells.  
 
Figure 43. In vitro reduction of Dlk1 reduces expression of genes commonly downregulated 
in quiescent mesenchymal stem cells and reduces cell culture coverage in immortalised 
dental pulp cell line  
Immortalised dental pulp cells were transfected with siRNAs, before mRNA samples were collected 
24hours later. Scrambled siRNA used as control, and 2 different siDlk1 probes. A Representative 
Real Time PCR analysis of the mRNA expression levels of genes which are downregulated in 
quiescent MSCs siDlk1 A & B treatment successfully reduced Dlk1 expression levels within the 
sample .n=2  *** p<0.001 B Relative area covered by cell growth compared to growth within the 
control treated cells, following crystal violet staining n=2 data not significant.  
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Initial experiments in this study investigated the local effects of Dlk1 protein on 
MTACs utilising a bound ligand culture method. As the protein was adhered to 
the cell culture surface before the cells were seeded, l the cells cannot be 
synchronised as they must be passaged into the prepared dish. However, within 
 
Figure 44. In vitro treatment of dental pulp cells with Dlk1 protein encourages a more transit 
amplifying transcription profile and greater coverage of cell culture surface area 
A Immortalised dental pulp cells cultured on culture surfaces pre-treated with bound Dlk1 protein. 
Representative Real-Time PCR analysis of mRNA expression levels of quiescent MSC marker 
genes, analysis undertaken by real time PCR. In the presence of Dlk1 the cultured cells 
downregulate the expression of MSC marker genes. (n=2) *p<0.05, **p<0.005, *** p<0.001 B 
Relative cell culture surface coverage of immortalised dental pulp cells, synchronised to quiescence 
and treated with soluble Dlk1 protein compared to coverage of control starved cells, following crystal 
violet staining. In the presence of Dlk1 cells grow to cover a greater area of the cell culture surface. 
(n=2) data not significant C Representative Real time PCR analysis of the mRNA expression levels 
of genes upregulated and downregulated in quiescent MSCs in immortalised dental pulp cells, 
synchronised to quiescent and treated with soluble Dlk1 protein (n=3).  *p<0.05, **p<0.005, *** 
p<0.001 
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the heterogenous “fed” cell population that was used, there are cells which exhibit 
MTAC-like properties and others which are more MSC-like (Figure 26). 
The addition of bound Dlk1 protein into this culture system provoked a 
downregulation in the expression of an array of quiescent MSC marker genes 
(Figure 44 A). Indicating the ability of Dlk1 to promote a loss of quiescent 
phenotype and the adoption of a more MTAC-like phenotype within the 
heterogenous population. 
This data supports the findings previously discussed in section 4.4.3 In vitro 
manipulation of Dlk1 reveals that Dlk1 is necessary for mesenchymal transit 
amplifying cell maintenance, that this effect may be due to the preservation and 
maintenance of the MTACs already within the heterogenous culture. 
In order to discern if diffusible Dlk1 protein can encourage the quiescent MSCs 
to transition into MTAC-like cells, soluble Dlk1 protein was added to synchronised 
cells. Cell cycle synchronisation was performed in order to produce quiescence 
within the culture, following this Dlk1 protein was added. A dose dependent 
upregulation of marker genes commonly downregulated in quiescent MSCs was 
observed (Figure 44 C). This indicates an apparent loss of quiescence by these 
cells. Coupled with the increased expression of MTAC marker Ki67 (Figure 44 C), 
it is clear that the addition of Dlk1 has encouraged these MSC-like cells to adopt 
a more MTAC-like phenotype. This push towards an MTAC-like phenotype is 
supported by the finding that the cells grew to cover a greater area of the cell 
culture container when Dlk1 was added (Figure 44 B). 
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The addition of Dlk1 protein to cultured quiescent dental mesenchymal cells, is 
sufficient to encourage cells to adopt an MTAC-like phenotype. Indicating that 
Dlk1 has an important role as a regulator of quiescent to TAC state. 
 
4.5 Mesenchymal stem cells and transit amplifying cells are 
epigenetically regulated within the mouse incisor  
 
4.5.1 Epigenetic regulation of Dlk1 is utilised differently in mesenchymal 
stem cells and mesenchymal transit amplifying cells 
Immunofluorescent analysis of the mouse incisor mesenchyme revealed different 
levels of common histone modifications, H3K9me3 and H3k27me3, between the 
MTAC and CL-MSC regions (Figure 45 B&C). This data indicates that there is a 
greater level of histone modification within the CL-MSC region.  
In order to determine if the Dlk1 gene itself is subjected to such epigenetic 
regulation, Chromatin Immunoprecipitation (ChIP) assays were conducted. 
Briefly, chromatin was extracted from dental mesenchymal cells grown in 
standard or starved culture conditions, to simulate MTAC-like and MSC-like cells 
respectively. This chromatin was pulled down using antibodies specific to 
methylated histone proteins. The resultant DNA was analysed by PCR using 
probes specific to the 5’ and 3’ CpG islands of the Dlk1 gene (Figure 45 A). 
When pulling down based on two common histone modifications, both 5’ and 3’ 
CpG islands of Dlk1 were more highly associated with the epigenetic regulatory 
marks in the starved cells than in the growing cells (Figure 45 B&C).  
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In the MSC-like cells, histone modification marks are a feature of the chromatin 
at the site of epigenetic DNA regulation regions. Indicating that Dlk1 expression 
may be inhibited in MSCs through an epigenetic mechanism. 
 
 
 
Figure 45. Cultured dental pulp cells display altered levels of epigenetic marks at key 
regulatory sequences around the Dlk1 gene when synchronised into quiescent or transit 
amplifying like status  
A Illustration of the Dlk1 loci with CpG islands as presented on USCS genome browser (2011). B&C 
Representative postnatal day 7 CD1 mouse incisor cervical loop region cryosectioned and 
immunofluorescently stained using antibody specific to B) H3k9me3 and C) H3k27me3 & 
counterstained with DAPI. Arrows mark positive immunoreactivity in the CL-MSCs.(n=2) D&E Real 
time PCR analysis of samples from fed and starved dental pulp cells assayed by ChIP, using 
antibodies specific to histone modification marks H3K9me3 & H3K27me3, probed for gDNA using 
primers specific to the region of gDNA containing CpG islands at the D) 5’ & E) 3’ regulatory regions 
of the Dlk1 gene. n=1 ** p<0.005 
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4.5.2 Chromatin remodelling factor SmarcA2 is necessary for the 
maintenance of mesenchymal stem cell like cell state 
SmarcA2 is a well characterised chromatin remodelling factor, which is also a 
known quiescent MSC marker. In order to determine the effect of losing SmarcA2 
function in quiescent cells, siSmarcA2 was transfected into synchronised dental 
mesenchymal cells. Although downregulation of SmarcA2 was only modest, 
MTAC marker genes Ki67 and Top2A showed a trend of upregulation (Figure 46 
A). This correlated with an increase in the relative amount of cell culture surface 
area covered by the cells, when treated with siSmarcA2 (Figure 46 B). The loss 
of SmarcA2 from this cell model appears to have prevented the MSC-like cells 
form maintaining their quiescent MSC-like state. 
 
 
Figure 46. In vitro reduction of quiescent mesenchymal stem cell marker, SmarcA2, increases 
expression of genes commonly downregulated in quiescent mesenchymal stem cells and 
increases cell culture coverage in immortalised dental pulp cell line  
Immortalised dental pulp cells were transfected with siRNAs, before mRNA samples were collected 
24hours later. Scrambled siRNA used as control, against 2 different siSmarcA2 probes. A 
Representative Real Time PCR analysis of the mRNA expression levels of genes which are 
downregulated or upregulated in quiescent MSCs. siSmarcA2 A & B treatment modestly reduced 
SmarcA2 expression levels within the sample. n=3 data not significant B Relative area covered by 
cell growth compared to growth within the control treated cells, following crystal violet staining. In the 
presence of siSmarcA2, cells grow to cover more of the cell culture surface. ** p<0.005 n=2 
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To further validate the effect of inhibiting SmarcA2 on MSC state, a fluorescent 
cell cycle indicator was utilised. The Fluorescent Ubiquitination-based Cell Cycle 
Indicator (FUCCI) system allows for the infection of cells with two fluorescently 
active constructs. Briefly, following infection and selection, cells within the mitotic 
phases exhibit green fluorescence (in S-M phases) and red fluorescence (in G1 
to early S phases). When the cells are quiescent, they are colourless. As the 
infection system requires the use of antibiotics for selection, the cell models used 
previously in this study were unsuitable for this assay. However human bone-
marrow mesenchymal cells (BMCs) were obtained for this purpose. Having 
subjected the cells to the synchronisation regime as described in section 4.2.2 
The cell cycle status of cultured cells can be synchronised through adjusting 
culture conditions. Synchronised infected cells were subjected to flow cytometric 
analysis. In comparison to the infected control cells, all three conditions displayed 
some cells which were mitotically active and therefore coloured. The proportion 
of colourless cells was highest in the starved condition, indicating that in this 
condition many of the cells were able to enter quiescence (Figure 47 A). In this 
cell type, 24 hours of treatment to recover the cells produced only a slight 
decrease in the number of quiescent cells. Perhaps indicating that these cells 
require longer exposure to nutrients before they re-enter the cell cycle following 
starvation. 
SmarcA2 was inhibited in these cells using small molecule inhibitor PFI3. This 
bromodomain specific probe sequesters SmarcA2 (and other bromodomain 
containing chromatin remodelling factors) thus preventing it from performing its 
endogenous function. Fluorescent microscopic analysis of FUCCI infected 
BMSCs revealed that with increasing doses of PFI3, the proportion of colourless 
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cells within the culture decreased (Figure 47 B). Furthermore, the number of cells 
within each field of view in each culture condition also increased (Figure 47 B).  
 
 
Figure 47. Inhibition of bromodomain containing chromatin remodelling factors reduces 
levels of quiescence in cultured mesenchymal cells 
A Flow cytometric analysis of BMCs infected with a ki67-FUCCI cell cycle indicator system. Levels 
of colourless (quiescent) cells within the BMC sample is increased with starvation. B Fluorescent 
microscope analysis of ki67-FUCCI infected BMCs following synchronisation and the treatment of 
cells with small molecule PFI3 after starvation. Key as in panel A. Size of charts are proportional to 
number of cells per field of view in each condition. C Percentage of cell culture surface area covered 
by cell growth of immortalised MO6-G3 dental pulp cells synchronised and treated with PFI3. *** 
p<0.001 n=2 
 
 
 
 
123 
 
When the same small molecule inhibitor was added to starved dental 
mesenchymal cells, they too began to show a dose dependent increase in the 
amount of area the cells grew to cover in culture (Figure 47 C). 
Together, this data suggests that, the inhibition of SmarcA2 encourages 
quiescent cells to lose their quiescent state and begin to proliferate. Indicating the 
SmarcA2 action is necessary for the maintenance of quiescence. 
 
4.5.3 Quiescent mesenchymal stem cell marker gene SmarcA2 expression 
may be regulated by Notch signalling components 
In addition to being an epigenetic regulator itself, SmarcA2 is also a marker of 
quiescent MSCs. The transcriptional regulation of this gene has been widely 
investigated. However, there are numerous RBP-Jκ binding sequence motifs in 
the DNA around the promoter region and first exon of SmarcA2 (Figure 16 A). 
Having designed primers to target these RBP-Jκ binding motif regions, ChIP was 
undertaken to determine if RBP-Jκ does indeed bind to these sites in dental 
mesenchymal cells.  
The preliminary data shows that some background pull down was occurring at 
many of these sites. However, the DNA containing RBP-Jκ binding sites, 9 &10, 
12 & 13 and 16, was exclusively pulled down with RBP-Jκ protein (Figure 48 B). 
Indicating that these sites are occupied by RBP-Jκ in these cells. The cells used 
in this preliminary work, were not synchronised, but rather represent a 
heterogenous population of fed dental mesenchymal cells.  
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Consequently, this work shows that SmarcA2 has the potential to be regulated 
by RBP-Jκ and thus Notch signalling. However, further assays are required to 
determine if this binding is differentially observed in cells exhibiting MSC-like and 
MTAC-like properties. 
 
4.6 Dlk1 protein can be used to enhance dentine regeneration after 
dental injury 
This study has discussed the role of Dlk1 in regulating the endogenous MSCs, 
and their progeny, in the incisor. Understanding these mechanisms may be 
important in the advancement of clinical SC applications generally. However, the 
human dentition does not contain continuously growing teeth, and so the 
translatability of this work into a clinical setting is limited.  
 
Figure 48. The region of the genome adjacent to the start codon of the SmarcA2 gene contains 
many potential RBP-Jκ binding sites, some of which are occupied by RBP-Jκ in dental pulp 
cells in vitro 
Gel image of PCR products following ChIP of MO6 G3 cells using RBP-Jκ specific antibodies, 
followed by PCR using probes designed to cover RBP-Jκ binding sites, as indicated in panel A. (n=1) 
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Within the non-continuously growing dental pulp, reactive SCs have been 
identified, which can respond to injury to promote repair and regeneration. As 
Dlk1 has been shown to be a powerful regulator of endogenous MSCs in the 
mouse incisor, the effect of this molecule on molar dental mesenchyme following 
injury was investigated. 
 
 
Figure 49. Addition of Dlk1 protein to dental material used in the treatment of dental injury 
enhances repair response and activation of differentiation within the dental pulp 
A&B Representative Haematoxylin and eosin staining of FFPE & sectioned teeth from rat following 
wounding of the molar tooth and subsequent capping with Dycal® (control) or Dycal® with Dlk1 
protein (Dlk1 Treated). n=4 C&D Representative Immunofluorescent analysis of FFPE & sectioned 
teeth from rat following wounding of the molar tooth and subsequent capping Stained using 
antibodies specific to DSPP and DMP1. Counterstained with DAPI. Dotted line and arrow marks 
wound/pulp boundary. n=4 
.  
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In order to investigate tooth injury and clinical treatment, the rat M1 was used as 
a model. This animal work was undertaken by Dr Heng Zhuang, who kindly 
provided the samples from this experiment. Briefly, bilateral wounds were made 
to open the pulp chamber in the mandibular 1st molars. The wounds were then 
capped with calcium hydroxide based filler. In the experimental tooth, Dlk1 protein 
was added to the capping material. The rats were later sacrificed and the effect 
of Dlk1 on the wound healing response was assessed. 
In the control teeth, the wound edge abutted the dental pulp with some 
remodelling of the mesenchymal tissue (Figure 49 A). The contralateral, Dlk1 
treated teeth, displayed the deposition of a substance resembling osteodentine 
at the pulp-wound boundary (Figure 49 B). Furthermore, while the dental pulp of 
control teeth displayed modest immunoreactivity to differentiation marker gene 
antibodies, the Dlk1 treated teeth showed a vast upregulation (Figure 49 C&D). 
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5 Discussion 
5.1 The identification and classification of endogenous mesenchymal 
stem cells within the murine incisor 
The cells of the CL-MSC region have here been shown to express a range of 
quiescent MSC marker genes. Comparisons to the established MTAC region 
within the incisor and the region containing the recently identified NVB-MSC, 
revealed the CL-MSCs to be a distinct population.  
Technically, the experiments required to determine the existence of the CL-MSC 
region required careful consideration. During this assessment it was important 
that LCM of the regions be confined to the most strongly suggestive region of 
MSCs, as the true size of the population was unknown and capturing non-MSC 
tissue within the sample would dilute the concentration of MSC cell mRNA. While 
it would be preferable to investigate each of the MSC marker genes in turn, 
limitations on time and resources made this impossible. Consequently, two genes 
which were consistently upregulated in the CL-MSC region were taken forward 
for further analysis, SmarcA2 and Zbtb20. The protein expression analysis 
confirmed that the proposed MSC region was presenting proteins which are 
expected to be produced in quiescent MSCs. This work also showed that the 
region of expression was larger than the region captured by LCM for mRNA 
assessment, however the region of Ki67 positive MTACs is distinct from the 
quiescent MSC marker expressing region. These studies were undertaken on 
immature mice, at a stage when the incisor tooth is only partially in use. Therefore, 
it was necessary to determine if the same patterns of cell population expression 
were observed in the mature incisor. Due to the density of the mandibular tissue 
after postnatal day 7, assessment was particularly difficult. Consequently, 
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dissection was undertaken prior to sample processing. This brought its own 
issues, chiefly that the morphology of the incisor tissue can be affected. However, 
it was still demonstrated that the expression levels of quiescent MSC marker 
genes remained higher in the MSC region of the adult incisor. This finding 
indicates that the MSCs identified persist in the adult tooth. 
The identification of a novel MSC population within the mouse incisor 
mesenchyme in this study was a primary aim of this work. Following the discovery 
of NVB-MSCs within the mouse incisor (An et al., 2018, Zhao et al., 2014, Kaukua 
et al., 2014b), it appears that this work has further identified the incisor 
mesenchyme as having two distinct MSC niches within the same tissue. 
Generally it is believed that single SC niches are present within tissues, so this is 
a particularly exciting discovery (Morrison and Spradling, 2008). The CL-MSC 
region is distinct both in its location, size (approximately 50μm in diameter) and 
expression profile. 
It is likely that the NVB-MSCs and CL-MSCs receive distinct signals from the NVB 
and the epithelium, being geographically closer to one or other. And possibly that 
these two populations are from subtly different lineages developmentally. In order 
to fully investigate the differences, transgenic in vivo labelling would be required, 
which was not possible under the scope of this study. However, it is interesting 
that the CL-MSCs and NVB-MSCs appear to be utilised and activated differently 
within the tissue. 
Specifically, the way in which the two MSC populations are utilised in 
physiological growth and in response to injury appears to be very different. NVB-
MSCs have been shown to activate upon injury to populate the odontoblast region 
and assist in the production of reparative dentine (Zhao et al., 2014, Kaukua et 
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al., 2014a). However, the CL-MSCs appear to be activated also under normal 
physiological conditions. This difference is particularly interesting when 
considering the MSCs of the molar teeth. In molars, there is no CL and thus no 
location for a CL-MSC niche and no epithelial signal input. However, the NVBs 
are present within the molar (Mitsiadis et al., 2017). In molar teeth, which do not 
continuously grow, the regeneration observed following injury may be more like 
that of the repair induced by NVB-MSCs in the incisor, although this is not 
definitive from this investigation. If this indication is found to be true this finding 
would further support the notion that the NVB-MSCs play a role only in 
regeneration, while CL-MSCs are the endogenous SCs required for physiological 
lineage differentiation of the continuously growing tooth. 
 
5.2 The determination of mesenchymal stem cell to odontoblast 
lineage 
Validation that the identified endogenous quiescent MSC cell population is made 
up of progenitor cells of the odontoblasts was attempted.  
Initially attempts were made to identify a transgenic mouse line with the option of 
applying an inducible label to the cells specifically expressing quiescent SC 
markers. Unfortunately, there are no existing transgenic mouse strains which 
allow for sensitive and specific tracing of the CL-MSC cells, and so alternative 
options have been investigated. 
Traditional in vivo methods of lineage tracing utilising injected dyes which can be 
visualised after the animals are sacrificed at different time points, was not 
possible due to limitations in licencing, funding and time available for animal work. 
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However, utilising an organ culture model, mouse incisors can be extracted and 
maintained in vitro. At pre-eruption and post-eruption aged mice, microinjection 
of explanted incisors was attempted. CM-DiI injections into the CL region were 
performed to label the mesenchyme in this area. After 7 days the location of the 
dyed cells was analysed through fixation, sectioning and fluorescent imaging of 
the samples. Upon analysis, no tracing was able to be visualised. The fluorescent 
signal retention of cells stained with this dye is reported by the manufacturer as 
“>72 hours”, while it may remain stable longer, it is likely that by 7 days this dye 
was no longer detectible in this preliminary experiment. The lack of visualisation 
is likely to also be compounded by the fact that maintaining the sample in organ 
culture for this length of time may have had a negative impact on the integrity of 
the tissues. Due to the unstable and toxic nature of the dyes, the inaccessibility 
of the tissue, and the issues with maintaining the integrity of this tissue in culture, 
these experiments were largely unsuccessful.  
 
 
Figure 50. Transgenic mice can be used to trace the lineage of incisor mesenchymal stem 
cells to the odontoblast layer 
Schematic explanation of conclusions based upon lineage tracing of endogenous CL-MSCs through 
the use of transgenic mice line 
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In an attempt to circumnavigate these problems transgenic mice were utilised. 
The expression of Cre recombinase under the promotion of Collagen 1 α2 in 
these mice was identified within the CL-MSC region.  
The MTAC region and odontoblast layer both showed no recombinase 
expression. Assessment of the action of Cre was undertaken through the use of 
mice bred from this strain and another strain which carried a region of floxed DNA 
within its genome. By assessing the location of cells with the deletion of this DNA, 
the location of cells which were the progeny of the CL-MSCs (at the time of Cre 
recombinase action) were traced. This data showed that although the deletion 
was most prominent within the MSC region in young mice, as the mice aged a 
greater proportion of the MTAC, and ultimately odontoblasts, carried the deletion. 
This indicates that the CL-MSCs which first acquired the deletion, go on to 
populate the MTAC and later odontoblast regions (Figure 50). 
While this system has been a useful tool to indicate the migration of the CL-MSC 
progeny, it would be preferable to validate this work using inducible transgenic 
mice lines, which could allow direct visualisation of the cells in real time. In 
addition, if this could be better targeted to the CL-MSCs specifically, this would 
allow for more robust assessment of the specific progeny of these cells. 
Unfortunately, neither of these options were available during the time of this 
research. However, the findings of this study do strongly indicate that the CL-
MSC’s progeny go on to populate the MTAC and odontoblast regions. 
While CL-MSCs of the mouse incisor produce progeny, which populate the 
odontoblast region, it is not clear from the lineage tracing if these cells are 
functional odontoblasts. The ability of CL-MSCs to produce mature odontoblasts 
was assessed through the utilisation of an in vitro culture model. By resecting the 
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CL-MSC containing mesenchyme and culturing it on devitalised dentine, 
explanted cells were able to adopt an odontoblast like morphology, sending 
protrusions into the existing dentine tubules. Furthermore, the cells were able to 
produce mature odontoblast marker proteins, DMP1 and DSP. This together 
indicates that the CL-MSC containing incisor mesenchyme has the ability to 
differentiate into mature odontoblasts.  
In order to be certain that it is the CL-MSCs themselves, and not other 
mesenchymal cells from within the resected tissue, that are producing these 
odontoblast-like cells, further work may be required. Work undertaken in the 
research group of Dr Bing Hu at the University of Plymouth, by other researchers 
in the group, has shown that extracted CL-MSCs, cultured from the resected 
tissue are also able to produce the morphology and expression pattern of 
odontoblast-like cells when grown on devitalised dentine (Walker et al., in review). 
Therefore, it is strongly suggestive that the CL-MSCs are the cells responsible 
for the observed effect in this study. 
 
5.3 The development of in vitro model systems to investigate the 
molecular mechanisms which mediate mesenchymal stem cell and 
transit amplifying cell maintenance and transition 
Further investigation into the role of Dlk1 in regulating dental mesenchymal cells 
required the development of appropriate in vitro systems. Primary cells can be a 
valuable tool when understanding the behaviours of cells. The fact that the cells 
are not artificially immortalised makes modelling their cell cycle potentially more 
relevant to the in vivo situation (Kaur and Dufour, 2012). However, this advantage 
has a corresponding disadvantage, the cells are not immortalised and therefore 
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cannot be passaged indefinitely. A similar boon/burden situation arises when 
considering the purity of the cells. In primary cell cultures, a mixed population of 
all cell types can potentially grow from the tissue (Stockholm et al., 2007). This 
can be a benefit, as it more closely resembles the in vivo environment and could 
provide additional growth factors, which the cells of interest require. The 
downside of this, is that any molecular samples collected from the cultured cells 
will be the combined molecules from all cell types, which may mask the molecular 
situation of the cells of interest.  
In this study, an incisor mesenchymal cell primary culture was undertaken. In 
order to address the issue of mixed population growth, cells were cultured under 
permissive conditions to encourage the cell type of interest to thrive. Through a 
combined approach of coating the cell culture surface with a molecule known to 
encourage mesenchymal cell adherence and providing a culture medium which 
favours non-epithelial cell growth, mesenchymal cells were selected for (Somaiah 
et al., 2015). Analysis of the molecular signature of the cells within this system 
showed that the cells were indeed mesenchymal in their phenotype. The 
longevity of these cells was minimal, with growth stalling profoundly after passage 
6. It was also noted that the cells did not readily survive the freezing and thawing 
process. Consequently, cells were used at low passages and always from fresh 
batches of cells. This has an inherent limitation, that each batch of cells was 
produced from a different litter of mice and therefore had a fair degree of genetic 
variation. However, repeated experiments did show similar results and 
reproducibility. This cell culture model was synchronised into a quiescent MSC-
like state through serum starvation. Replenishment of the serum was also 
sufficient to encourage the cells to adopt a more MTAC-like phenotype and 
expression profile. Unfortunately, these cells were not very robust. Manipulation 
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of the cells through the use of recombinant proteins, small molecular inhibitors 
and plasmids, caused the cells to lose integrity and degenerate. An alternative 
model was required to investigate the molecular mechanisms which underpin the 
regulation of these cells in vivo. 
Established cell lines are able to circumvent many of the pitfalls which can occur 
when using primary cells (Geraghty et al., 2014). However, they are not without 
their own issues. Chiefly, cell lines tend to be robust and have almost limitless 
mitotic potential. While they are often not as phenotypically similar to their original 
source tissue (and may acquire genetic alterations with time), established cell 
lines can be made from many organs and so can model tissue specific events. In 
this study, immortalised dental pulp cells were utilised. These cells were able to 
be synchronised into a state of quiescence in order to mimic quiescent MSC-like 
dental cells. This model allowed for the investigation of molecular mechanisms 
as the cells were robust and able to withstand an array of manipulation 
techniques. 
 
5.4 The maintenance and transition of mesenchymal stem cell and 
transit amplifying cells, the role of Notch signalling 
Having identified and characterised an endogenous quiescent CL-MSC pool 
within the murine incisor, understanding the molecular mechanisms which 
regulate the ability of MSCs to self-renew and to differentiate was a key aim of 
this work.  
The number of active TACs directly influence and define the number of TDCs 
within a tissue. Insufficient activation of SCs results in insufficient TAC 
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populations and ultimately a failure of tissue replenishment (Chen et al., 2012b). 
However, overactivation of SCs can result in an exhaustion of the pool of 
available cells (Scheller et al., 2006). Therefore, fine regulation of this activation 
process throughout the lineage is imperative for proper functioning and 
maintenance of the tissue.  
The identification of Notch receptors being utilised differentially between the CL-
MSC and MTAC regions led to the investigation of Notch ligand expression 
pattern differences within the mouse incisor. Through the use of transgenic 
mouse lines with altered Notch pathway gene expression within the incisor 
mesenchyme, an important role for Notch signalling was reinforced.  
In mice which are conditionally deficient in RBP-Jκ, the dentine displays an 
abnormal phenotype. Further investigation of this mouse line revealed that the 
odontoblasts were disorganised and appeared to be prematurely differentiated. 
Clearly canonical Notch signalling is an important signalling pathway in regulating 
the lineage and differentiation of the CL-MSCs of the incisor mesenchyme. A 
similar dentine phenotype has been observed in the Dlk1 KO mice. Whereby 
apparent precocious differentiation occurred, resulting in an aberrant dentine 
structure being seen. 
Within mice deficient of Dlk1, the MTAC region was reduced in volume. Therefore, 
it is likely that the LCM regions captured were more greatly diluted by cells from 
outside of the targeted population. This is a probable reason for the apparent 
similarity between the expression profiles of the MTAC and CL-MSC sample. 
Nonetheless, it was clear that the MTAC region is diminished in the absence of 
Dlk1, thus indicating a potential loss of SC to TAC transition, a loss of MTAC 
maintenance or a combination of both of these factors.  
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The preliminary investigation of the Dlk1 Tg mice, in which Dlk1 was over 
expressed within the incisor mesenchyme, showed signs of MTAC pool 
exhaustion. This suggests that while some Dlk1 is required for MTAC 
maintenance, too much can cause over proliferation of these cells and 
subsequent reduction of MTACs from the tissue. Further investigation of these 
mice at a range of ages may illuminate how this phenomenon develops within 
these mice. However, during the time of this study such mice were unavailable. 
This study has found that Dlk1 is expressed most strongly within the MTAC region. 
However, it’s function on MSC-like and MTAC-like cells in culture indicate that it 
may have different modes of action on these cell types. In vitro bound Dlk1 
appears to encourage mesenchymal cells to lose their MSC-like properties, 
indicating a role for bound Dlk1 in encouraging MSC to MTAC transition. 
Meanwhile, soluble Dlk1 protein added to the cells seems to encourage a greater 
adoption of MTAC-like marker expression. Together this data suggests that Dlk1, 
whether bound or soluble, is sufficient to encourage the shift of mesenchymal 
cells to a more MTAC-like state and a maintenance of this new state.  Conversely, 
the inhibition of Dlk1 through the use of siRNAs in cultures containing proliferative 
cells, revealed that Dlk1 is necessary for the maintenance of the MTAC-like state 
of these cells. In vivo Dlk1 is likely to function differently both due to differences 
in presence of the soluble or membrane-bound form of the protein, but also in 
terms of different receptor availability. 
Although Dlk1 has been long identified as having a role in BMSC differentiation 
in adipogenesis (Sul, 2009), no established specific Notch receptor for Dlk1 has 
been identified. In this study, Notch2 was found to be expressed in a similar 
pattern throughout the incisor mesenchyme to Dlk1, indicating a potential link 
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between them. Furthermore, a striking increase in Notch effector Hes5 has been 
observed in the MTAC region. If a Dlk1>Notch2>Hes5 axis is present within this 
tissue, it may indicate a potential pathway which could be explored further.  
It is clear from this study together that Notch signalling plays an important function 
in MSC and MTAC lineage differentiation, activation and maintenance. 
Furthermore, physiological levels of Dlk1 are inextricably involved in the 
maintenance of MTACs and in prevention of precocious differentiation of this 
lineage. 
Additional Notch pathway findings identified in this study, which have not been 
fully investigated here, include the clear spatial restriction of Jag1 and Jag2 
expression within the CL epithelium. Both the MTAC and CL-MSC regions directly 
contact the CL epithelium. Many signalling pathways have been implicated in the 
epithelial-mesenchymal crosstalk of the incisor tooth (Kettunen et al., 2000, Balic 
and Thesleff, 2015). The clear localisation of Notch ligands within the CL 
epithelium, and the observed differences in Notch signalling between the MTAC 
and CL-MSC regions would make further investigation of this potential epithelial-
mesenchymal interaction an attractive and, obvious, next step following this work. 
 
5.5 The epigenetic regulation of markers and modifiers of 
mesenchymal stem cell and transit amplifying cell maintenance 
In addition to the main aims set out prior to undertaking this study, an interesting 
avenue of investigation into epigenetic regulation within the incisor tooth 
mesenchyme arose during the course of the project. Two molecules which 
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showed promise as important regulators of maintenance and transition within the 
cell lineage of interest, have strong links to epigenetics.  
Dlk1 is a gene which has long been known to be heavily epigenetically regulated. 
Having been identified as residing within a maternally imprinted locus, the CpG 
islands around the Dlk1 gene are a prime target for epigenetic regulation 
throughout the life of a cell. Histone methylation marks are often used to identify 
regions of chromatin which are repressed. In this study, such marks were 
identified adjacent to the CpG islands of Dlk1 in starved (but not proliferative) 
cultured dental pulp cells. This highlights that epigenetic marks are in place in 
these MSC-like cells, indicating that Dlk1 expression may be influenced 
epigenetically. 
The notion that CL-MSC and MTACs may be utilising epigenetic regulation to 
modulate the phenotype of the two populations is also supported by the 
differential expression of known epigenetic regulatory protein SmarcA2. SmarcA2, 
a quiescent MSC marker gene, displayed strong expression within the CL-MSC 
region of the murine incisor. This molecule is an important chromatin remodeller 
(Tang et al., 2010). The expression of SmarcA2 within the CL-MSCs indicates a 
potential role for this form of epigenetic modulation to be regulating the behaviour 
of the cells. Indeed, when SmarcA2 was inhibited in MSC-like cells in culture, 
using siRNAs, the cells upregulated the expression of a number of genes which 
were formerly downregulated. These treated cells also grow to cover a greater 
proportion of the culture surface. Together indicating that SmarcA2 may have 
been necessary in the repression of MTAC-like phenotype in the CL-MSCs, thus 
ensuring the maintenance of the MSCs in a quiescent state. 
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The transcription of SmarcA2 itself is regulated between the CL-MSC and MTAC 
region.  
 
The lack of expression within the MTAC region indicates a strong inhibition of 
transcription here. In order to begin to address which molecules and pathways 
may be responsible for the alternate expression patterns within the CL-MSC and 
MTAC regions, the promoter region of SmarcA2 was investigated. Interestingly, 
there are many RBP-Jκ potential binding sites within the promoter region of 
SmarcA2. Preliminary ChIP experiments revealed that the RBP-Jκ protein does 
 
Figure 51. A postulated mechanism for the regulation of the mouse incisor mechanism 
Schematic explanation of conclusions based upon the findings of this study. In addition to further 
questions which are open to further investigation, in order to better understand the molecular 
mechanisms with underpin this complex tissue. 
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bind to many of these sites within cultured dental pulp cells. This combined with 
the knowledge that RBP-Jκ has been shown to interact with SmarcA2 protein 
itself (Schwanbeck, 2015), indicates the potential for a feedback loop whereby 
RBP-Jκ regulates SmarcA2 expression levels, and also acts in conjunction with 
the SmarcA2 as an epigenetic regulator itself. Moving forward from here, the 
effect of synchronising these cells on the binding state of these sites is now being 
investigated by colleagues at The University of Plymouth. 
The postulated mechanism or regulation within the mouse incisor mesenchyme 
(Figure 51) requires further investigation in order to determine if, and how RBP-
Jκ regulates cell behaviours within this model. The high expression of other Notch 
ligands within the epithelial tissue of this organ may also have a bearing on the 
function of RBP-Jκ, thus creating a complex inter tissue regulatory network. 
 
5.6 The potential clinical impact of the molecular mechanisms which 
underpin mesenchymal stem cell regulation being utilised 
therapeutically 
This study has investigated the role of Dlk1 in regulating the endogenous MSCs, 
and their progeny, in the incisor. While this may add to the body of knowledge 
regarding the maintenance and activation of MSCs generally, the translational 
applications would require a great deal more study. Within the human dentition 
there are no continuously growing teeth similar to the mouse incisor. However, 
there are known pools of reactive DPSCs. This study has shown that Dlk1 is a 
potent regulator of murine incisor MSCs and their progeny, the effect of Dlk1 on 
DPSCs in non-continuously growing teeth, however, is largely unknown. In order 
to model human dental injury and repair under the influence of Dlk1, a rat model 
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was utilised. Wounds were made in the rat molar teeth which were either treated 
with a hydroxyapatite based capping substance, or with the same substance 
impregnated with Dlk1. In the Dlk1 treated teeth, there was a greater level or 
osteodentine deposition, indicative of enhanced repair mechanisms. It is 
presumed that the Dlk1 protein is acting upon reactive DPSCs within the tooth to 
create this enhanced repair. While further investigation is required, it is 
encouraging that Dlk1 may be a simple additive which could be used in 
conjunction with traditional dental materials to enhance dental repair. Dental 
injury and its treatment is a costly and laborious affair, which when handled 
inappropriately can lead to tooth loss which impacts quality of life for the patient. 
If the process of repair and healing following dental injury can be accelerated, it 
would be a great boon for patients and health care providers alike. 
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6 Conclusions 
Within the CL-MSC region identified by this work, Notch signalling plays a role 
in the molecular regulation of the cells. As outlined in the initial aims, a novel 
CL-MSC population has been found to exist within the mouse incisor 
mesenchyme. The CL-MSC and MTAC regions exhibit different quiescent MSC 
marker gene expression profiles. Strikingly, the Notch effector Dk1 is also 
differentially expressed, with an increased level of Dlk1 protein within the MTAC 
region. In vivo modulation of the Notch pathway results in aberrant incisor 
development, indicating the important role of this pathway in dental 
mesenchymal cell function. In vitro manipulation of this same pathway further 
supports the role of Notch signalling in maintenance and transition of the cells of 
the CL-MSC and MTAC regions. Although investigation of the translational 
applications of these findings is still at a preliminary stage, it appears that Notch 
effector Dlk1 may exert an effect on the cellular behaviour of wounded dental 
pulp during regeneration. 
Specific conclusions are as follows: 
 
6.1 There is a novel endogenous mesenchymal stem cell region in the 
incisor tooth  
Within the murine incisor a distinct region of MSC containing cells has been 
identified. This region presents a quiescent MSC-like marker signature, both in 
terms of mRNA and protein expression. This region is geographically and 
phenotypically distinct from the known region of MTACs and the region of NVB-
MSCs within the incisor mesenchyme. 
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6.2 Notch signalling molecules are expressed at different levels 
between the distinct mesenchymal regions 
The MTAC region highly expresses Notch2 and Notch ligand, Dlk1. These 
markers are expressed much less within the MSC region. Furthermore, the MTAC 
region displays a greater level of Notch2 activation. The differences in Notch 
pathway expression and activation between the CL-MSC and MTAC regions, 
indicate alternate utilisation of this pathway between the two cell populations. 
 
6.3 The endogenous mesenchymal stem cell region can give rise to 
odontoblasts 
Through in vivo lineage tracing of cells from the CL-MSC region, their progeny 
has been traced to the MTAC and odontoblast regions within the mouse incisor. 
Further in vitro assays revealed that tissue containing the CL-MSC region is 
capable of forming odontoblast like cells (both in terms of their morphology and 
their expression profile) when in contact with dentine. This together indicates the 
potential ability of MSCs to give rise to odontoblasts. 
 
6.4 Mesenchymal stem cell to transit amplifying cell transition can be 
modelled in vitro 
Utilising both primary cell culture and established cell lines, the MSC and MTACs 
of the incisor mesenchyme have been successfully modelled. These cells can be 
manipulated into a quiescent MSC-like state or encouraged to proliferate and take 
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on an MTAC-like phenotype. This cell model has then been successfully 
employed to investigate the role of specific molecules in regulating the behaviour 
of MSC-like and MTAC-like cells. 
 
6.5 Modulation of Notch pathway activity regulates the maintenance 
and transition of mesenchymal stem cells and transit amplifying cells 
Phenotypic analysis of RBP-Jκ conditional knock out mice, revealed that 
canonical Notch signalling is an important regulator of the dental mesenchymal 
cell lineage which gives rise to the odontoblasts. Analysis of Dlk1 overexpressing 
mice and Dlk1 knock out mice, revealed that Dlk1 is a vital molecule which 
regulates the MTACs maintenance and transition. 
In vitro investigation went on to further identify that Dlk1 is necessary for the 
maintenance of an MTAC-like phenotype. Furthermore, Dlk1 is sufficient to 
induce an MSC to MTAC-like transition in cultured dental mesenchymal cells. 
 
6.6 Notch ligand, Dlk1, may be epigenetically regulated within the 
incisor mesenchyme 
The Dlk1 gene is located within a region of chromatin which is highly 
epigenetically regulated. Between MSC-like and MTAC-like cells there is a 
significant difference in the levels of epigenetic markers around the Dlk1 locus. 
Thus, indicating an epigenetic regulation of the expression level of Dlk1 difference 
between CL-MSC and MTACs in the incisor tooth. 
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6.7 Notch pathway ligand, Dlk1, can promote dentine reparation 
following injury 
The addition of Dlk1 to the dental material used to cap wounded teeth, enhanced 
the levels of osteodentine deposition and repair in damaged rat molar teeth. The 
enhanced osteodentine deposition indicates an activation of DPSCs within the 
tooth, further supporting a regulatory role for Dlk1 in dental stem cells generally. 
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